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ABSTRACT
Lower airway disease (LAD) of the training Thoroughbred horse is characterised by 
poor performance and excess mucus and pus in the trachea. This condition, although 
often referred to as ‘the virus’, is significantly associated with Streptococcus 
zooepidemicus and Actinobacillus/Pasteurella species without evidence of viral 
infection.
The degree of antigenic variability in these bacteria was assessed, to judge the number
of strains that might be required in future vaccines. Particular attention was paid to
• • •
the putative virulence determinants of the M-like protein and capsule of S. 
zooepidemicus and the iron regulated proteins (IRPs), produced only in low available
iron concentrations, of Actinobacillus equuli. '  * ' ,
■ -V-!-
A range of Actinobacillus/Pasteurella species were isolated from the lower airway of 
horses, but more than half were accounted for by A.equuli. A. equuli bound and 
utilised equine holotransferrin for growth. The constitutive proteins of A. equuli were 
antigenically cross-reactive, but IRPs were more antigenically varied. Vaccines 
based on interference of IRPs would be likely to need more than one strain of A. 
equuli.
Hot acid extracts of S. zooepidemicus were antigenically cross-reactive, but there was 
less opsonogenic cross-reactivity in horse blood containing natural antibodies than 
rabbit antisera to extracts. A vaccine based on M-like protein would be likely to need 
more thah one type of S. zooepidemicus, but no relationship could be found between 
ribotype / antigenic profile and opsonogenic behaviour, suggesting that M-like protein 
is not necessarily the principal anti-phagocytic mechanism for these isolates, at least 
in vitro. •
s. zooepidemicus produces a hyaluronate capsule thought to be a virulence 
determinant, which is tightly bound by a protein (HAP). Immunisation with 
recombinant HAP significantly increased survival time and clearance of bacteria in 
mice challenged intraperitoneally with S. zooepidemicus. Recombinant HAP may 
have acted as a surrogate antigen for the capsule.
Introduction of bacteria into ponies intratracheally produced a dose response for S. 
zooepidemicus and A. equuli. However, so much intercurrent infection developed 
(due to S. zooepidemicus and Bordetella bronchiseptica) it was concluded that 
conventional ponies would be unsuitable for sttaightforward studies of vaccine 
efficacy in response to experimental challenge. Alternative ways forward are 
discussed.
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SUMMARY
Lower airway disease (LAD) of the training Thoroughbred horse is characterized by poor 
performance and excess mucus and pus in the trachea. This condition, although frequently 
referred to as “the virus”, is significantly associated with Streptococcus zooepidemicus and 
Actinobacillus/Pasteurella species without evidence of viral infection.
The objective was to assess the degree of antigenic variability in these bacteria to judge the 
number of strains that might be required in future vaccines. Particular attention was paid to 
the putative virulence determinants of the M-like protein and capsule of S. zooepidemicus 
and the iron regulated proteins (IRPs), produced only in low available iron concentrations, 
of Actinobacillus equuli.
More than half (52.1%) of the tracheal wash isolates originally characterized as 
Actinobacillus/Pasteurella species involved were identified as A. equuli, 18.3% were
Actinobacillus suis -like, 12.7% were Pasteurella pneumotropica, 8.5% were
Actinobacillus ligniersii , 7.0% were Pasteurella haemolytica and 5.6% were P. mairii, 
suggesting that a range of Actinobacillus/Pasteurella species can be isolated from the lower 
airway of horses, but more than half are accounted for by A.equuli.
All isolates cultured from cases of LAD were selected on the basis of their temporal and 
geographical separation. In iron limited media, all isolates bound and utilised equine 
holotransferrin for growth, but not iron bound to rabbit transferrin, human transferrin, or a 
number of other equine iron carrying proteins. The constitutive proteins of A. equuli were 
antigenically cross-reactive, but IRPs were more antigenically varied. Vaccines based on 
interference of IRPs would be likely to need more than one strain of A. equuli.
Hot acid extracts of S. zooepidemicus were antigenically cross-reactive, but there was less 
opsonogenic cross-reactivity in horse blood containing natural antibodies than rabbit 
antisera to extracts. A vaccine based on M-like protein would be likely to need more than 
one type of S. zooepidemicus, but no relationship could be found between ribotype /
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antigenic profile and opsonogenic behaviour, suggesting that M-like protein is not 
necessarily the principal anti-phagocytic mechanism for these isolates, at least in vitro.
S. zooepidemicus produces a hyaluronate capsule thought to be a virulence determinant, 
which is tightly bound by a protein (HAP). Immunisation with recombinant HAP 
significantly increased survival time and clearance of bacteria in mice challenged 
intraperitoneally with S. zooepidemicus. Recombinant HAP may have acted as a surrogate 
antigen for the capsule.
Ponies were selected for challenge at the place of supply on the basis of their limited serum 
antibody to IRPs or M-like proteins for the strains under study. After transport to Home 
Office designated premises and following introduction of 10*°, 10’ and 10® cfu 
intratracheally, a dose response for S. zooepidemicus and A. equuli was observed in 
severity of clinical observations and gross pathology at post mortem examination, 3 or 4 
days after infection. However, so much intercurrent infection developed (due to S. 
zooepidemicus and Bordetella bronchiseptica ) it was concluded that conventional ponies 
would be unsuitable for straighforward studies of vaccine efficacy in response to 
experimental challenge. Alternative ways forward are discussed.
ward, u. 199/
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13 PREFACE TO THE INTRODUCTION
The anatomy, physiology, cytology, defence mechanisms and bacterial flora will be
outlined in the healthy equine respiratory tract. The diagnosis and aetiology o f  airway 
disease in the equine will be reviewed, then a more detailed review o f bacteria and 
vaccination will be made. Throughout the introduction, comparisons with other 
respiratory diseases in other species will be drawn and differences contrasted where they 
might throw light on the equine disease. Respiratory disease in the horse and particularly 
the discovery that Streptococcus zooepidemicus and Actinobacillus/Pasteurella are 
associated lower respiratory tract infections (LRTIs) will be examined in detail. The 
biology o f S. zooepidemicus and Actinobacillus/Pasteurella infections and their involvement 
in other equine and mammalian diseases will be reviewed. The vaccination strategies used 
for other infectious agents will be assessed as they might relate to equine bacterial LRTIs. 
Gaps in our knowledge o f S. zooepidemicus and Actinobacillus/Pasteurella in relation to 
immunity in the horse will be identified to help prepare the objectives o f the study.
18
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1.3 INTRODUCTION
1.3.1 The equine respiratory tract - in health
1.3.1.1 Anatomy and physiology
The lungs and the passages through which air passes to and from the lungs comprise the 
respiratory tract. The main function of the lungs are to supply inspired air containing 
oxygen, for metabolism by the tissues and to remove metabolic carbon dioxide via the 
bloodstream (Derksen, 1991).
The nose is divided internally into two vestibules (where the nasal mucosa begins), leading 
to the larger nasal cavity from which diverticula called paranasal sinuses extend. The nasal 
cavity is divided by the nasal septum and mucosa covered turbinate bones (conchae) 
protmde from the dorsal and lateral walls into the cavity interior, which warm, humidify 
and filter the inspired air. The lower compartment of the equine pharynx is divided into the 
oropharynx, which extends to the epiglottis ^ d  is surrounded by tonsillar tissue, and the 
laryngopharynx, which narrows down to the oesophagus. The laryngbpharynx connects 
with the tracheobronchial tree. The laryngeal mucous membrane contains many mucous 
glands and lymphoid aggregations. The trachea and bronchi form a continuous tube held 
open by rings of cartilage, which connects the larynx with the lungs. The trachea extends 
from the larynx and bifurcates above the heart. It lies close to major blood vessels and their 
tributaries, the oesophagus and mediastinal lymph nodes. The structure of the large bronchi 
are very similar to the trachea but on smaller bronchi, the cartilage rings are gradually 
replaced by irregular plaques, eventually becoming bronchioli, which are small enough to 
be kept expanded by air pressure in the respiratory tree. The left lung has cramai and caudal 
lobes^ and partly due to the position of the heart, is slightly thinner than the right lung in the 
horse, which also has an accessory lobe at its base. The pulmonary artery and pulmonary 
vein combine with the chief bronchus, and division of the artery corresponds to the bronchi. 
Lymph associated with the equine airway drains to small pulmonary nodes, then to larger 
tracheobronchial lymph nodes (Dyce et al. 1996).
14
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The bulk movement of air into and out of the respiratory tract, or ventilation (Murray,
1986), is matched with metabolic rate by the respiratory centres in the brain stem, which 
uses receptors to coordinate the muscles controlling breathing (Berger, Mitchell & 
Severinghouse, 1977). Breathing is achieved by the movement of the diaphragm and 
intercostal muscles, which exert a driving pressure to overcome pulmonary elastic recoil, 
airflow resistance and inertial forces such that air enters the lung. Exhalation is passive in 
most animals, but the horse uses abdominal muscles to further decrease lung volume, once 
residual capacity is reached.
The volumes of air involved in breathing are less than the tidal volume of the lungs because 
as much as 70% in the horse at rest is used to ventilate the conducting airways, leaving 
approximately 30% for ventilation of the alveoli (Derksen et a l  1982). Much of the 
airflow resistance is due to the upper airway (Robinson & Sorensen, 1978). Exercising 
horses i n e r t e  the airflow through the upper airway from approximately 4L/sec at rest to 
more than 75L/sec (Derksen, 1991). Cardiac output and pulmonary artery pressure also 
increases markedly in the exercising horse; the pulmonary circulation comprises an 
extensive capillary network, which delivers blood to the alveoli for gaseous exchange (Fung 
& Sowbin, 1969). Gravity ensures that the dorsal region receives less blood tlian the ventral 
lung mass (Amis, Pascoe & Homof, 1984) and the air pressure in the dorsal lung region of 
the horse is sub-atmospheric (Derksen & Robinson, 1980) resulting in preferential 
ventilation of the ventral regions.
1.3 1:2 Airwav defence mechanisms
The single layer of epithelial cells is needed for gaseous exchange between inspired air and 
the bloodstream, the surface is more susceptible to allergens, infectious, chemical and 
physical agents than the hard, dry multilayered skin covering most of the body surface. The 
horse lung for example, has more than 2000 m^ of surface exposed to the external 
environment to allow enough gaseous exchange surface for metabolic needs (Gehr et al.
15
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1981). These surfaces are protected by both mechanical and immunological defence 
mechanisms.
The turbinates inside the nasal cavity cause turbulence that may direct aerosol particles onto 
their mucus covered walls, where they can stick. Mucus comprises a viscoelastic gel layer 
mainly of associated glycoproteins and proteoglycans, which traps particles, and a sol layer 
which also contains lipids (Coles et a l  1984). The serous sol layer is produced in the 
terminal bronchioles and alveoli, probably in part by Clara cells (Widdicombe and Pack,
1982). Goblet cells in the bronchioles, trachea and upper respiratory tract (URT) secrete the 
viscous gel layer over the sol layer, which is protected from dessication. The gel layer is 
continuous in the central airway, whilst rafts may float on the sol layer in the distal airways 
(Iravani & Melville, 1976). If the sol layer is thickened, clearance of mucus is retarded 
(Dalhamn, 1956), so airway fluid balance, regulated by sodium chloride absorption and 
secretion, is probably cmcial to health (Frizzel, 1988).
Ciliated cells, mucus secreting cells, sub-epithelial uni- and multicellular mucus glands with 
associated myoepithelial cells, line most of the upper respiratory tract and the tracheal wall. 
Mechanical stimulation is thought to control mucus production (Sleigh, Blake & lison , 
1988). Increased mucus secretion is caused by parasympathetic stimulation 
(Nadel, 1981), which in turn stimulates ciliary motility (Satin & Derksen, 1985). 
Myoepithelial cells aid the movement of secretions into the airway from secretory cells 
(Nadel, Davis &Phipps, 1979), to provide a protective mucous covering which is moved 
towards the pharynx by cilia, which coordinate their action with cilia on adjacent cells. 
Cilia are microtubular structures of 5-6pm long, with 3-7 25-35 nm long claws at the tip; 
there are approximately 200 cilia per cell. Cillia are powered by hydrolysis of ATP, which 
enables an outer microtubule to slide along the inner microtubule of an adjacent pair, which 
when coordinated with other adjacent pairs, results in cilliary bending (Greenstone and 
Cole, 1985; Satir, 1974). Particles can be trapped in the mucus, which is transported by 
cilia to the pharynx and then swallowed (Sleigh, Blake & Lison, 1988). Cilia propel fluids 
of certain composition by asymmetric cyclic movements, where when fully extended, the tip
16
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passes through the sol layer and contacts the gel layer above. In human infants, it has been 
suggested that the immature ciliary apparatus leads to inefficient removal of bacteria and 
inflammatory debris (Koterba, 1991), and impaired ciliary motion is thought to predispose 
adult humans (Afzelius, 1979), and dogs (Killingsworth, Slocombe & Wilsman, 1987) to 
infection.
Airborne particles smaller than 0.5pm tend to remain in suspension so are exhaled (Brain & 
Valberg, 1979). If particles manage to bypass the mechanical mucociliary host defences 
(typically 0.5-10pm in size), they can be phagocytosed by alveolar macrophages, then 
digested, or macrophages can migrate to the mucociliary escalator once particles have been 
successfully ingested, where they are transported to the pharynx and are eliminated, (Brain, 
1985). Some penetrate alveolar epithelia and are removed by the lymphatic system. 
Macrophages have a long life in lung tissue, are capable of synthesizing large quantities of 
enzymes and show chemotactic behaviour. Lysosomal enzymes and an oxygen dependent 
antimicrobial system are the killing mechanisms, although some macrophages produce 
reactive nitrogen intermediates for which the functions are uncertain. The cell surface has 
Fc and complement receptors to enable attachment to opsonised particles. Neutrophils are 
also chemotactic and have the ability to move through tissues to sites of infection, where 
they phagocytose opsonised particles very rapidly, but they are short lived. They contain 
different lysosomal enzymes to macrophages and an equivalent but different oxygen- 
dependant antimicrobial system. Eosinophils are less effective at phagocytosis and killing 
microbes generally, but are effective at removing immune complexes and killing parasites. 
Their granules distinctly contain inflammatory mediator blockers. T lymphocytes 
differentiate to release lymphokines in the course of the cell mediated response, whilst B 
lymphocytes are stimulated to differentiate into antibody secreting cells.
Immunological surface protective mechanisms against bacteria that give resistance to 
disease primarily involve antibody and complement. For example, convalescent sera of 
lambs challenged with P. haemolytica (Sutherland, 1988) show complement dependent 
antibody mediated killing. Specific antibody can be generated by prior exposure to antigen.
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If the animal has mucosal memory cells from prior exposure to antigen, many will be 
stimulated to produce antibody producing a greater response with a shorter time lag and 
minimizing host cell damage. Even if antibody levels are undetectable, there can be enough 
mucosal memory cells to generate an accelerated response. Secretory IgA is produced by B 
lymphocytes distributed throughout the lung and the walls of the airway in response to local 
antigenic stimulation. The predominant antibody isotype in the equine upper respiratory 
tract is secretory IgA, whereas the bronchioles and alveoli contain a large proportion of IgG 
(Mair, Stokes and Bourne, 1987), which is probably secreted through tight junctions in the 
airway epithelia. There are intermediate concentrations of these isotypes in the trachea and 
in serum. The main function of secretory IgA present in mucus is to block adherence of 
bacteria and viruses to the respiratory epithelia, although it can neutralize viruses and some 
viral and bacterial enzymes or toxins. IgG is formed in the body for many years after 
exposure to antigen and opsonises particles, which leads to enhanced phagocytosis and 
removal (Mimms et al, 1995); it is probably only important once inflammation and 
transudation of serum occur (Tizard, 1992). Whilst older aniihals are protected by antibody 
raised by their prior exposure to antigen (active immunity), neonatal foals are only protected 
by passive immune transference of IgG from colostrum. The IgG passes into the circulation 
and tissues and peaks at 48 hours after birth, then declines according to a half life of 
approximately 23 days. Colostrum also contains lymphocytes and complement which may 
have a protective function (Rossdale, 1995).
1.3.1:3 Cvtologv and bacteriology
Alveolar macrophages, along with small numbers of lymphocytes, neutrophils and 
eosinophils, are present in the walls and air spaces of the healthy airway (Derksen et al. 
1985), but a study of Thoroughbred horses in training suggested that macrophages and 
lymphocytes were the predominant cell types, and haemosiderophages were found in 90% 
of cases or more, the presence of which indicates pulmonary haemorrhage or previous 
presence of blood in the airways (Whitwell and Greet, 1984).
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An autopsy study of Thoroughbred and non-Thoroughbred horses found that the lungs are 
normally sterile, or contain low numbers of bacteria which, in the absence of inflammation, 
aie thought to be transient contaminants in the process of being removed by clearance 
mechanisms (Blunden and Mackintosh, 1991). Similar observations have been made for 
cattle (Collier and Rossow,1964). A similar study of healthy horses found that only 8% 
contained organisms of known pathogenicity (Sweeney, Beech and Roby, 1985). These 
bacteria were present in small numbers, so it was suggested that in any study, cultures must 
be quantitated and assessed in relation to the presence of inflammation to determine the true 
significance of a bacterial presence (Mansmann, 1976).
1.3.2 The equine respiratory tract - in disease
1.3.2.1 Diagnosis
Inflammatory disease of the lower airway has clinical signs which vary in severity. These 
range from unexpectedly poor performance on training gallops or in races, to symptoms of 
pneumonia, or pleuropneumonia, which include pyrexia, tachypnea, depression, and varied 
amounts of coughing and mucopurulent discharge. Thickening of the mucosa around the 
entrance to the sinus system may obstruct its drainage, damming back catarrhal exudate 
(Dyce et a l  1996). During a fast gallop, the horse on average breathes in and out twice per 
second, so the slightest thickening of the trachea, or increase in exudate has the capacity to 
reduce performance enormously (Art and Lekeux, 1989). Bacterial lower airway disease 
(LAD) involves bacterial colonization of the lung, which can develop into pneumonia and / 
or pulmonary abscess formation and subsequent extension to the pleura, leading eventually 
to pleural effusion. Pneumonia is an inflammation of the lung, whilst pleuropneumonia 
also affects the pleural cavity. Severe infections such as pleuropneumonia Me considered 
uncommon in the United Kingdom (Mair and Lane, 1989), but the more common sub- 
clinical infections are thought to be particularly important in disease transmission (Gordis, 
1996).
Clinical signs are usually noticed as poor performance by the trainer, who calls a veterinary 
surgeon to carry out further investigation. This involves examination of the trachea by
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endoscopy, and collection of a lavage sample via a catheter inserted down the biopsy 
channel, which is then used for routine bacteriological and cytological investigations 
(Whitwell and Greet, 1984; Morris, 1984; Sweeney er a/, 1985,1989,1991). It is assumed 
that isolates cultured represent a mixture of tracheal and lung tissue flora (Hoffman et al. 
1993). Tracheal lavage samples can also be collected by a technique known as transtracheal 
aspiration, which involves aseptic puncture of the trachea, but rare secondary complications 
can occur from transfer of infection upon withdrawal of the needle (Mansmann and Kmght, 
1972). Consequently, it is less commonly used, although its advantage is that it avoids 
contamination of the sample by nasopharygeal organisms collected as the endoscope is 
inserted. The epithelial lining fluid and cells in the alveoli can be sampled using either an 
endoscope or blind tube in a technique known as bronchoalveolar lavage. Bacteria from 
foals can be most easily sampled using this technique, (Hoffman et al. 1993), but it is of 
limited use for diagnosis of non-diffuse lung disease, because only a specific area is lavaged 
and diseased areas stand a good chance of being missed. Consequently, tracheal lavage is 
believed to give a better indicator of the health of the whole lung (Beech, 1991). Cytology, 
along with evaluation of the amount of visible tracheal mucopus, leads to an evaluation of 
the degree of lower airway inflammation (Wood and Chanter, 1994). Nasopharyngeal 
swabs can also be taken at the same time for virology investigation, but bacteriology of the 
nasopharynx is of limited use for lower airway disease diagnosis because bacterial species 
isolated in high numbers from tracheal washes are frequently not cultured in the 
nasopharynx (Wood and Chanter, 1994).
Ultrasonography, radiography and occasionally scintigraphic imaging techniques, lung 
biopsy, and thoracocentesis can also be used to aid tiie diagnosis of respiratory problems, 
although they are not a substitute for sampling for bacteriology, virology, or cytology. 
Radiology is the method of choice if the horse appears normal on ausculation but disease is 
suspected, as may be the case with poor performance syndrome and enables lesions deep 
in the pulmonary parenchyma to be seen, although only lateral films can be obtained. 
However, it is probably a technique confined to specialist centres, because the powerful
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generator required to overcome the size and respiratory motion of the horse make 
equipment non-portable and expensive (Leyland and Baker, 1975). Ultrasonography is 
useful to characterize disease severity, adhesions, pleural thickening, necrosis, compression, 
or atelectasis (Sweeney and Maxson, 1995). Equipment is cheaper and portable, but it is 
the method of choice if the horse is abnormal on ausculation, such as might be heard with 
pleuropneumonia, because it is difficult to see lesions in the normally aerated lung (Reimer, 
Reef and Spencer, 1989). Thoroughbred racehorses with symptoms of poor performance 
typically have small consolidations along the ventral lung margins, visible on ultrasound 
(Rantanen, 1993). Thoracocentesis is indicated when there is evidence of pleural effusion, 
whilst lung biopsies are taken for diffuse interstitial lung disease cases, but the technique 
risks lacerating blood vessels (Raphael and Gunson, 1981).
Whilst these more technological diagnostic tools are helpful, bacteriology is essential as an 
adjunct to differentiate between bacterial lower airway disease and other diseases, such as 
allergic lung disease (Whitwell and Greet, 1984; Wood et cd, 1993; Blunden et cU. 1985).
1.3.2.2 Aetioloev
A survey evaluating losses that occurred in the Thoroughbred industry in the UK and 
Ireland revealed that respiratory problems were a common cause of wastage (Jeffcott et al. 
1982). Further study into why racehorses were unfit for training identified respiratory 
problems as the second largest cause of wasted training days (after lameness) in young 
Thoroughbred horses aged up to four years (Burrel et al. 1985). A more recent study of 
British Thoroughbred horses in training revealed that 27% of clinically normal horses had 
evidence of inflammatory lower airway disease (Sweeney et al, 1993). Although not so 
well documented, similar problems have been identified elsewhere. For instance, a survey 
of the Australian Thoroughbred industry indicated that infectious respiratory disease was 
the main cause of wastage and a scientific study is currently in progress (Equine Research 
News, 1996). Clinical respiratory disease is experienced in the yards of most trainers each 
year and is commonly refened to as “the cough” (Johnson, 1986). Animals with sub- 
clinical episodes of “poor performance syndrome” referred to “as having the virus”,
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describes unexpectedly poor performance during training gallops or in races, of many 
horses in one stable (Mumford and Rossdale, 1982).
The most well documented infectious agents of equine airway disease are viruses; these 
include equine influenza, equine herpes viruses (EHV-1- rhinopneumonitis, EHV-4 and 
EHV-2- cytomegalovirus), equine adenovirus, equine arteritis virus (EAV) and 
Picomaviruses (rhinovirus). An epidemic of equine influenza is generally considered to be 
devastating as it has high morbidity and is highly infectious, but attempts are made to 
vaccinate as many animals as possible against it, using a preparation which is regularly 
updated. EAV is also devastating as it can be veneareally transmitted and cause abortion, 
in addition to being a respiratory pathogen (Timoney and McCollum, 1988), but until 
recently it was not found in the United Kingdom, and the one outbreak was successfully 
contained; there is no vaccine available. Adenovirus causes mild upper respiratory tract 
infections, which are especially common in foals and rhinovirus a mild infection which 
usually requires no treatment (Johnson, 1986; Beech, 1991). EHV has gradually increased 
in the UK since the 1970s, and although it does not cause epidemics, EHV-1 is a particular 
cause for concern, since it can cause neurological disorder, abortion, stillbirth and neonatal 
death; at present there is no effective vaccine. These viral infections can be diagnosed by 
serology and / or virus isolation and it was noticed by some that some equines had signs of 
respiratory disease uncomplicated by viruses.
Bacteria were found to be of greater significance than previously thought, as one study 
isolated beta haemolytic streptococci, Pasteurella spp. and E. coli from in horses with 
pneumonia or pleuropneumonia (Sweeney et al. 1991). Large numbers of a beta 
haemolytic streptococcus, identified as Streptococcus zooepidemicus in another study along 
with,;S. pneumoniae and Actinobacillus/Pastuerella species, were statistically associated 
with inflammatory lower airway disease in young training Thoroughbred horses (Wood et 
al, 1993). S. zooepidemicus had long been thought of as a cause of secondary infection 
following Influenza or Adenovirus infection of the respiratory tract, but in these cases, it 
was uncomplicated by the presence of viruses. Serial episodes of disease in the same group
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of horses commonly involved these bacteria. Recent work confirmed the association of S. 
zooepidemicus with LAD in Thoroughbred horses, but showed that S. pneumoniae and 
Pasteurella species were less significantly associated with LAD than originally thought. It 
was calculated that Thoroughbred horses in training aged between two and three years old 
spend approximately 33% of their time in training with LAD, which could impair 
performance and has considerable welfare implications. Two year olds were found to be 
most affected, the implications of which are important for the racing industry since this is 
when horses have to prove their ability (Burrell et al. 1996). A study comparing the 
winnings of horses with a history of bacterial LAD to those with none suggested that beta 
haemolytic Streptococcal infections did influence performance (Bernard et al. 1991).
LAD most commonly manifests itself as poor performance because the horse at a fast gallop 
of 150 strides per minute takes less than half a second per breath, so if compromised by 
small increases in mucus production, or thickening, breathing and hence performance may 
be impaired (Oikawa et al. 1994). Although the disease is classified as “poor 
performance syndrome”, this is a relatively rmld form of disease, of which pneumonia and 
pleuropneumonia are related and much more severe. A. equuli and a beta haemolytic 
Streptococcus have been isolated together from cases of pleuropneumonia with pleural 
effusion (Sweeney and Maxson, 1995), confirming that lower airway disease involving 
these particular bacteria may vary in severity. Several uncontrolled field studies confirm 
these findings, that 6 haemolytic streptococci (most of which are likely to be S. 
zooepidemicus ), S. pneumoniae and pasteurella sp. or actinobacillus sp. are commonly 
isolated from tracheal washes (Sweeney et al. 1985,1989,1991). Recent evidence 
suggested that Mycoplasma felis and Mycoplasma equihirinis were also associated wiÜi 
equine lower airway disease (Wood cr a/. 1994, 1996), but S. pneumoniae was associated 
with inflammation of the upper airway (Wood, 1996). Mycoplasma spp. have been isolated 
from the respiratory tract of both diseased and clinically normal horses before (reviewed by 
Beech and Sweeney, 1991), but until now, its association with disease has been unknown. 
Disease was defined as an increase in the amount of mucopus visible during endoscopy, an
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increased proportion of neutrophils and a nucleated cell count of over 1000 per ml in the 
tracheal wash (Whitwell and Greet, 1984).
A number of other bacterial species have been associated with the equine respiratory tract. 
Investigations suggest that LAD is common in Thoroughbred foals as well as young horses 
in training and is likely to have a bacterial aetiology (Hoffman et a l  1993). Rhodococcus 
equi causes pneumonia with a mortahty rate of up to 80% (Ellissalde, Renshaw and 
Walberg, 1980; Ellenberger and Genetzky,1986), but it is uncommon in the U.K. 
Bordetella bronchiseptica has long been known as a cause of respiratory illness in dogs and 
swine, and has more recently been recognized in horses with signs of respiratory disease. It 
was cultured from nasal discharge (Gallagher, 1965; Vandevemme et al. 1995), the 
tracheal washes of horses aged 2 years or less, and older horses which had halothane 
anaesthesia in the 7 days preceding. Miller (1965) isolated B. bronchiseptica from a horse 
with conjunctivitis and respiratory infection. The guttural pouch was an isolation site for 
cases of chronic pharyngitis (Noren, 1985) and strangles - like symptoms (Cockram and 
Webb, 1981). Klebsiella spp., Escherichia coli. Staphylococcus spp.. Pseudomonas spp. 
and Nocardia spp. can also been isolated from the respiratory tract, but often with no clear 
association with disease. There are a few species of pathogenic fungi, but they tend not to 
occur much in the U.K.; Aspergillus, Phycomycetes and Candida spp. only tend to cause 
problems in the immunocompromised patient. Parasitic infections of the lung are also 
uncommon in domesticated horses in the U.K. since most are wormed routinely, but 
Dictyocaulus amfieldi, Parascaris equorum and Pneumocysitis carinii can affect the 
respiratory tract.
1.3.23 Immune mechanisms during bacterial infection
Whether an infectious agent causes disease depends upon the immune system of the host as 
well as the virulence of the microbe. For instance, macrophages in the lung are a primary 
defence mechanism, but stress caused by transport or intense exercise has been associated 
with declining alveolar macrophage function (Laegreid et al. 1988).
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When bacteria enter the lung, there is an influx of neutrophils which mediate phagocytosis 
and killing (Newhouse, Sanchis and Bienenstock, 1976). Several common bacterial 
components activate the alternative complement pathway, with consequent release of C3a 
and C5a, opsonisation of bacteria and possibly complement mediated lysis; activation of 
neutrophils and macrophages; triggering of cytokine release; mast cell degranulation 
leading to increased blood flow in the local capillary network; increased adhesion of cells 
and fibrin to endothelial cells. The clotting system and fibrin formation may also be 
activated, limiting bacterial spread. Antigen is processed and presented to helper T 
lymphocytes, which produce interleukins to activate macrophages, and B lymphocytes to 
differentiate into antibody producing plasma cells. The lymphoid tissue associated with the 
bronchus is the main area of antigen presentation and immunoglobulin production in the 
horse (Warner, 1990).
The immune response to infection can cause tissue damage, which tends to lower pH, 
particularly as intracellular enzymes are released; for instance, P. haemolytica can inflict 
severe pulmonary tissue damage to calves through the response of neutrophils (Breider et 
cd. 1988). P. haemolytica can also mediate more subtle changes to the pulmonary vascular 
system, resulting in oedema (Greenlees et al. 1987) and its lipopolysaceharide (LPS) can 
induce the production of inflammatory cytokines in bovine alveolar macrophages (Yoo et 
al. 1995).
The LPS characteristic of gram negative bacteria can be responsible for some of the clinical 
and histopathological signs in a disease process, even though some effects may be 
beneficial to the host in clearing the infection, hiterleukin 1 (IL-1) is thought to enhance 
non-specific host defences; it is synthesised in response to LPS and released by 
macrophages, where it acts upon the hypothalamus to raise the body temperature, resulting 
in fever (Kenedi et al. 1982), which in turn increases leucocyte mobility and killing of 
bacteria (Roberts and Steigbigel, 1977; Sebag, Reed and Williams, 1977) and enhances 
proliferation and transformation of lymphocytes (Ashman and Nahmias, 1977; Roberts and 
Steigbigel, 1977). Hypoferraemia is also triggered by IL-1, which is the reduction of
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plasma iron and zinc, by storage in the liver and absorption by the gut, further starving 
pathogens of iron.
LPS and lipoteichoic acid (LTA) present in Gram positive bacteria induce the production 
of interferon gamma, which activates killing mechanisms by macrophages and recruits 
circulating neutrophils and lymphocytes to the site of infection, and Tumour necrosis factor 
alpha production by monocytes and macrophages, which activates phagocytic cells. At high 
levels both of these cytokines can cause considerable damage to the host. LTA can directly 
induce macrophages to produce IL-12, which induces the T cell responses and further 
increases interferon gamma production. IL-12, TNF alpha and IL-1 act synergistically to 
induce proliferation of T h l clones (Trinchieri and Scott, 1994). Although there is 
information available about the interactions between bacteria and the host generally, little 
specific information is available on interactions between the equine host and bacterial 
pathogens.
1.3.2:4 Treatment and prevention of infection/transmission
Nursing care which promotes the patient’s appetite and good attitude, is an important 
contribution to a favourable outcome (Beech and Sweeney, 1991). Adequate ventilation 
with minimal dust should be provided for healthy horses as a preventative measure, as well 
as for diseased animals, since inadequate ventilation, when combined with other pollutants 
such as ammonia and dust, damages the nasal and epithelial tissue (Kovacs et al. 1967, 
Martin, 1970; Martin and Willoughby, 1972; Doig and Willoughby, 1971; Jones et al.
1987). Mucking out should not take place with the horse in the stable where possible, to 
minimize exposure to airborne particles, which increase at such times (Pavell, 1996). A 
controlled study found a higher incidence of lower respiratory tract disease in horses kept in 
loose, boxes on straw bedding, than those housed in a bam on paper bedding (Burrell et al.
1982). Patients should be rested and not transported or otherwise stressed (Beech and 
Sweeney, 1991), since transport was associated with respiratory compromise and disease 
(Oikawa et a l  1994; Raidal, Love and Bailey, 1996). Also, food and water receptacles 
should be placed on the floor, since keeping the head up slows mucociliary transport
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(Raidal, Love and Bailey, 1996). Isolation of affected animals and attention to hygiene, 
such as disinfecting grooming tools and rugs, are suggested to be useful in restricting the 
spread of disease, since personnel or equipment can transfer bacteria from horse to horse.
Treatment with antibiotics is the usual course of action in these cases, because if 10"^  or 
more bacterial colony forming units (cfu) per ml are cultured from a tracheal wash, they are 
likely to be damaging the horse’s lungs and / or trachea, whether they are primary or 
secondary pathogens (Wood and Chanter, 1994). Antibiotics are chosen, based on the in 
vitro sensitivity of the bacteria (Wood and Chanter, 1994). Penicillin can be is rendered 
ineffective by acid pH and the presence of pus, and some Pasteurella isolates and A. 
pleuropneumoniae produce a constitutive penicillinase in any case (Girard et cd. 1987), but 
erythromycin however, penetrates the lungs, pleural fluid and neutrophils. Other drugs 
which may be effective include chloramphenicol, cephalosporins, trimethoprim- 
sulphonamide combinations and synthetic penicillins. Immune modulating drugs are of 
unknown efficacy in the treatment of bacterial LAD of the horse. Non-steroidal anti­
inflammatory drugs may help to alleviate symptoms, but they are antipyrectic, which may 
hinder temperature monitoring as a guide to therapeutic efficacy of antibiotics (Beech and 
Sweeney, 1991). Use of sulphanilamide has been reported as effective for the treatment of 
pneumonic horses bacteraemic with haemolytic streptococci (Boddie, 1939). At present, 
there are no effective vaccines for bacterial LAD since until relatively recently, they were 
mostly considered opportunistic colonizers, secondary to viruses, but the demand for a 
vaccine is likely to increase as knowledge of the etiology and prevalence is disseminated 
among practitioners.
1.33 Streptococcus zooepidemicus and related bacterial pathogens
1.3.3.1 Classification
The first classification of the genus Streptococcus by Brown (1919), was based on 
haemolytic reactions seen on blood agar plates, which are alpha, beta and gamma; S. 
zooepidemicus is beta haemolytic, which produces a clear zone of haemolysis on blood 
agar. Rebecca Lancefield (1933) further differentiated the beta haemolytic organisms by
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group specific carbohydrate antigens named A -0. In 1937, Sherman divided the genus into 
four groups: pyogenic, viridans, lactic and enterococci. S. zooepidemicus is part of the 
pyogenic group, which also includes S. equi and S. pyogenes. Comparative 16S rRNA 
phylogenetic trees constructed by Bentley, Leigh and Collins (1991), suggested that S. equi 
was closely related to S. pyogenes. Kilper Baltz and Schleifer (1984) reviewed comparative 
16S data, hybridization studies and cell wall analysis to make a phylogenetic tree which was 
in agreement with Bergey’s Manual o f Determinative Bacteriology, which recogmzes S. 
equi, S. zooepidemicus and S. equisimilis as subspecies of S. equi, but Chanter et al. 
(1996), suggested that S. equi was more likely to be a subspecies of S. zooepidemicus.
1.3.3.2 S. zooepidemicus disease in mammals
S. zooepidemicus is present in the normal flora of equines. It has been isolated from the 
mouth, nose, respiratory and genital tracts of healthy individuals (Welsh, 1984). Woolcock
(1975) isolated mainly S. zooepidemicus from tonsils, throat, mandibular and pharyngeal 
lymph nodes. Kester, Lesser and Dowd (1993) found that S. zooepidemicus was isolated 
from 34% of cases of equine respiratory disease. Nevertheless, it can be pathogenic in 
certain circumstances to equines, other domestic animals and occasionally man. S. 
zooepidemicus and S. equi have only been isolated from patients with what were believed 
to be zoonotic infections (Cimolai et al. 1988; Ghoneim & Cooke, 1980), particularly 
following ingestion of unpasteurised milk (Bamham et al. 1983; Duca et al. 1969; 
Edwards et al. 1988), or contact with pigs (Yuen et al. 1990).
S.zooepidemicus can significantly affect fertility. It causes placentitis, endometritis 
(Causey,Todd & Paccamonti, 1994), abortion and stillbirth in the mare (Hong et al, 1993). 
Stallions can succumb following infections carried in semen, which causes a reduction in 
the numbers and quality of spermatozoa. It is also associated with inflammatory infection, 
particularly wounds such as bites and bums. It has also been isolated from deep seated 
abscesses in such sites as the brain, lung and abdominal tissue. It has been associated with 
septicaemia, infectious arthritis of joints and occasionally the digestive tract.
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1.3.33 Pathogenic determinants
Streptococci produce a number of virulence factors, including membrane damaging 
streptolysins O and S, pyogenic exotoxins (superantigens), hyaluronidase, streptokinase, 
proteases, (particularly C5a peptidase, which cleaves human serum chemotaxin C5a at the 
polymorph binding site, fibronectin binding proteins (adhesins) and IgG/IgA binding 
proteins.
Much of the work done on pathogenic streptococci has been carried out with S. pyogenes, 
which causes glomerulonephritis, rheumatic fever (Fischetti, 1989) and toxic shock. M 
proteins are thought to be major protective antigens (Lancefield, 1962, Fischetti, 1989, 
Kehoe, 1991), which are members of a larger family of M-like proteins, which probably 
arose through gene duplication and divergence (Fischetti, 1989), which include the group C 
and G streptococci. There are over 100 types of S. pyogenes based on amino terminal 
variability (Kehoe, 1991). They have sequence homology with mammalian proteins 
(Fischetti, 1989), which can induce a harmful host response due to cross-reactive antibody 
(Froude et al, 1989). They are also antiphagocytic (Kehoe, 1991). They inhibit non- 
immune opsonisation by binding fibrinogen and complement factor H. It is suggested that 
plasma fibrinogen masks C3b binding sites on the cell surface and binding of factor H 
inhibits alternative pathway C3 convertase and classical C5 convertase (Hong et al, 1990). 
Subsequent phagocytosis by C3b receptor bearing neutrophils would be prevented. Immune 
opsonisation is not inhibited by fibrinogen or factor H. Antibody directed to the extreme 
amino terminal end of the M protein opsonises still in the presence of bound fibrinogen 
(Rye et al, 1989). Immunity in humans and experimental animals is due to type specific 
opsonic antibody to the variable amino terminal half of the M protein.
Proteins in hot acid extracts elicit the production of opsonic antibody in both S. 
zooepidemicus and the related S. equi, the causative agent of strangles in equids. However, 
whilst S. equi M-like protein is antigenically conserved, M-like protein of S. 
zooepidemicus is heterogeneous in antigenicity and molecular weight. Despite the 
similarity between the two, shown by DNA hybridisation studies, they each have distinct
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pathogenicities and S. zooepidemicus has a broader range of host species (Farrow and 
Collins, 1984).
Type specific antibody to M-like protein may play an important role in susceptibility and 
recovery in the horse. S. zooepidemicus may be similar to Streptococcus pyogenes with 
respect to cross- protection between strains with different M-like proteins. S. pyogenes has 
many serotypes of M protein; usually a single serotype is expressed by each strain. 
Immunity in man is conferred by a type-specific opsonic anti M protein antibody, with no 
reported cross-protection between types. Moore and Bryans, (1970), described at least 15 
serotypes of M-like proteins in S. zooepidemicus isolates from Europe and the USA on the 
basis of immunoprécipitation using cross-absorbed antisera.
Some bacteria possess capsules made of hyaluronic acid (HA), or hyaluronate, which is a 
polyrner of high molecular mass, comprising equimolar proportions of D-glucuronic acid 
and N-acetyl-D-glucosamine and is of similar composition, regardless of the source (Meyer 
et al. 1956). HA from Lancefield Group A and C Streptococci is chemically 
indistinguishable from mammalian hyaluronate (Froude et al. 1989). Streptococci of 
groups A and C, S. uberis and Pasteurella multocida type A (Pandit and Smith, 1993), are 
the only well characterized prokaryotes that produce a HA capsule, although other species 
produce capsular polysaccharide. HA is common throughout the ammal kingdom in 
vertebrates and invertebrates. It is one of the main components of the extracellular matrix 
in mammals, which influences cell-cell adhesion (Pessac and Defendi, 1972; Underhill and 
Dorfman, 1978), stimulates locomotion and phagocytosis (Hakansson, Hallgren and Venge, 
1980; Hakansson and Venge, 1985), and modulates angiogenesis (Feinberg and Beebe, 
1983; West et al. 1985). It is concentrated in parts of the body, where it has a supporting 
and cushioning function, in the joints and the anterior segment of the eye (Rittig et al.
1993).
The locus encoding capsule characterized for group A Streptococci encodes hyaluronate 
synthase (HasA ) (DeAngelis, Papaconstantinou and Weigel, 1993; Dougherty and van de
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Rijn, 1994), UDP-glucose dehydrogenase {HasB ) (Dougherty and van de Rijn, 1993) and a 
gene with homology to UDP-glucose pyrophosphorylase {HasC ) (Crater and van de Rijn, 
1995). Hyaluronate capsule is thought to be a virulence factor for S. pyogenes (Kass and 
Seastone, 1944; Wessels et al. 1991) and group C Streptococci (Hirst, 1941). S. pyogenes 
acapsular mutants, which had no functional hyaluronate synthase enzyme, were avirulent in 
mice that suggested that the capsule may prevent phagocytosis (Wessels et al. 1994). 
Further investigation suggested that capsule was variably important in the mechamsm of 
resistance to opsonisation and phagocytic killing (Dale et al. 1996; Moses et al. 1997). 
Ability to resist phagocytosis in the non-immune host correlated with virulence, and this 
might be due at least in part to the ability of HA to be degraded by free radicals (Schenck et 
al. 1995), hence scavenging free radicals produced by the host and protecting membranes. 
Alternatively, host phagocytic cells may be repelled by a net negative charge (Whimack, 
Bisno and Beachey, 1981). Possession of capsule for group B Streptococci, although not 
made of HA, was also correlated with virulence (Rubens et al. 1987). Chanter et al, 1994, 
showed that the increased resistance of young cultures of S. equi to phagocytosis by 
polymorphonuclear leukocytes was due in part to a much elevated rate of capsule 
production, whilst Griffith, (1923) demonstrated that mixing heat killed virulent 
encapsulated S. pneumoniae, with non-encapsulated avirulent cells, yielded encapsulated 
bacteria which were lethal for mice.
Hyaluronate synthase (HS) is an enzyme thought to have a universally similar mechanism, 
with the exception of plants (Feingold and Franzen, 1981). HS is thought to reside in the 
plasma membranes of eukaryotic cells, where it synthesizes HA into the extracellular matrix 
(Prehm, 1984); HS resides in the protoplast membrane of Streptococci (Markovitz and 
Dorfman, 1962). The bovine enzyme has been studied in the most detail and was found to 
be a UDP-glucose dehydrogenase, made of three dimeric 52 KDa subunits, which catalyses 
the formation of UDP-glucuronic acid. The equivalent enzyme in S. pyogenes was cloned 
and the 47 KDa protein expressed was demonstrated to have HS activity (DeAngelis, 
Papaconstantinou and Weigel, 1993). The DNA sequence was found to be similar to the
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Pseudomonas aeruginosa AlgD sequence, a dehydrogenase which catalyses GDP- 
mannuronic acid production for the alginate capsule (Dougherty and van de Rijn, 1993).
A protein which bound precursor nucleotide sugars and was complexed with nascent 
hyaluronate, so was originally designated as HS, was isolated from Streptococcus 
equisimilis cholate-solubilized protoplast membranes (Prehm and Mausolf, 1986) and was 
later cloned and sequenced, and found to be 56KDa (Lansing et al. 1993). Antibody to the 
56 KDa protein cross-reacted with eukaryotic plasma membrane protein (Mausolf et al. 
1990). At the same time, Triscott and van de Rijn (1986) found that a 42 KDa HS could be 
isolated from S. equisimilis digitonin-solubilized membranes. This inconsistency between 
the 56 and 42 KDa proteins was not fully explained until DeAngelis, Yang and Weigel, 
(1994), used a sequence database to assess the similarity of the S. pyogenes HS to other 
gene products. They found that the 42 KDa protein from S. equisimilis was very similar, 
although not identical to the sequence deduced for S. pyogenes, but different to the 56 KDa 
protein previously described by Prehm and Mausolf, (1986), and Lansing et al. (1993). 
Subsequent work has purified a 42 KDa HS from S. equisimilis (Prehm, Nickel and Prehm,
in Press).
The 56 KDa protein is now thought to be a threonine kinase, but more work is required to 
confirm this (Prehm, personal communication, 1996). Antisera to the S. equisimilis 56 
KDa protein reacted with a 50 KDa eukaryotic protein, (Prehm 1989), which was known to 
catalyse the alternate addition of the substrate sugars UDP-glucuronic acid and UDP-N - 
acetyiglucosamine (Prehm, 1983), a different reaction to that described as being catalyzed 
by HÈ. This eukaryotic enzyme required phosphorylation to attain its active form, and was 
important for fibroblast detachment during mitosis (Prehm, 1989). Less is known about the 
S. equsimilis enzyme, although work carried out when it was thought to be the HS, 
demonstrated that it is shed associated with hyaluronate into the medium of growing 
cultures (Mausolf et al. 1990), rather than residing in the protoplast membrane like 
Stteptococcal HS (Markovitz and Dorfman, 1962).
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1.3.3.4 Vaccination strategies
Although epidemiological data indicated an association between S. zooepidemicus and 
equine respiratory disease, Koch’s postulates have not been fulfilled, which is necessary if a 
candidate vaccine is to be tested. An equine experimental model could be used to test for 
the fulfillment of Koch’s postulates in this instance and provide a way of testing in vivo 
the efficacy of trial vaccines. A septicaemic model of S. zooepidemicus disease in the 
equine exists, (Varma et cd, 1984), but a respiratory challenge model would be more 
realistic for an investigation of lower airway disease.
There are no reports in the literature of S. zooepidemicus vaccination, although prevention 
of the related S. equi has a long history, which was reviewed by Todd (1910). The 
Russians, who exposed their horses to extreme cold in an attempt to reduce strangles 
mortality. The first vaccination was reported by Jensen and Sand, who injected cultures 
intravenously; this was said to protect against challenge, but had dangerous side effects. 
Kitt and Gabritchewski (1906) protected foals from nasal challenge with killed cultures, but 
efforts in the early twentieth century were mostly directed towards the use of convalescent 
serum to protect against strangles and to reduce the symptoms of aiffected horses (Delvos, 
Rohrs and Jacoulet). Danonville and Wissocq (1905) produced thempeutic hyperimmune 
sera, but this was expensive and found to be short lived (Todd, 1910).
Bazely (1942) found that heat inactivated young cultures of S. equi protected mice, so in 
the first fully documented field test, vaccinated 2486 horses with a similar preparation and 
compared the incidence of strangles with another group of 1922 horses. 1.17% of the 
vaccinates developed strangles, compared with 5,26% of the controls, which was 
considered significant, but the work was ignored for years. Twenty-two years later, Bryans, 
Doll and Shephard (1964), conducted a similar trial of a similar vaccine, and again 
found that disease incidence was reduced following vaccination, so this time, the 
preparation was sold commercially.
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Only five years later, Engelbrecht (1969) published complaints that vaccination gave rise to 
local reactions and breaks in immunity, but these were considered infrequent and it was 
said that the vaccine was generally accepted. One of the problems with strangles, is that 
some animals can recover from infection and become asymptomatic carriers of S. equi, who 
have type specific immunity, but still can infect healthy susceptible animals (Woolcock, 
1975). Efficacy of vaccination was later questioned by Srivastava and Bamum (1981), who 
found that outbreaks of strangles had been occurring annually in Canada since 1975, despite 
a vaccination programme. They tried to improve the vaccine formulation by giving ponies 
mixtures of formalin treated cells and hot acid extracts; ponies were still only partially 
protected from challenge, so they tried M protein alone, mixed with aluminium hydroxide 
adjuvant, but again only achieved partial protection (Srivastava and Bamum, 1983). At the 
same time, another paper questioned the efficacy of bacterin based strangles vaccines 
(Anon, 1983).
Srivastava and Bamum (1985) then investigated why protection was incomplete, and 
suggested that the immune response following vaccination with several doses of bacterin 
was short-lived. At the same time, Timoney and Eggers (1985) suggested that the role of 
serum bactericidal antibody was overrated, and found that animals convalescing from 
challenge were resistant to ten times the dose of S. equi and had antibody to M protein in 
the nasopharyngeal mucus (Galan and Timoney, 1985).
Now it was more widely acknowledged that vaccination was not fully protective and could 
give rise to adverse reactions, efforts concentrated on identifying which animals might 
derive the most benefit from vaccination, formulating products with fewer side effects and 
identifying what factors reduced the efficacy of vaccination programmes. A study of foals 
inoculated with three doses of M protein based vaccine, found that they were less than half 
as likely to have clinical signs of strangles as non-vaccinates (Hoffman et al. 1991). The 
implication was that it was worth vaccinating a naive foal if it was to be in contact with 
strangles rather than risking complications, but there were side effects and questions over 
long term protection that meant that the risks might outweigh the benefits. A survey of
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vaccination in the field found that the recommended program was rarely followed (Jorm, 
1990), although this survey was criticised by Fairley (1991), highlighting the difficulties of 
field evaluation and giving possible reasons why problems with vaccination took so long to 
emerge. To illustrate this point, Bryant et al, (1985), found that the efficacy of mutanolysin 
extracts of S. equi depended upon the severity of the challenge.
Vaccines based upon cell free M protein extracts largely replaced bacterins, because they 
had fewer side effects (Smith, 1994), although Timoney (1993), found that commercially 
available hot acid extracts, or mutanolysin extracted M protein, occasionally caused purpura 
haemorrhagica. This is a serious allergic reaction to antigen, where antigen-antibody 
complexes circulate and damage the blood vessel linings, allowing blood to escape into the 
tissues; even with careful nursing, only 50% of horses recover.
Newer approaches to strangles vaccination have involved recombinant DNA technology. 
Galan and Timoney (1987), constructed a genetically modified avirulent E. coli, which 
expressed M protein antigens of S. equi and a stable, avirulent bacteriophage modified S. 
equi has also been produced (Timoney, 1993). Wallace et al. (1995) tried formalin killed 
S. equi orally and intraperitoneally, live avirulent 5. equi and microencapsulated M protein 
with a rat model of strangles, and from this, formalin killed and live avirulent S. equi were 
chosen for study in horses. These only resulted in partial protection to horses, meamng that 
vaccinates were less ill than controls.
At present, there is still no success in finding a vaccine against strangles that is safe, fully 
protective and halts the spread of disease. Studies with monoclonal antibody to M  protein 
suggest that it is protective in mice (Jean-Francois et al. 1991), but serum antibody alone is 
not fully protective in the horse, so it is likely that some other mechamsm imght be helping 
S, equi to evade the immune response, because phagocytic cells migrate to the site of a 
lesion, but do not ingest the bacteria. Young cultures of S. equi can be phagocytosed in the 
presence of specific antibody if the thick hyaluronate capsule is removed (Chanter et al.
35
ware, u. lyy/
1994). This suggests that one of the ways forward for strangles research, like research into 
S. pyogenes, is to investigate ways of dealing with both capsule and M protein.
For S. zooepidemicus vaccination, such an approach m i^ t  be equally valid, although 
unlike S. equi, S. zooepidemicus is thought to have a number of different M-types, rather 
like S. pyogenes.
1.3.4 ActinobaciUus eauuU and related pathogens
1.3.4.1 Classification
The classification of Actinobacillus equuli has varied, which is reflected in a number of 
name changes in the past (reviewed by Kim, 1976). A. equuli, and A. suis from the oral 
cavity of horses were provisionally designated as Taxon 11 by Bisgaard et al., (1984), as 
they are distinct from porcine A. suis, but Bergey’s Manual of Determinative Bacteriology 
(Holt, 1994), has not been amended. A. equuli is a pleimorphic gram-negative bacterium, 
currently classified as part of the family Pasteurellaceae, which includes the genera, 
Actinobacillus, Pasteurella and Haemophilus (Holt et al. 1994). There were found to 
be antigenic relationships between Pasteurella and Actinobacillus species (Mraz, 1977). 
More recently, molecular techniques have been employed to determine relatedness between 
members of the Pasteurellaceae. An early DNA-DNA hybridisation study suggested that A. 
equuli was closely related to A. suis, P. ureae, A. ligniersii and A. capsulatus, but not to P. 
haemolytica (Escande et al. 1984), but Mutters et al. (1986), used DNA-DNA or 
DNA-rRNA data, to confirm that P. haemolytica should be grouped with the 
Actinobacillaceae. Borr et al. (1991), used both DNA hybridization and restriction 
endonuclease fingerprinting, and concluded that A. equuli, A. suis and A  ligniersii were 
close relatives. A. pleuropneumoniae was also found to be closely related, whilst P. 
haemolytica was found to share some homology. Dewhirst et al. (1992) used 16S 
ribosomal RNA studies and agreed with the conclusion of Borr et al., but along with P. 
haemolytica, also grouped H. parahaemolyticus, H. parainfluenzae, H. 
paraphrohaetnolyticus, H. ducreyi, Bisgaard Taxon 11 and A. ureae in together with A. 
equuli and the others.
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Confusion about the placing of P. haemolytica might be due to the fact that two biotypes, 
each with distinct pathogenicities have been identified, A and T, based upon fermentation of 
arabinose and trehalose respectively. Classification into separate species was proposed 
(Tsai, Colhns and Hoiby, 1988; Murray et al, 1992) and P. haemolytica now refers to the
A biotype, whilst the T biotype is now known as P. trehalosi (Holt et al. 1994).
1.3.4.2 A. equuli and related disease in mammals
In equines, A. equuli is widely recognized as a cause of septicaemic disease leading to
neonatal death in foals (Bain 1954, Platt 1973). Causes of death include pneumonia, 
abscess, arthritis and peritonitis, for which there are a number of case reports around the 
world (Lutzelschwab et al., 1987; Carter and Martens, 1986, Lee et al., 1985). One 
analysis of foal losses found that bacterial septicaemia, some caused by A. equuli , 
pneumonia and arthritis were significant causes of loss. Particularly affected are foals which 
were colostrum deficient, or there was failure of colostrum immunoglobulin transfer 
(Vaissaire er a/. 1988; K am adaera/., 1985). Studies of the causes of perinatal mortality 
found that bacteria, including A. equuli, were isolated from many foals, whilst virological 
exantinations, where performed were usually negative (Joseph and Dcvcndran, 1987; 
Vaissaire gr fl/., 1987; Kanemaru er a/., 1985).
Isolates from older horses have previously been regarded as commensal and unlikely to be 
pathogenic (Smith 1965); haemolytic A. equuli and A. suis -like bacteria are thought to be 
part of the normal flora of the oral cavity (Bisgaard et al., 1984). A. equuli was however, 
isolated from cases of pericarditis (Dill et a l  1982), retropharangeal infection (Todhunter, 
Brown and Stickle, 1985), abscess (Vaissaire et al. 1988), peritonitis (Gay and Lording, 
1980) and infection of the gastrointestinal mucosa (Al-Mashat and Taylor, 1986). Abortion 
in mares can be the result of A. equuli infection (Webb, Cockram and Pryde, 1976) and it is 
sometimes present in the milk (Vaissaire et al. 1988); A. equuli was isolated from routine 
cervical swabs, but was uncommon in the Hannover breed tested (Fluge, Kruger and 
Scherbarth, 1972). In stallions, A. equuli products are thought to affect fertility, as in vitro
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data suggested that culture filtrate reduced sperm motility; A. equuli was isolated from a 
case of periorchitis (Belknap, Arden and Yamini, 1988).
A. equuli was also associated with mortality in the Cape mountain zebra (Penzhom, 1984), 
which is of the genus Equus, a close relative of the horse. Amongst other mammals, A. 
equuli is found in diseased swine (Schwartz, 1986, Windsor, 1973), and has been isolated 
from adults and piglets with septicaemia or joint inflammation, endocarditis, osteomyelitis 
and embolic pneumonia (Pedersen, 1977). It has been suggested as a cause of porcine 
abortion (Werdin et cd. 1976) and was isolated from dead neonatal piglets, whom were 
thought to be infected from the sow, who was in turn thought to be infected from horses 
present at the market (Okolo, 1987).
Related bacterial species are principally respiratory pathogens. A. suis and A. 
pleuropneumoniae cause severe pleuropneumonia in pigs (Sebunya and Saunders, 1983), 
whilst P. haemolytica causes pneumonia in sheep and lambs (Malone et cd. 1988), goats 
(Z am riero/. 1987), cattle (Devreise gf oZ. 1987; Fischer e ra /. 1987) and fowls (Infante, 
etal. 1984; Lin, 1986).
1.3.4.3 Pathogenic determinants
Knowledge of the pathogenic mechanisms of A. equuli and related bacteria in the horse is 
scant, but most pathogenic bacteria, including some which are related to A. equuli, have 
mechanisms which enable them to survive and multiply in the sometimes hostile 
environment provided by the host.
Firstly, bacterial respiratory pathogens need a mechanism which enables colonisation of the 
respiratory epithelium and avoids removal by the host mucociliary escalator; P. 
haemolytica adheres to calf respiratory epithelia in vitro, in a manner dependent on the 
number of bacteria and contact time (Muller et al. 1988).
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Toxins are important virulence determinants in a number of pathogenic bacteria, including 
A. pleuropneumoniae. Three exotoxins, APX I, H and m  all belonging to the pore-forming 
RTX toxins, have been discovered amongst the serotypes (Frey et al. 1993). Each serotype 
has been found to secrete one, or a combination of two of the toxins. The degree of 
virulence of the serotypes is associated with the toxins expressed (Beck et al. 1994). All 
form cation selective channels of different sizes. Expression of APX I is associated with 
severe outbreaks of pleuropneumonia; it is haemolytic for swine red blood cells and 
cytotoxic, producing the most channels in host cell membranes. APX II is weakly 
haemolytic and the least cytotoxic, producing the fewest channels. P. haemolytica also 
produces a leucotoxin (Chang et al. 1987), which is similar to APX H. APX m  is non- 
haemolytic, but strongly cytotoxic, producing the second most channels.
There is a large amount of iron in vertebrate body fluids, but only 1 0 * ^ is potentially 
available for bacterial growth (Bullen et al, 1978, Chrichton and Charloteaux- 
Wauters,1987, Weinberg, 1990). Fe(m) has a low solubility in vivo and is mostly 
associated with carrier proteins such as haemoglobin within red blood cells, ferritin and 
myoglobin (Lanskowsky, 1976). Transferrin, which supplies iron to the bone marrow for 
haemoglobin synthesis, is present mainly in the blood (Aisen and Lcibman, 1972), whilst 
lactoferrin occurs intracellularly and in secretions. Both maintain iron stores as a small 
proportion of the total iron and have a high iron association constant, so little is free for 
bacterial utilization (Bullen et al, 1978). In cases of severe inflammation, the concentration 
of serum iron declines (hypoferraemia), because iron free lactoferrin released from 
neutrophils removes iron from holotransferrin; iron-lactoferrin complexes are then taken up 
by macrophages, which have membrane bound lactoferrin receptors and are rapidly 
removed from the circulation (van Snick et al, 1974). Increased ferritin synthesis in the 
liver, which diverts labile iron into ferritin stores, further reduces the concentration of 
extracellular available iron in tissue (Konijn and Hershko, 1977).
Some bacteria possess methods of specifically acquiring iron which promote or are required
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for survival and multiplication in the host. There are two main iron uptake systems 
(reviewed by Otto, Verweij-van Vught and Maclaren, 1992): These are i) Synthesis of low 
molecular weight siderophores which sequester iron from transferrin and lactoferrin, then 
convey it to the bacterium where interaction with a specific outer membrane receptor 
internalises the iron; examples include Escherichia, Salmonella, Klebsiella, Shiga and 
Enterobacter species, ii) Direct interaction with transferrin, lactoferrin, or haem containing 
proteins via a specific bacterial outer membrane receptor; examples include. Neisseria 
gonorrhoeae and Neisseria meningitidis, which can use transferrin, lactoferrin and haem- 
compounds for growth. Outer membrane proteins produced by bacteria only in conditions 
where the amount of available iron is limited are known variously as iron regulated proteins 
(IRPs), or iron regulated outer membrane proteins (IROMPs).
The epidemiology and pathogenic mechanisms of A. equuli and related bacteria in the horse 
are not well characterized. In particular, there is no record of outer membrane protein 
antigen characterization from equine tracheal isolates, nor studies of their relatedness. Kim
(1976), divided 128 foal A. equuli isolates into 28 serogroups using an immunodiffusion 
precipitin test that differentiated the heat stable O antigens, but no serogroups were 
consistently associated with disease. Serotyping based on proteins produced in response to 
iron hmitation has not been previously investigated. It is not known whether A. equuli 
produce IRPs which could elicit the production of antibody, or how isolates are 
antigenically related.
A. pleuropneumoniae and P. haemolytica are thought to bind holotransferrin directly to 
the cell surface via a receptor in iron limited conditions; IRPs are produced by both. 
Another potential virulence determinant, described for A. pleuropneumoniae is the 
production of a secreted copper/ zinc superoxide dismutase (SodA). It is speculated that it 
accelerates the dismutation of superoxide derived from neutrophils. Interestingly, the 
production of sodA by A. pleuropneumoniae increases anaerobically only with iron 
restriction (Langford, lAynds and Kroll, 1996).
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1.3.4.4 Vaccination strategies
Although epidemiological data indicated an association between Actinobacillus/Pasteurella 
species and equine respiratory disease, Koch’s postulates have not been fulfilled, which is 
necessary if a candidate vaccine is to be tested. An equine experimental model could be 
used to test for the fulfilment of Koch’s postulates in this instance and provide a way of 
testing in vivo the efficacy of trial vaccines. There are no animal models documented for A. 
equuli, although challenge models in the taxonomically related P. haemolytica and A. 
pleuropneumoniae have been successfully developed for cattle and sheep, and pigs, 
respectively. IRPs are produced by P. haemolytica are immunogenic and sodium salicylate 
extracts of iron limited cultures containing IRPs, successfully protect specific pathogen free 
lambs against the development of pneumonic lesions (Gilmour et al, 1991). The intranasal 
immunization route was demonstrated to protect calves against pasteurellosis (Klein, 1987).
For a vaccine, it is also essential to know whether cross-reactive bacterial components are 
present, to gain an impression of how many strains to put into a vaccine. Vaccines to 
protect pigs against A. pleuropneumoniae infection originally consisted of killed bacteria 
mixed with an adjuvant; these gave protection against homologous, but not heterologous 
serotypes (Neilsen, 1988). Similarly, experimental infection protected against homologous 
challenge, but the degree of protection against heterologous challenge varied (Cruijsen et al. 
1995i). One author concluded that vaccination should be combined with the use of 
antibiotics, whilst another found that isolating affected animals was as effective as 
medication and vaccination in controlling an outbreak (Clark et al. 1994). The 
environment the pigs were kept in was also judged to have a role in the pathogenesis of 
disease (Beskow, Soderlind and Thafvelin, 1989). Bacterin based vaccines were thought to 
fail because of antigenic differences in lipopolysaccharide within serotypes (Jolie, Mulks 
and Thacker, 1995). This indicated that vaccination was not optimally effective and 
envirpnmental changes were not always practical, so some workers attempted to enhance 
non-specific responses by the addition of interleukin 2 (Anderson, Fedorka-Cray and Urban, 
1988), or Propionibacterium avidum (Markowska et al. 1992). Studies were also set up to 
test the efficacy of different adjuvants; oil based ones gave a good response, but the most
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extensive tissue reactions (Willson, Rossi-Campos and Potter, 1995). .The core 
components of gram negative bacterial cell walls could prevent mortality, but not infection 
or disease (Fenwick et al. 1986), so the search for vaccine components became more 
specific to A. pleuropneumoniae.
It was suggested that neutralizing antibody to toxins may be important for the induction of 
protective immunity in pigs (Bertram, 1988; Devenish, Rosendal and Bossé, 1990, 
Fedorka-Cray er a/. 1990; Cruijsen er a/. 1995Ü). It was claimed that a haemolysin, when 
mixed with outer membrane protein extract, gave complete heterologous protection against 
experimental challenge (Bosch et al. 1990). Suggestions have been made that there are 
other mechanisms of protection besides antibodies to toxins (Haesebrouk et al. 1996), 
such as iron regulated proteins, which could also contribute to protection (Gerlach et al.
1993), although most recent evidence still indicates that anti-haemolysin antibodies are 
important (Furesz gf a/. 1997).
Recent efforts have been made to design a live, attenuated vaccine. A genetically defined 
riboflavin auxotroph which does not give rise to signs of disease at 500 times the LD50 
dose has been described, but it has yet to be tested in a porcine challenge (Fuller, Thacker 
and Mulks, 1996), and it remains to be seen whether attenuated strains will protect against 
challenge by heterologous strains. Taken together, the evidence so far suggests that the 
control of A. pleuropneumoniae in swine would be likely to involve a vaccine with a 
number of components, combined with improvements to the ammals environment.
The history of f  haemolytica vaccination in sheep is similar to that for A. 
pleuropneumoniae. Experimental challenge models were developed for pneumonic 
Pasteurellosis Initially, bacterin based vaccines were tried experimentally and sold 
commercially, but their success was limited to protection from homologous challenge 
because serotypes were poorly cross-reactive. Sodium salicylate extracts, which contained 
the proteins in the outer bacterial cell membrane were more successful, particularly when 
bacteria were cultured in iron limited conditions (Gilmour et al. 1991).
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1.3.4 Justification for study
It is thought that bacteria, whether primary or secondary agents, possibly cause more 
damage to the equine lower respiratory tract than any other group of pathogens, so it is 
probably most beneficial to vaccinate against those most strongly associated with equine 
lower airway disease (Wood and Chanter, 1994). S. zooepidemicus and A. equuli were 
chosen for this study because they were most strongly associated with equine lower airway 
disease and most frequently isolated (Wood, 1996). As both of these bacteria can be 
present in the equine without producing disease, there must be a fine balance in the battle of 
survival between microbe and host. The balance may be affected by the size of the 
infecting dose and causes which diminish host resistance, such as stress (Rossdale, 1995). 
Conversely, the balance may be influenced to favour the host by vaccination. It is helpful 
that precedents are already set for vaccination research in related bacteria.
This is most commonly a sub-clinical infection, meaning that the airway is inflamed and 
damaged by the time symptoms are noticed and therapy initiated, causing lost training days 
for convalescence, spreading infection to other individuals and suffering to the horse which 
is exercised whilst sick. Antibiotics are commonly used to treat bacterial infections, but 
may penetrate fibrinous lung tissue poorly; some antibiotics have reduced activity caused 
by enzymes, purulent exudate, and the acidic environment of infected lung tissue (Aronson 
and Brownie, 1978). As bacterial respiratory illness is common in the equine, increasingly 
widespread use of the antibiotics not banned by the Jockey Club, could to select resistant 
pathogens in the longer term, further reducing the number of treatment options for the 
control of outbreaks. Evidence is available for antibiotic resistance carried on plasmids in 
P. haemolytica and antibiotic treatment failure for calves with pneumonic pasteurellosis 
has been documented, where it was suggested that methods for assessing antibiotic 
sensitivity may be inadequate and hence underestimating the problem. Another 
complication is that infections are often mixed and there are sometimes different patterns of 
antibiotic resistance between species, necessitating combination therapy, which is expensive 
and restricts treatment options.
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There is an urgent need to discover precisely which Actinobacillus /Pasteurella species are 
associated with lower airway inflammation, whether they produce iron regulated proteins 
upon which a vaccine could be based, whether they bind any host iron carrying compounds, 
and whether it is possible to produce a model of disease for both bacteria. For S. 
zooepidemicus, it is important to know whether there is any prospect for cross-protection 
between strains with different M-types, and if the prospects are poor, whether a novel 
approach using hyaluronate associated proteins as surrogate antigens would induce 
protective immunity. This thesis will attempt to answer these questions and hence give an 
indication of whether vaccination against bacterial LAD in the horse is an option worth 
pursuing.
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1.4 AIMS AND OBJECTIV ES
The principal requirements of identifying a strategy towards protective immunization 
against lower airway disease (LAD) in the horse are (a) to identify the variety of pathogens 
and their virulence determinants upon which vaccination might depend and (b) to provide a 
model of disease in which to test potential protective immunogens. It is with these overall 
aims that the following objectives were identified as the subject of this thesis with particular 
reference to iron scavenging mechamsms of the Actinobacillus/Pasteurella group of 
bacteria, the M-like proteins of S. zooepidemicus and the capsule of Lancefield group C 
Streptococci.
1. To speciate isolates of the Actinobacillus/Pasteurella group from cases of lower airway 
disease and controls to assess if the epideimological association of this general group of 
bacteria with the disease can be attributed to a predominant species or to a defined group of 
species.
2. To investigate the production of iron regulated proteins (IRPs) by the dominant species 
of the Actinobacillus/Pasteurella group associated with LAD with respect (a) to binding of 
host iron carrier proteins; (b) to the association of IRPs and host iron earner binding with 
requirement of host iron earner protein for growth in iron limited conditions, and (c) to an 
assessment of the antigenic variability and cross-reactivity of IRPs.
3. To assess the antigenic and opsonogenic variability in M-like protein extracts of 
temporally and geographically disparate isolates of S. zooepidemicus from cases of LAD.
4. To clone and express fragments of a hyaluronate associated protein of S. equi and assess 
their potential to cross-protect against S. zooepidemicus challenge of mice and hence as an 
immunogen with the potential to cross-protect between different types of S. zooepidemicus.
5. To assess the feasibility of experimental S. zooepidemicus and A. equuli challenge in 
conventional ponies.
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Objectives
A strong association was found between lower airway inflammation and the presence of 
Pasteurella / Actinobacillus-like bacteria in the tracheal washes of young Thoroughbred 
horses in training (Wood et al. 1993), but the species involved were not established.
The inflammation scores were collected for each tracheal wash sample to establish if one 
principal species accounted for the association between lower airway inflammation and 
disease. The objectives of this study were to establish the identities of the isolates by 
comparison with characteristics listed in Bergey’s Manual of Determinative Bacteriology 
(Holt, 1994), and to assess if  lower airway disease was associated with a large or 
comparatively small number of species of this general group of bacteria.
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Summary
Undifferentiated members of the Actinobacillus/Pasteurella group of bacteria were found to 
be significantly associated with lower airway disease in young training Thoroughbred 
horses (Wood et al, 1993). The identities of 71 isolates from 65 horses with or without 
evidence of lower airway disease, were determined to assess if the association with disease 
was accounted for by a small or large number of species. Fifty-two percent were 
Actinobacillus equuli, 18.3% were Actinobacillus suis -like, 12.7% were Pasteurella 
pneumotropica, 8.5% were Actinobacillus ligniersii, 7.0% were Pasteurella haemolytica 
and 5.6% were P. mairii. These results suggest that a range of Actinobacillus/Pasteurella 
species can be isolated from the lower airways of horses, but greater than half of the 
isolates are A. equuli. Lower airway inflammation was significantly associated with A. 
suis -like bacteria and A. ligniersii , but association was unclear for A. equuli. A much 
larger sample would be required for statistical purposes.
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Materials and methods
Sources of the isolates
Details of horses are given in Table 1. Samples were taken from horses kept at nineteen 
different yards around England. Eleven of the yards were in Suffolk, two each were in 
Berkshire, West Sussex and Yorkshire, and one each was in Norfolk and Lancashire. 
Fifty-five of the horses were Thoroughbred horses in training, four were hunter-types, one 
was a pony, one was a Thoroughbred horse at stud and four were of unknown breed. Each 
was assigned a number (1-65), and the yards from which they came were identified by a 
designated letter (A-U) and the county. Tracheal wash lavage samples were taken and 
processed by the methods of Whitwell and Greet (1984). Briefiy, the tip of an endoscope 
was introduced via the ventral nasal meatus, then glottis, and guided into the tracheal until 
the Carina could be seen. A sterile plastic catheter was placed into the biopsy channel of the 
endoscope and 30ml of sterile phosphate buffered saline was squirted through this using a 
syringe. The fluid pooled at the thoracic inlet (which is the lowest point of the trachea in a 
horse standing with its head up), from where it was sucked back into the syringe via the 
catheter. In between horses, the endoscope was disinfected and sterilized at the end of the 
day. The sample was divided into three; the first aliquot was put into a sterile container for 
bacteriology, the second into an equal volume of 10% formalin for differential cytology and 
the third into an EDTA tube for a total nucleated cell count. The inflammation score 
comprised three equally contributing parameters, each adding one unit to the score. One 
unit was added to the score for each of the following; 1) if the count per millilitre of 
nucleated cells was greater than 1000. 2) if the degree of mucopus visible on endoscopy 
was moderate or greater and 3) if neutrophils were present in moderate or greater 
proportions relative to other cell types.
Identification tests
Isolates from fresh samples were identified upon the third passage and isolates processed 
before October 1993 were revived from storage at -50 C, necessitating two additional 
passages. Colonies were inspected after 3 passages on Wilkins-Chalgren agar (Unipath) 
supplemented with 5% citrated horse blood, or heparinised sheep blood. Note was made
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of colony morphology and in particular of any haemolysis, or stickiness when picked up 
with a loop. Smears were made onto glass slides, heat fixed. Gram stained and examined 
under the microscope with xlOO objective lens under oil immersion. One colony of each 
isolate was inoculated into a separate 10ml Tryptic soya broth (Difco) and incubated for 18 
hours at 37 C, the ten drops of each (approximately 1ml) were added to broths containing 
different sugars. The fermentation of lactose, salicin, sorbitol, trehalose, or melibiose was 
tested using the medium described by Thompson and Knudsen (1958), quoted by Cowan 
and Steel (1993). These were incubated at 37 C and inspected after 24 and 48 hours. A 
positive result was recorded when the broth changed to a yellow colouration and a 
negative result if the broth remained orange/red. A delayed result was recorded if a 
particular broth was negative upon inspection after 24 hours, but positive after 48 hours. 
After incubation, sugar and peptone waters were sub-inoculated onto blood agar plates 
incubated at 37-C for 48 hours at each stage to test for purity. Tests for growth on 
MacConkey agar and production of indole, catalase and oxidase were as described by 
Cowan and Steel (1993). Physical, biochemical and cultural characteristics of the isolates 
were compared with those listed in Bergey’s Manual of Determinative Bacteriology (Holt,
1994).
Type strains from the National Collection of Type Cultures (NCTC) were used as 
references for identification tests. These were A. equuli NCTC 8529, A.ligniersii NCTC 
4189, P. haemolytica serotype 2 NCTC 9380, P. maini NCTC 10699, and P. 
pneumotropica NCTC 8141. No type strain was available for A. suis so A. suis NCTC 
12182, from a human wound from a horse bite was used.
Statistical analvses
One objective was to identify the isolates to find evidence of subtypes behaving 
epidemiologically as though they are primary pathogens. The testing of whether each 
species was more common amongst cases positive for Actinobacillus/Pasteurella bacteria 
compared with controls was analyzed by Chi-square using Epi info (Dean et a l, 1990).
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Such evidence might be taken as support for a subtype which was causing disease more 
frequently than not when it is present.
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Results and Discussion
The colony morphology of all isolates was very similar; they were grey and up to 3 
millimetres in diameter. However, some colonies were stickier to pick up with a loop than 
others; those ultimately identified as A. equuli were particularly sticky. All of the isolates 
and most of the type strains were weakly haemolytic on Wilkins Chalgren agar (Unipath 
Ltd), with 5% citrated horse blood added, but isolates eventually identified as A. equuli, A. 
suis, or A. ligniersii, plus their NCTC strains, were weakly haemolytic on sheep blood agar, 
whilst P. pneumotropica and P. mairii were not. Colonies of the P. haemolytica type 
strain were beta haemolytic on both types of blood agar. The differential properties of all 
test and NCTC isolates are shown in Table 2. Isolates produced pink, lactose fermenting, 
colonies on MacConkey agar, with the exception of half of those identified as P. 
pneumotropica , (excluding the type strain of P. pneumotropica). Microscopically, 
isolates from solid and broth cultures were Gram negative and pleiomorphic, with evidence 
of bipolar staining. All of the isolates were oxidase and catalase positive. The results of 
carbohydrate fermentation identified 37 isolates from 34 horses and one pony as A. equuli, 
based on fermentation of lactose, trehalose and melibiose, and failure to ferment salicin. 
O f these, 22 fermented sorbitol like the type strain, and 12 did not. Three further isolates 
fermented sorbitol after a delay of approximately 48 hours. All were urease positive, but 
negative for indole production.
There were 13 A. suis isolates from 12 horses, which fermented lactose, salicin, trehalose 
and melibiose, but did not ferment sorbitol. All were urease positive and indole negative. 
The A. suis NCTC strain had the same properties. These fermented L- arabinose so may 
not be identical to Bisgaard Taxon 11, which is a previously described equine isolate 
(Bisgaard et al., 1984).
Eight isolates from 8 horses were identified as P.pneumotropica. These fermented lactose, 
but did not ferment salicin or sorbitol. Half fermented trehalose and six of the eight 
fermented melibiose. The type strain of P.pneumotropica had similar properties, except
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that it fermented salicin; it also fermented trehalose and melibiose. All were positive for 
urease and indole production.
Six isolates from 6 horses were AAigniersii. These fermented lactose and sorbitol, but did 
not ferment salicin, trehalose or melibiose. The type strain of A. ligniersii had similar 
properties, but it did not ferment sorbitol. All isolates were urease positive, but negative 
for indole production.
Five isolates from 5 horses were P. haemolytica,. These fermented lactose, sorbitol and 
melibiose, but did not ferment salicin or trehalose. All five isolates were urease negative 
and negative for indole production. The type strain of P.haemolytica had similar 
properties, but it fermented salicin yet not lactose. Four isolates from 4 horses were 
P.mairii. These fermented trehalose, and sorbitol at 48 hours incubation, but did not 
ferment salicin and only one isolate fermented melibiose. The type strain behaved 
similarly, but did not ferment lactose and fermented salicin. Half fermented lactose and all 
were positive for urease, but negative for indole production.
Actinobacillus/ Pasteurella species were isolated from six horses on more than one 
occasion. Sorbitol fermenting A. equuli was isolated from horse 24 (yard P in Suffolk) on 
two occasions, two months apart. A. equuli, which did not ferment sorbitol, was isolated 
from horse 60 (yard S, also in Suffolk) but A. equuli that fermented sorbitol was isolated 
from this animal two months later. A. suis was isolated from horse 19 (yard L in Suffolk) 
for two consecutive sampling dates one month apart. P. mairii was isolated from horse 48 
(yard S) one month after isolating P. pneumotropica. P. pneumotropica was isolated from 
horse; 18 (yard F, Berkshire) five months after A. ligniersii was isolated. P. pneumotropica 
was isolated from horse 42 (yard R, Suffolk) one month after P. haemolytica was isolated.
Typically of bacterial lower airway infection, overt signs of disease were not evident by 
superficial examination of the horse at rest in the majority of cases and was only detected 
by endoscopy (Wood gf aZ. 1993). S e v e n  had a cough (horses 3,4,5,17,19,20 and 57). The
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inflammation score of five of these was recorded as 3/3. Horse 21 had respiratory distress 
and an inflammation score of 2/3. Five of these horses yielded A. equuli ( 3,4,20, 21 and 
57) and the other three yielded A. suis -like isolates (5,17 and 19).
Inflammation scores, where given, varied between the minimum (0/3) and maximum (3/3). 
Analysis of whether the different species were more common amongst horses with a score 
of 1 or more, revealed an association of cases for A. suis -like isolates (OR = 11.68; 
95%C1; 0.64-210; p = 0.026) and A . ( O R  = 11.00; 95%C1; 1.18-102; p = 
0.022). In contrast, P.pneumotropica was associated with horses with a tracheal pathology 
score of 0 (OR = 0.19; 95%C1; 0.04-0.91; p = 0.04). There was no clear association with 
A. equuli. These statistical tests should be interpreted with some caution, given the small 
number of animals involved, but they suggest a stronger pathogenic role for A. suis -like 
isolates and A. ligniersii. Given the greater prevalence of A. equuli and the overall 
association of the Actinobacillus/Pasteurella group of bacteria with bacterial lower airway 
disease, it is still probable that A. equuli would be associated with disease when all animals 
are included in an analysis (i.e. including those animals without the 
Actinobacillus/Pasteurella group of bacteria).
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Table 1. Actinobacillus/Pasteurella species identified from tracheal wash samples. (N/A 
= data not available).
Sampling date Horse number Yard and county Inflammation score Species identification
May 1992 1 A, W est Sussex N/A A. equuli
December 1992 2 B, Suffolk N/A A. equuli
December 1992 3 0 , Suffolk 3/3 A. equuli
February 1993 4 D, W est Sussex N/A A. equuli
March 1993 5 E, Suffolk 3/3 A. suis
April 1993 6 F, Berkshire 1/2 A. ligniersii
June 1993 7 G, Suffolk 2/2 P. haemolytica
July 1993 8 H, Berkshire N/A P. haemolytica
October 1993 9 J, Suffolk 1/3 A. equuli
November 1993 10 K, Norfolk N/A A. equuli
December 1993 11 E, Suffolk N/A A. equuli
December 1993 12 J. Suffolk 2/2 A. equuli
December 1993 13 J, Suffolk 3/3 A. suis
December 1993 14 F, Berkshire N/A A. equuli
Docombor 1993 15 E. Suffolk 3/3 A. equuli
January 1994 16 F, Berkshire 2/2 A. equuli
January 1994 17 J, Suffolk 3/3 A. suis
January 1994 20 J, Suffolk N/A A. equuli
February 1994 18 F, Berkshire 3/3 A. ligniersii
February 1994 19 L, Suffolk 3/3 A. suis
February 1994 21 M, W. Yorkshire 2/3 A. equuli
March 1994 22 J, Suffolk 1/3 A. suis
March 1994 23 N, Suffolk N/A A. equuli
March 1994 24 P, Suffolk 0/3 A. equuli
March 1994 25 J. Suffolk 3/3 A. equuli
March 1994 19 L, Suffolk 1/3 A. suis
March 1994 26 J, Suffolk 1/3 A. equuli
March 1994 27 J, Suffolk 3/3 A. equuli
April 1994 28 F, Berkshire ■ N/A P. haemolytica
^ r i l  1994 29 J, Suffolk N/A À. suis
April 1994 30 Q, Lancashire 2/2 A. equuli
April 1994 31 E, Suffolk 0/3 A. equuii
May 1994 32 P, Suffolk 0/3 A. equuli
May 1994 24 P, Suffolk 0/3 A. equuli
May 1994 33 P, Suffolk 0/3 P. mairii
May 1994 34 P, Suffolk 2/3 A. equuli
May 1994 35 P, Suffolk 1/3 A. equuli
May 1994 36 J, Suffolk N/A A. equuli
June 1994 37 F, Berkshire N/A P. mairii
ilune 1994 38 P, Suffolk 3/3 A. suis
June 1994 39 P, Suffolk 0/3 A. equuli
June 1994 40 P, Suffolk 2/3 A. suis
July 1994 18 F, Berkshire 0/3 P. pneumotropica
July 1994 41 F, Berkshire 2/3 P. pneumotropica
August 1994 42 R, Suffolk 0/3 P. haemolytica
August 1994 43 S, Suffolk 0/3 A. equuli + A. ligniersii
September 1994 44 R, Suffolk 1/3 A. equuli
September 1994 42 R, Suffolk 0/3 P. pneumotropica
September 1994 45 S, Suffolk 0/3 ■ A. equuli
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Table 1. Actinobacillus/Pasteurella species identified from tracheal wash samples. (N/A 
= data not available).
Month / Year Horse number Yard and county Inflammation score Species
October 1994 46 S, Suffolk 1/3 P. haemolytica
October 1994 47 S, Suffolk 1/3 A. ligniersii
October 1994 48 S, Suffolk 0/3 P. pneumotropica
October 1994 49 S, Suffolk 1/3 P. mairii
November 1994 48 S, Suffolk 0/3 P. mairii
November 1994 50 S, Suffolk 1/2 A. suis
November 1994 51 S, Suffolk 1/3 A. ligniersii
November 1994 52 S, Suffolk 1/3 A. ligniersii
January 1995 53 F, Berkshire 0/3 P. pneumotropica
January 1995 54 F, Berkshire 1/3 P. pneumo. + A. suis
January 1995 55 P, Suffolk 0/3 P. pneumotropica
February 1995 56 J, Suffolk N/A A. equuli
Fe|bruary 1995 57 S, Suffolk 3/3 A. equuli
May 1995 58 J, Suffolk N/A A. equuli
May 1995 59 J, Suffolk N/A A. equuii
September 1995 60 S, Suffolk 0/3 A. equuli
November 1995 61 R, Suffolk 1/3 A. suis
November 1995 60 S, Suffolk 2/3 A. equuli
January 1996 62 P, Suffolk 1/3 P. pneumotropica
April 1996 63 T, Suffolk N/A A. equuli
April 1996 64 T, Suffolk 3/3 A. equuli
September 1996 65 U, W. Yorkshire N/A A. suis
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Objectives
Four tracheal wash isolates of A.equuli from horses with lower airway disease, from 
geographically and temporally separate outbreaks, were selected : a) to test for interactions 
with host iron carrier proteins; b) to look for production of IRPs; and c) if IRPs were 
detected, to ascertain their antigenic diversity.
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Summary
Four isolates of Actinobacillus equuli, cultured from tracheal lavage samples taken from 
horses in separate outbreaks of lower airway disease, were examined for their ability to use 
iron carried by different iron carrying proteins. Cultures were inoculated onto medium 
containing just, enough iron chelator to inhibit growth. Growth of all four isolates was 
restored by the addition of equine holotransferrin, but not by the addition of equine apo- 
transferrin, haemin, myoglobin, cytochrome C, ferritin, haemoglobin, rabbit 
holotransferrin, or human holotransferrin. Binding of equine holotransferrin was detected 
in all isolates cultured in iron limited media by probing colony blots with anti equine 
transferrin conjugated to horseradish peroxidase. None of the isolates bound any of the 
iron carrying compounds when they had been grown in iron replete conditions. Sodium 
salicylate extracts of the isolates grown in iron limited conditions analyzed by SDS-PAGE, 
contained proteins that were not present in extracts of iron replete cultures. Seven so 
callqd iron regulated proteins (IRPs) of different molecular masses, were present in all of 
the isolates. Major constitutively produced proteins of all of the isolates were similar in 
molecular mass and were antigenically related in irmnunoblots of SDS-PAGE gels 
incubated with rabbit antisera to sodium salicylate extracts of iron limited cultures. In 
contrast, there were varying degrees of antigenic cross-reactivity between the IRPs. Sera 
from young ponies geographically isolated from other equids, showed more selective 
reactivity for IRPs than rabbit antisera. Together, these results suggested a spectrum of 
IRP antigenic relatedness that was more sharply defined in the responses of horses to 
natural infection. Binding of equine holotransferrin by inducible iron regulated proteins 
may represent part of the mechanism by which A. equuli obtains iron essential for growth 
in vivo.
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Materials and methods
Bacteria
A. equuli isolated from the tracheal washes of four horses with evidence of lower airway 
disease, supplied by the Animal Health Trust’s (Newmarket,UK.) diagnostic laboratory, 
were labeled R, S, X and Y. R cmne from a Thoroughbred horse trained in Newmarket, 
Suffolk in December 1992; S came from a horse in a different training yard in 
Newmarket in October 1993; X came from a Thoroughbred horse trained in Lamboum, 
Berkshire, in December 1993; Y was from a hunter type kept in work at the Animal 
Health Trust, Newmarket, in December 1993. All were present in tracheal washes in 
numbers greater than 1Œ cfu / ml in association with mucopus and large numbers of 
polymorphonuclear leukocytes. Isolates were identified as A. equuli using methods 
described previously in Chapter 2.
Culture media
Isolates were stored at -70-C, revived and maintained as described in Chapter 2. TSB with 
added 2,2-dipyridyl (Sigma) was used to produce iron limited broth cultures. For the iron 
compound utilization assay, tryptic soya agar (TSA) was prepared by adding 5mg/ml 
bacteriological agar (Unipath Ltd), to TSB containing 2,2-dipyridyl at various 
concentrations specified below. All incubations were at 37 C unless stated otherwise and 
blood agar plates were incubated in the presence of 5% carbon dioxide, in air.
Determination of conditions for iron limited culture and iron compound utilization assay. 
An 18 hour static culture of each isolate was added to prewarmed broths (37 C) without or 
with 2,2-dipyridyl (50 - 500pM) and incubated with shaking at 150rpm. After 4 hours, 
when turbid to the eye, the optical density (ODeoo) was measured at 30 minute intervals. 
Once cultures had stopped growing, on the basis of optical density measurement, viable 
counts were made by counting the colonies resulting from spread inoculating lOOpl of 
culture serially diluted in 150 mM phosphate buffered saline, pH 7.2 (PBS), onto horse 
blood agar, which were incubated for 18 hours. A concentration of 170pM 2,2-dipyridyl 
was sufficient to reduce the growth of all isolates by 10-fold in TSB. The concentration of
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2,2-dipyridyl for the iron utilization assay was chosen by spreading lOOpl of an 8 hour 
static culture of each isolate on a separate set of TSA plates made with a range of 2,2- 
dipyridyl concentrations, from 50 - lOOOpM. A concentration of 300pM was just 
sufficient to completely inhibit growth on TSA without a supplementary iron source.
Iron compound utilization assay
A lOOpl aliquot of an 8 hour static culture of each isolate (TSB without added 2,2- 
dipyridyl) was spread over the surface of TSA containing 300pM 2,2-dipyridyl and wells 
of 5mm diameter were aseptically punched into the agar. lOpl of a 10 mg / ml solution of 
each of the iron carrying compounds mixed with phosphate buffered saline was added to 
an individual well in the agar plate. Equine haemin, myoglobin, cytochrome C, ferritin, 
apo-transferrin, haemoglobin, human holo-transferrin and rabbit holo-transferrin were 
supplied by Sigma. The equine holotransferrin was prepared by modification of a 
previously described method (Caldwell and Archibald, 1987). Briefly, lOmg/ml apo- 
transferrin was mixed for 1 hour with 0.1% (w/v) ferric ammonium citrate dissolved in 
40mM tris-bicarbonate buffer, pH 7.4, followed by dialysis with 3 changes of 1 litre 
40mM tris-bicarbonate buffer, pH 7.4, over 3 hours, followed by 4 changes of 3 litre PBS 
over 4 hours. Equine haemoglobin was prepared fresh each time. Ferric ammonium 
citrate at O.IM concentration, O.IM ferrous sulphate, 40mM tris-bicarbonate buffer, pH 
7.4, and PBS, were also added to separate wells on each plate as positive and negative 
controls. The plates were incubated lids uppermost for 24 hours, after which areas of 
growth around the wells were recorded.
Growth of isolates in iron limited and replete media
A 50ml, TSB culture of each isolate grown statically for 18 hours, was used to inoculate a 
sterüe fermentation vessel of 800 ml TSB containing 170pM 2,2-dipyridyl. A separate 
vessel containing TSB without 2,2-dipyridyl was similarly treated. The vessels were kept 
at 37 C and the dissolved oxygen was adjusted to 30% by a combination of different rates 
of oxygen supplementation and stirring. Optical density readings (ODgoo) were taken 
hourly and both pH and dissolved oxygen recorded automatically at ten minute intervals.
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When these values no longer changed, the cultures were refrigerated at 4 C overnight. The 
viable and total bacterial cell count was determined using aliquots from each fermentation. 
Cultures were centrifuged at 10,000g and the supernatant separated off and freeze dried. 
The pellet was resuspended in 8ml PBS and fieeze dried.
Transferrin binding assav
Four A. equuli isolates grown with the concentration of 2,2-dipyridyl which reduced 
growth ten fold for each isolate (170pM), or grown without 2,2-dipyridyl, were freeze 
dried and sodium salicylate extracts made of each (see below for preparation). Cells of 
each isolate were resuspended to total counts of 10®, 10^ and 10^, and along with their 
culture supernatants, were separately transferred onto nitrocellulose (Schleicher and 
Schuell) using a BioDot apparatus (BioRad) according to the manufacturer’s instructions. 
Ten micrograms of sodium salicylate extract of each isolate, were applied to three separate 
wells as a 50 pg / ml solution in; a) PBS, b) PBS containing 0.2% (w/v) SDS, or c) PBS 
containing 0.2% (v/v) 2-mercaptoethanol. Blots were shaken on a rocking platform 
throughout at room temperature (approximately 20 C). Unreacted areas of the dot blots 
were blocked with 5% (w/v) skimmed milk powder dissolved in 0.1% (v/v) Tween 20 in 
PBS (PBS-T) for one hour. After washing in three changes of PBS-T, once for 15 minutes 
then twice for five minutes, dot blots were mixed with lOpg/ml equine holotransferrin in 
PBS-T for 1 hour. Washing was repeated in PBS-T as before, after which horseradish 
peroxidase (HRP) conjugated sheep anti-horse transferrin antibody (Cambio) diluted 
1:3000 in PBS-T was added for 1 hour. After rewashing in five changes of PBS-T, once 
for 15 minutes then four times for five minutes, cells binding transferrin and hence HRP 
conjugated anti transferrin, were detected using the Enhanced Chemiluminescence 
detection system (ECL, Amersham).
Preparation of sodium salicvlate exfracts
Freeze dried cultures grown with or without 170pM 2,2-dipyridyl were resuspended in IM 
sodium salicylate and shaken at 37 C for 3 hours. The supernatant fraction was collected 
after centrifugation at 3000g for 40 minutes at 4 C and dialyzed in two changes of 3 litres
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PBS over 24 hours, followed by distilled water for 18 hours. The protein concentration of 
the extracts were measured using a bicinchoninic acid assay (Pierce).
SDS- polvacrvlamide gel electrophoresis
Sodium salicylate extracts of cells (equivalent to 25pg of protein) grown with or without 
170pM 2,2-dipyridyl, and molecular mass markers (Sigma), boiled in Laemmli sample 
buffer containing marker dye for 2 minutes, were separated by sodium dodecyl sulphate - 
polyacrylamide gel electrophoresis (SDS-PAGE), as previously described (Laemmli, 
1970), with a 12% (w/v) polyacrylamide separating gel and a 4% (w/v) stacking gel in a 
Protean II apparatus (BioRad) and a constant current of 24mA at room temperature for 
approximately 4 hours.
Proteins in the gel were detected by silver staining. Gels were serially incubated and 
shaken at room temperature a) in an aqueous mixture of 50% (w/v) ethanol and 10% (w/v) 
methanol for 30 minutes, b) in an aqueous mixture of 6.8% (w/v) sodium acetate, 0.2% 
(w/v) sodium thiosulphate, 33% (w/v) ethanol and 2% (w/v) glutaraldehyde for 30 
minutes, c) in three water washes of 5 minutes each, d) in an aqueous mixture of 0.1% 
(w/V) silver nitrate and 0.0076% (w/v) formaldehyde, for 20 minutes, e) in water bnefly, f) 
in an aqueous mixture of 0.23% (w/v) sodium carbonate containing 0.0003% (v/v) 
formaldehyde, until bands were visible without excess background, and finally g) in 1.5% 
(w/v) aqueous EDTA solution for ten minutes. Gels were soaked in 10% (v/v) glycerol for 
15 ininutes and dried between polythene (Pharmacia), on a gel drier (Biorad), for 2 hours 
at 8Ô C. Molecular masses of proteins were calculated by their relative mobility in relation 
to proteins of known molecular mass in the standards.
Native polvacrvlamide eel electrophoresis
Sodium salicylate extracts of cells grown with or without 170pM 2,2-dipyridyl (equivalent 
to 25pg of protein), were mixed with Laemmli sample buffer without the SDS or 2- 
mercaptoethanol, and were separated by polyacrylamide gel electrophoresis (PAGE), 
without SDS, in a 12% (v/v) polyacrylamide separating gel and a 4% (v/v) stacking gel in a
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Protean H apparatus (BioRad) and a constant current of 24mA at room temperature until 
the dye front reached the bottom of the gel. The gel was then electroblotted onto 
nitrocellulose (see below).
Serum samples
Each of four, six month old, specific pathogen free, female. New Zealand White rabbits 
(Charles River), were test bled and separately given 150 pg of dipyridyl grown sodium 
salicylate extract from one of the four strains, mixed with Freund’s Incomplete adjuvant 
(Sigma), by subcutaneous injection. Two subsequent monthly booster inoculations were 
given, but each extract was mixed with an equal volume of PBS without adjuvant. 
Rabbits were bled weekly and the sera were harvested; blood was kept at 4-C overnight to 
allow the clot to shrink and serum was removed and spun briefly to remove any red blood 
cells remaining. The antibody response was inonitored by immunoblotting, as described 
below.
Sera from three groups of ponies were obtained. Group A were twenty-one Welsh 
Mountain ponies aged less than six months, with no known previous contact with other 
equines. These ponies were selected as those as young as were available in the hope that 
they had been infected with, and immunologically responded to a limited range of A. equuli 
proteins, so that the pattern of their reactivity with IRPs would be more likely to be 
restricted and discriminatory. Group B consisted of twelve ponies of approximately one 
year old kept at the Animal Health Trust, Newmarket, UK and not extensively mixed with 
other ponies. Group C consisted of eight ponies of approximately eighteen months old that 
had been extensively mixed with other ponies at the Animal Health Trust.
Western immunoblotting
Sodium salicylate extracts of each culture separated by SDS-PAGE were 
electrophoretically transferred to nitrocellulose (Schleicher and Schuell) as previously 
described (Towbin et a l  1979), using a TransBlot wet blotting apparatus (BioRad; used 
according to the manufacturer’s instructions) at lOOV for 3 hours at 4*C. Blots were
68
Ward, C. 1997
shaken on a rocking platform throughout at room temperature, first in 5% (w/v) dried 
skimmed milk powder dissolved in PBS-T for one hour. After washing in three changes of 
PBS-T, once for 15 minutes then twice for five minutes, horse or rabbit antiserum diluted 
1:100 in PBS-T was added, for 1 hour. After washing in PBS-T as described above, 
horseradish peroxidase (HRP) conjugated anti-horse or anti-rabbit immunoglobulin 
(Sigma) diluted 1:10 000 in PBS-T, was added for 1 hour. After washing in five changes 
of PBS-T, once for 15 minutes and four times for 5 minutes, proteins which bound serum 
antibody, and hence HRP conjugate were detected with Enhanced Chemiluminescence 
detection reagents (ECL, Amersham).
Rxamination of bacterial cell morphology and medium viscositv
Cultures of each isolate shaken at 150 rpm for 18 hours with or without 2,2-dipyridyl, were 
compared by the Gram staining technique. Viable counts were made for each culture, and 
aliquots were spun for 1 minute in a microfuge, then culture supernatants were quickly 
analyzed in a viscometer (Viscometer IT; Coulter Diagnostics) and viscosity measurements 
were compared with those of sterile culture medium with or without ITOpM 2,2-dipyridyl 
added.
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Results and Discussion
Utilization of iron compounds for growth bv A. equuli
All isolates of A. equuli grew around wells containing equine holotransferrin, ferric 
ammonium citrate and ferrous sulphate on medium containing enough 2,2-dipyridyl to 
completely inhibit growth without supplements, but not around wells containing equine 
apo-transferrin, haemin, myoglobin, cytochrome C, ferritin, or haemoglobin, or human 
holotransferrin or rabbit holotransferrin. Growth of all of the isolates on medium without
2,2-dipyridyl added was confluent.
Binding of holotransferrin bv A. eauuli cells and sodium salicvlate extracts 
Whole cells of each isolate grown in iron limited conditions and coated onto nitrocellulose, 
bound equine holotransferrin. However, when the A. equuli isolates were grown in iron 
replete medium, transferrin binding could not be detected for any of the isolates (Figure 
1).
Sodium salicylate extracts of isolates S, X and Y grown in iron limited conditions tested in 
the same way also bound equine holoteansfcrrin when mixed with PBS, or PBS containing 
0.2% (w/v) 2-mercaptoethanol, but did not bind transferrin when mixed with PBS 
containing 0.1% (w/v) SDS. None of the extracts of isolates grown in iron replete medium 
were seen to bind transferrin and no binding ability could be detected by extracts of isolate 
R in any of the conditions tested. None of the resuspended culture media, or the sodium 
salicylate extracts separated by native PAGE and transferred to nitrocellulose, bound 
equine holotransferrin.
Proteins in extracts of isolates grown in iron limited and replete media 
The distribution of proteins of different molecular mass in silver stained SDS-PAGE gels 
of extracts were complex but similar between isolates irrespective of whether they were 
grown in medium in which iron was replete or limited. All four isolates contained seven 
proteins in extracts of cultures grown in iron limited conditions which were absent or
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much fainter in extracts of cultures grown in iron replete conditions (iron regulated 
proteins, IRPs). The molecular masses of these were approximately 99, 73, 69, 65, 60, 48 
and 20.5 KDa (Figure 2 and Table 3).
The 99 KDa IRP was faintly detectable in the iron replete extracts of three of the isolates 
and the 73, 69 and 65 and 48 KDa IRPs were present faintly in all of the iron replete 
extracts. The 60, 20.5 and 20 KDa proteins could not be detected in the iron replete 
extracts. Polypeptides induced by the iron replete culture conditions were not detected. 
Constitutively produced proteins were of similar molecular mass for all four A. equuli 
isolates.
Antigenic relatedness of IRPs and other proteins characterized using immune rabbit 
antisera
Pre immune sera contained antibodies to some of the major non-IRPs detected in 
immunoblots of sodium salicylate extracts of both iron limited and replete cultures of the 
isolates R,S,X and Y (Table 4), suggesting that the rabbits had encountered similar 
determinants before and that there is a high degree of cross-reactivity between A. equuli 
and other bacteria colonizing rabbits.
Immunoblotting detected antibodies in immune sera to all of the R,S,X and Y IRPs seen in 
stained gels (99, 73, 69, 65, 60, 48 and 20.5 KDa) in homologous reactions to and in many 
heterologous reactions (Figures 3-6). An additional 36KDa protein, which could be an IRP 
was detected in all extracts, which was undetectable in stained SDS-PAGE gels, possibly 
because of eo-migration with non-IRPs.
Sonie of the IRPs were not detected in some of the heterologous reactions, but were 
detected in homologous reactions, which indicated that failure to detect antibodies in 
heterologous antisera was due to antigenic differences between these proteins in the 
different isolates (Figures 3-6).
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The IRPs of isolates R and X were the least cross-reactive, although each antiserum had 
cross-reactive antibody to one polypeptide of 48 KDa. The IRPs of R and S showed 
mutual strong antigenic cross-reactivity. The IRPs of Y showed strongest antigenic cross­
reactivity to those of S. Many IRPs of S and Y reacted with antibody in antisera to R and 
X. However, the antibodies in antisera to S and Y had a more restricted pattern of 
reactivity for IRPs of isolates R and X.
Antigenic relatedness between IRPs and other proteins of isolates R,S.X and Y 
characterized using equine sera
Three separate sets of pony sera designated A, B and C, were tested for antibody to IRPs 
and non-IRPs in extracts of each isolate separated by SDS-PAGE and transferred to 
nitrocellulose (Figure 7). The pony sera were more discriminating than the rabbit sera and 
showed less cross-reactivity. There were however, antibodies in most sera to many of the 
non-IRPs in extracts of,all of the isolates, and to the 36KDa IRP detected with immune 
rabbit antisera.
Antibodies in the sera of some group A ponies, reacted with IRPs in extracts of isolates X 
and Y. Most of the reactivity for the IRPs of isolate Y was for the 73 KDa polypeptide 
whereas for isolate X it was for polypeptides of 60 KDa and below. None of the group A 
sera had antibodies to the IRPs of extracts of R or S although rabbit antisera to IRPs in 
isolate Y were strongly cross-reactive for those in isolate S.
Antibodies in the sera of group B ponies also reacted with IRPs in extracts of isolates X 
and Y, but not R or S. There were only antibodies to the 48 KDa and 20.5 KDa IRPs in 
extracts of both X and Y isolates. Antibody in most of the sera reacted to some non-IRPs 
present in all four extracts.
Antibodies in all of the group C pony sera reacted with some IRPs in the extracts of all 
four isolates. The reactivity of antibodies in these sera to extract Y was for a broader range 
of IRPs than for isolate X, whose IRPs of only 60 KDa and below were detected.
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Conversely, antibodies were only detected in the extract of isolate R to IRPs of 60 KDa 
and above. Antibodies in all sera reacted with a broad range of IRPs in the extract of 
isolate S. The pattern of reactivity to IRPs in extracts of isolates R and X were most 
different as antibodies in most sera detected IRPs of 60 KDa and above in extract of isolate 
R, but detected IRPs of 60 KDa and below in extract of X.
Comparative cell morpholoev and viscositv of A. equuli cultures grown in iron limited and 
replete media
Microscopic examination of all cultures revealed that bacteria grown in the presence of 
2i2-dipyridyl appeared shorter and were more darldy stained by the safranin counterstain 
used in Gram staining, than those grown in the absence of 2,2-dipyridyl. There was no 
difference in the viscosity of TSB with or without 2,2-dipyridyl. The viscosity of the 
culture supernatants of both media increased upon inoculation and incubation in the case 
of all four isolates. However, the relative viscosity of culture supernatants containing 2,2- 
dipyridyl increased more than those without 2,2-dipyiidyl (Figure 8). Interestingly, the 
supernatant viscosity diminished as the time after centrifuging the cultures was increased.
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Figure 1. Binding o f equine holotransferrin by A. equuli isolates R, S, X and Y, grown in 
iron limited conditions and in standard medium. Columns 1,3,5 and 7 show isolates R, S, 
X and Y respectively, grown in standard medium. Columns 2,4,6 and 8 show isolates R, S, 
X and Y respectively, grown in iron lim ited medium. The left hand column shows the 
number o f cells comprising each dot, in duplicate.
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Figure 2. Silver stained SDS-PAGE o f  sodium salicylate extracts o f A. equuli isolates R, 
S, X and Y, grown in iron limited and standard culture media. Lanes 2,4,6 and 8 show 
extracts o f isolates R, S, X and Y respectively, grown in standard medium. Lanes 3,5,7 and 
9 show extracts o f isolates R, S, X and Y respectively, grown in iron limited medium. 
Lanes 1 and 10 show high m olecular weight and Dalton Mark Vll-L standards (Sigma). 
IRPs are indicated by their molecular mass (KDa).
1 2 3  4 5  6  7 8 9  10
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Figure 3. Immunoblot o f rabbit antisera to sodium salicylate extracts o f A. equuli isolates 
R, S, X and Y, with isolate R extract polypeptides (KDa), made from culture in iron 
limited and standard media. Lanes 1,3,5 and 7 show the reactions o f antisera to extracts o f 
isolates R, S, X and Y respectively, grown in standard medium. Lanes 2,4,6 and 8 show 
the reaction o f  antisera to extracts o f isolates R, S, X and Y respectively, grown in iron 
limited medium.
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Figure 4. Immunoblot o f rabbit antisera to sodium salicylate extracts o f /I. equuli isolates 
R, S, X and Y, with isolate S extract polypeptides (KDa), made from culture in iron limited 
and standard media. Lanes 1,3,5 and 7 show the reactions o f antisera to extracts o f isolates 
R, S, X and Y respectively, grown in standard medium. Lanes 2,4,6 and 8 show the 
reactions o f antisera to extracts o f  isolates R, S, X and Y respectively, grown in iron 
limited medium.
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F igure  5. Immunoblot o f rabbit antisera to sodium salicylate extracts o f A. equuli isolates 
R, S, X and Y, with isolate X extract polypeptides (KDa), made from cultures in iron 
limited and standard media. Lanes 1,3,5 and 7 show the reactions o f  antisera to extracts o f 
isolates R, S, X and Y respectively, grown in standard medium. Lanes 2,4,6 and 8 show 
the reactions o f  antisera to extracts o f isolates R, S, X and Y respectively, grown in iron 
limited medium.
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F igure  6. Immunoblot o f rabbit antisera to sodium salicylate extracts o f A. equuli isolates 
R, S, X and Y, with isolate Y extract polypeptides (KDa), with cultures in iron limited and 
standard media. Lanes 1,3,5 and 7 show the reactions o f antisera to extracts o f isolates R, 
S, X and Y respectively, grown in standard medium. Lanes 2,4,6 and 8 show the reactions 
o f  antisera to extracts o f  isolates R, S, X and Y respectively, grown in iron limited 
medium.
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Figure 7. Iron restriction proteins (IRPs) o ï A ctinobacilh is equuli isolates R, S, X 
and Y, separated by SDS-PAGE and immunoblotted, detected by antibodies in the sera 
o f pony groups A (< 6 months old) , B (12 months old) and C (18 months old)
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4.0 CHAPTER FOUR
VARIATIONS IN TH E AN TIGENICITY. OPSO NOG ENICITY AND 
RESISTANCE TO PHAGOCYTOSIS O F D IFFEREN T ISOLATES OF 
STREPTOCOCCUS ZOOEPIDEMICUS FROM  TH E FO U IN E TRACHEA.
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Objectives
The aims of the study were i) to investigate the antigenic relatedness between M-like 
proteins of the five distinct S. zooepidemicus isolates using immunoblotting and assays of 
opsonisation; ii) to develop a mouse model of challenge; iii) to assess the potential of 
bacterin immunization to protect against homologous challenge in a mouse model: iv) to 
assess the potential for cross-protection between isolates with the most dissimilar M-like 
proteins and opsonogenic determinants and v) to determine the relatedness of these isolates 
using the ribotyping scheme described by Chanter et al, (1996).
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Sum m ary
Five isolates of Streptococcus zooepidemicus, cultured from tracheal lavage samples taken 
from horses in separate outbreaks of lower airway disease, contained a similar polypeptide 
profile when hot acid extracts were analyzed by SDS-PAGE. These extracts are said to 
comprise mostly of M-like protein fragments, which are thought to be antiphagocytic. 
Immunoblots probed with rabbit antisera to the extracts of each isolate revealed a complex 
pattern of antigenic variation between the isolates, with some cross-reactivity. A 
ribotyping scheme based upon the 16S-23S RNA intergenic spacers (Chanter et al., 1996) 
confirmed that these three were of the same ribotype, whilst the others were both different.
Each antiserum opsonised at least two of the isolates, in phagocytosis assays using rabbit 
blood as a source of polymorphonuclear leukocytes (PMN). A similar assay employing 
naturally occurring opsonic antibodies in ponies, using whole pony blood, suggested that 
there were no cross-reactive opsonins for all five S. zooepidemicus isolates. No 
relationship could be found between ribotype / antigenic profile and opsonogenic behavior, 
suggesting that M-like protein is not necessarily the principal anti-phagocytic mechanism 
for these isolates, at least in vitro.
Two of the isolates were selected for the greatest dissimilarity based on the results of 
immunoblots and phagocytosis assays to assess the potential for cross-protection in a 
mouse challenge model. Intranasal challenge of several inbred strains of mice was not a 
reliable respiratory model of infection. Intraperitoneal challenge however, was more 
reliable and was chosen to assess the effects of immunization. Immunization with 
formalin killed bacteria in Freund’s incomplete adjuvant followed by homologous 
challenge significantly delayed the time to euthanasia in extremis against homologous 
infection, but too few mice survived to test any protective effect of immunization against 
heterologous challenge.
Analysis of a much greater number of isolates would be required to determine how many 
types of S. zooepidemicus should be included in an equine vaccine; this preliminary work
W ard,C. 1997
suggests that more than one type would be needed to provide protection against a broad 
range o f isolates.
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M aterials and methods
Bacteria
S. zooepidemicus isolates from the tracheal washes of five horses with evidence of lower 
airway disease, supplied by the Animal Health Trust s (Newmarket, U.K.) diagnostic 
laboratory, were labeled A, B, C ,D and E; A came from a Thoroughbred horse trained in 
Newmarket, Suffolk in November 1992; B came from a horse trained in Sussex in May 
1992; C came from a Thoroughbred horse trained in Yorkshire, in November 1991; D 
was from a Thoroughbred horse trained in Lamboum, in M ay 1992. E came from the lung 
of a Welsh pony, examined post mortem, in June 1993 . All were present in tracheal 
washes in numbers greater than 10  ^ cfu / ml in association with mucopus and large 
numbers of polymorphonuclear leukocytes.
Colonies were beta haemolytic, mucoid, transparent, catalase negative, and of 
approximately 2mm in diameter. Gram staining revealed gram positive cocci of 
approximately 0.3-0.4pm  diameter. One colony of each isolate was used to inoculate a 
10ml THB, which was incubated statically for 18 hours, then ten drops of culture and four 
drops of horse serum (Unipath Ltd) were used to inoculate separate purple indicator broths 
(Purple broth base, Difco; made according to m anufacturer’s instructions) containing 
either salicin, sorbitol, lactose, or trehalose. After 24 hours incubation, the S. 
zooepidemicus isolates were positive (green/yellow colour) for lactose, salicin and sorbitol, 
but negative for trehalose (remained purple).
Culture media
Streptococci were stored at -50 C, revived and maintained as described for Pasteurella / 
Actinobacillus isolates in Chapter 2, but Todd Hewitt broth (THB; Unipath Ltd) was used 
in place of TSB for broth cultures. Incubations were at 37-C unless stated otherwise, and 
blood agar plates were incubated in the presence of 5% (v/v) carbon dioxide in air.
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Preparation of M -like proteins
Methods reported by Boschwitz et al. (1991), were modified as follows: An 18 hour 10ml 
THB static culture incubated at 37-C for each isolate was inoculated into a separate 500ml 
THB and incubated at 37-C with continuous shaking. Bacteria were harvested by 
centrifugation at 10 OOOg (Sorvall RC-5B, GSA rotor) at 4-C for 20 minutes, then washed 
in PBS and centrifuged at 12 OOOg (Sorvall RC-5B, SS34 rotor) twice for thirty minutes. 
Cells were extracted in IM  hydrochloric acid at pH 2.5 and 100-C and neutralized after 
five minutes with IM  sodium hydroxide. Cells were pelleted by centrifugation at 12 000 
g (Sorvall RC-5B, SS34 rotor) for 30 minutes. Supernatant fractions were dialyzed against 
two changes of 3 litres of PBS, at 4-C with stirring over 24 hours. The protein 
concentrations of the extracts were measured using a bicinchoninic acid assay (Pierce).
SDS-PAGE
Acid extracted M-like proteins (equivalent to 20pg of protein) were analyzed by SDS- 
PAGE and silver staining as described in Chapter 3.
Serum samples
Each of five six month old, specific pathogen free, female. New Zealand W hite rabbits 
(Charles River) were test bled, then separately immunized with 25pg of extract from one 
of the five isolates mixed with an equal volume of Freund’s Incomplete adjuvant (Sigma), 
by subcutaneous injection. Three subsequent monthly booster inoculations were given, but 
each extract was mixed with an equal volume of PBS without adjuvant. Rabbits were bled 
weekly and the sera were harvested. The antibody response was monitored by 
immunoblotting, as described in Chapter 3.
The sera from three groups of young ponies named A, B and C, described in Chapter 3, 
were selected in the hope that they had been infected with, and immunologically responded 
to a restricted range of S. zooepidemicus, so that the pattern of their reactivity with M-like 
proteins of isolates would be restricted and discriminatory.
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W estern immunoblotting
Hot acid extracts separated by SDS-PAGE were transferred to nitrocellulose and tested for 
binding of antibody as described in Chapter 3.
Characterization of the S. zooepidemicus isolates using rabbit opsonic antisera and equine 
whole b lood ,
Rabbit antisera were tested for their ability to separately opsonise each of the five isolates 
as follows: An 18 hour statically incubated culture of each S. zooepidemicus isolate was 
diluted 1:4 in PBS, then 6pl of diluted culture was mixed with a separate microcentrifuge 
tube containing 150pl of one of the rabbit antisera and 450pl of whole, hepannised naive 
rabbit blood. Control mixtures contained pre-immune rabbit sera, which replaced rabbit 
antisera; all tubes were mixed at 37-C for 2 hours. At the beginning and end of the 
incubation period, an aliquot from each tube was serially diluted in PBS and spread plate 
inoculated onto horse blood agar which was incubated for 18 hours. Blood agar plates 
with between 30 and 330 colonies were counted and the number of colony forming units 
per millilitre (cfu/ml) were calculated from the dilution. The percentage reduction in 
cfu/ml against controls after two hours incubation were calculated. This was repeated 
three times and the mean percentage growth/reduction calculated.
A 15pl aliquot of an 18 hour statically incubated culture of each S. zooepidemicus isolate 
was mixed separately with each heparinised blood from five 9 month old ponies (from 
group A, see Chapter 3), for two hours at 37-C. Antibody naturally present acted as an 
opsonin. The percentage reductions in cfu/ml were calculated using a similar method to 
that employed for the rabbit anti serum experiments, with the exception that the numbers of 
bacteria at the start of the incubation was used as a control. Each assay was repeated five 
times and the mean percentage growth/reduction calculated. Sera from the same ponies 
were also used in immunoblots against hot acid extracts of each S. zooepidemicus isolate 
as described above.
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Ribotyping of isolates with primers for the 16S-23S RNA intergenic spacer.
DNA was extracted from each isolate, then PCR and agarose gel electrophoresis carried 
out as described by Chanter et a l  (1996). Briefly, DNA was extracted using guanidine 
thiocyanate and prepared for PCR using the W izard DNA Clean Up System. PCR was 
carried out using a set of eight primers derived from the variant sequences of regions 1 and 
5 to 6 of the Lancefield Group C 16S-23S RNA gene intergenic spacer. PCR products 
were analyzed by agarose gel electrophoresis and each isolate assigned to one of eight 
types according to which combinations of reactions were positive.
Attempts to develop a murine intranasal challenge model of S. zooepidemicus infection 
Selection of a susceptible inbred strain  of mouse, (Experim ent 1). Females of four 
inbred strains of mouse were tested for susceptibility to intranasal challenge with 
Streptococcus zooepidemicus ( C3H, BalbC, C57/BL6 and CBA/CA). Six of each strain 
were given 5 x 10  ^cfu of isolate C shaken for four hours in THB intranasally and 
symptoms noted for five days. After euthanasia, specimens of lung, thymus, myocardium, 
spleen, kidney and liver were collected in neutral buffered formalin for histopathology. 
Longitudinal decalcified sections of each mouse head were also prepared to include the 
nasal and oral cavities, pharyngeal tissues and brain.
Effect of increasing the in tranasal challenge dose, (Experim ent 2). Six individually 
marked female CBA/CA mice were given 5.6 x 10^ cfu of isolate C shaken for four hours 
in THB, intranasally. Individual mouse weights were recorded daily and after euthanasia 
at five days, samples were taken as above for histopathology.
In tranasal challenge and histopathology in mice a t post m ortem  examination at daily 
intervals, (Experim ent 3). Thirty female CBA/CA mice were given 2.1 x 10  ^ cfu of 
isolate C and six mice were kept as controls. All mice were individually marked and 
controls were kept separately. Mice were weighed and after daily euthanasia of five test 
plus one control mouse, histological samples were taken as above with the addition of
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pancreas, adrenal gland, thyroid gland, nasal and oro-pharangeal mucosa, brain and 
mandibular lymph node.
Attem pts to enhance the virulence of the S. zooepidem icus challenge (Experim ent 4).
Isolate C was grown for four hours with 10% sterile foetal calf serum and 4.6 x 10^ cfu 
was inoculated intranasally into each of six female CBA/CA inbred mice. After 
euthanasia, three days later, specimens of mandibular lymph node, thymus, lung, 
myocardium, liver, spleen, kidney, pancreas, ovary and uterus were collected in neutral 
buffered formalin for histopathology.
Development of a murine intraperitoneal challenge model of S. zooepidemicus infection 
LDiooof 5. zooepidem icus isolates C and D, (Experim ent 5). Tenfold serial dilutions in 
PBS of 18 hour static cultures of isolates C and D in THB were inoculated 
intraperitoneally into female CBA/CA mice, at doses of between 7 cells and 9.5 x 10’ cfu 
per mouse for isolate C, and between 7 cells and 9.7 x 10’ cfu per mouse for isolate D.
Eight mice were inoculated per dilution. After euthanasia, when clinical signs suggested 
the development of systemic infection, samples of liver, spleen, lung and nares were 
collected and inoculated onto horse blood agar and incubated for 18 hours.
Vaccination and homologous in traperitoneal challenge, (Experim ent 6). Cultures of 
isolates C and D grown to I x I O *  cfu/ml were made into bacterins by incubation for four 
hours with shaking in the presence of 0.01% (v/v) formalin. Each bacterin was separately 
mixed with an equal volume of FIA and O.Iml was administered intraperitoneally to 
separate female CBA/CA mice for each isolate. This was followed by a booster dose, 
prepared with FIA as the first, one month later. Twenty mice were kept as un vaccinated 
controls. One month later, as part of what was intended to be immunization to test 
heterologous challenge, all vaccinates were challenged intraperitoneally with O.Iml of 18 
hour static culture in THB of the homologous isolate and the control mice were similarly 
challenged for each isolate. Immediately prior to challenge, plasma was collected from
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five mice of each group, plus the control group, from the tail tip and allowing 
approximately 20pl of blood to mix with 180pl of PBS containing heparin (a dilution of 
approximately 1:10). After euthanasia, when clinical signs suggested the development of 
systemic infection, samples of liver, spleen and lung were collected and inoculated onto 
horse blood agar and incubated for 18 hours. Plasma was collected from mice who 
recovered from the challenge before euthanasia. All plasma samples were tested against 
immunoblots of homologous isolate hot acid extracts at a dilution of 1:100 and detected 
with a horse radish peroxidase labeled anti mouse conjugate (Sigma) at a dilution of 
1:2000. All other method details were as above for rabbit antisera immunoblotting.
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Results and discussion
Antigenic relatedness of proteins in hot acid extracts of different S. zooepidemicus isolates 
characterized using immune rabbit antisera
SDS-PAGE gels of extracts stained with silver, showed that all of the isolates possessed a 
number of polypeptides of a similar distribution of molecular masses (Figure 8). 
Immunoblotting detected antibodies in rabbit antisera to some of the polypeptides seen in 
stained gels in homologous reactions and fewer in heterologous reactions. For example, 
twelve polypeptides of isolate A reacted with antibodies in homologous antiserum, but 
only 6, 11, 6 and 6 polypeptides reacted with antibodies in the antisera to isolates B, C, D 
and E, respectively (Figure 9-13).
The polypeptides that reacted with antibodies in the different antisera are detailed in Table
6. Some polypeptides of the same molecular mass in all extracts reacted with antibodies in 
all of the antisera. The 41 KDa polypeptide is a typical example. Other polypeptides 
present in all extracts, however, did not react with antibodies in all of the antisera. The 52 
KDa polypeptide in extract B is an example of this. Examination of the silver stained 
SDS-PAGE gels showed that this polypeptide was present in extracts of A, C, D and E, but 
was fainter. Failure of antibodies to react with this in these extracts may have been related 
to low antigenic weight. Variation in the amounts of some polypeptides in the extracts 
may have been due to variation in acid hydrolysis between isolates since great care was 
taken in standardizing the conditions employed for this extraction method. The number 
and sizes of hydrolysis products may vary for surface proteins on different isolates that are 
nonetheless antigenically related.
Since antisera to isolates A and C contained antibodies to more polypeptides in the extract 
of isolate E than antiserum to E, the rabbits immunized with A and C may have responded 
better, rather than this difference being due to differences in the surface polypeptides of the 
isolates. However, not all differences may be explained in this way since the antibodies in 
some homologous anti sera reacted with more polypeptides in homologous extracts than 
any of the heterologous extracts, suggesting real antigenic differences. The anti serum to
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isolate B was a clear example of this (Table 5). Nonetheless, the immunogenic and 
antigenic hydrolytic breakdown products were similar in molecular mass between isolates 
and antibodies in rabbit antisera suggest that they are strongly antigenically related.
Antigenic relatedness of polypeptides in hot acid extract proteins of S. zooepidemicus 
isolates characterized using equine sera
Three separate sets of pony sera designated A, B and C, were tested for antibody to 
polypeptides in hot acid extracts of each isolate separated by SDS-PAGE and transferred to 
nitrocellulose.
All twenty-one of the group A ponies had antibodies to a 52KDa polypeptide in extracts of 
isolates A and D, whilst few had antibody to the 52KDa polypeptide in extracts of isolates 
B and E, and none to an equivalent polypeptide in the extract of isolate C. This was in 
spite of a possible problem of insufficient antigen in extracts of A and D suggested by the 
results obtained with the rabbit antisera. Since rabbit antisera to four of the isolates 
contained antibody which reacted with this polypeptide in the extract of B, the lack of 
antibody in equine sera which nonetheless reacted with a 52 KDa component in some of 
the other isolates suggest antigenic variation. Furthermore, this difference could only be 
identified using antibodies present naturally in equine sera.
Thirteen ponies had antibody to polypeptides of 46 to 36KDa in the extract of isolate D, 
but antibodies reacting with this range of polypeptides in the extracts of the other isolates 
were present in far fewer ponies. Sixteen, thirteen, eight and zero ponies had antibody to 
a 46KDa polypeptide in extracts of isolates B, C, A and E respectively. Nineteen ponies 
had antibody to the 35KDa polypeptide in extracts of isolates B and C, which was not 
reactive with the 36KDa polypeptides in extracts of the isolates A or E.
Group B pony sera (n=12) had no antibody to the polypeptides in the extract of isolate C, 
but there was antibody to a range of polypeptides in the extracts of isolates A and B and at
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least the 46 and 35KDa polypeptides in the extracts of isolates D, and E. Ten ponies had 
antibody to a 52KDa polypeptide in the extract of isolate A.
Group C pony sera (n=8), did not have any antibody to the polypeptides in the extracts of 
the isolates C and D, but had antibody to a broad range of polypeptides in the extract of 
isolate B. There was a narrower range of antibody reactivity for polypeptides in the 
extracts of the isolates A and E.
The sera of all three groups of ponies were more discriminating between the antigens of 
different isolates than the rabbit antisera and showed less cross-reactivity.
Characterization of the S. zooepidemicus isolates using rabbit opsonic antisera 
The opsonic activity of antisera to extracts of the five isolates were tested against 
the homologous and heterologous isolates (Table 7). Heparinised non-immune rabbit 
blood was used as a source of neutrophils rather than equine cells to rule out the possible 
lack of recognition of rabbit opsonins by equine polymorphonuclear leukocytes. Sera from 
the rabbit blood used as a source of neutrophils and complement for the assay did not 
show any reactivity for polypeptides in any of the extracts of isolates A-E in immunoblots 
of SDS-PAGE gels and pre-immune serum was not opsonic in blood from these animals. 
This was a surprising result because antisera to isolates A and E were opsonic for other 
isolates.
Isolates B and C were uniformly phagocytosed by all five antisera. The behavior of isolate 
D was more complex, with a reduction in cfu’s for two replicates of the assay, but growth 
in another, even with the homologous antiserum. Isolate A was generally not 
phagocytosed. Isolate E grew in the presence of all antisera including the homologous 
antiserum.
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Characterization of the S. zooevidemicus isolates using equine whole blood 
Equine blood was used as a natural source of antibody as well as complement and 
polymorphonuclear leukocytes, which might have the potential to discriminate between 
opsonogenic antigens of the different isolates according to their history of related S. 
zooepidemicus infection (Table 8). Five ponies from group A were bled on five 
occasions over a ten day period. Isolates B and C were phagocytosed by all of the blood 
samples. Isolate A was resistant to phagocytosis in the first two blood samples but 
susceptible in subsequent samples suggesting the development of immunity over the period 
during which blood samples were taken; some nasal mucopurulent discharge and coughing 
associated with the presence of S. zooepidemicus was noticed in this group of animals.
Isolates D and E were inconsistently phagocytosed and, therefore, results for these were 
difficult to interpret. Blood from two of the ponies reduced cfu’s of isolate D but not on 
all occasions. Isolate E was generally susceptible to phagocytosis with the blood of all of 
the ponies but not always to as great an extent as seen with isolates B and C.
Reaction of antibodies in sera from ponies used as a source of blood for phagocytosis 
assessed against extracts of the S. zooepidemicus isolates in immunoblots of SDS-PAGE 
gels
Sera from all ponies collected at the end of phagocytosis tests (Table 9), reacted strongly 
with the 41 and 46KDa proteins in the extract of isolate A, but only weakly with the 72 
KDa polypeptide. The blood of two ponies (1 and 2) which reduced the numbers of isolate 
A the most in phagocytosis assays, reacted most strongly with the 46KDa polypeptide. 
Otherwise, there were a cluster of faint bands in the extract of isolate A ranging from 27- 
48KDa, to which all five ponies had antibodies and which did not appear related to 
opsonisation.
Isolate B was uniformly phagocytosed by blood from all of the ponies and surprisingly in 
contrast to earlier samples, their sera reacted strongly with a 52KDa polypeptide in the 
extract of isolate B. The first serum sample characterized by immunoblotting (see above),
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which lacked antibody to this polypeptide was taken six months earlier. A cluster of 
polypeptides of isolate B, between 26.5 and 48KDa, reacted with antibodies in sera of all 
of the ponies but to different extents.
Isolate C was generally phagocytosed by all pony bloods but not to the same extent as 
isolate B. Antibodies in all sera reacted with polypeptides between 50 and 29KDa in the 
extract of isolate C. The 36 and 44KDa polypeptides were the most strongly detected of 
these. Polypeptides of 72, 63.5, 59, and 54KDa were also detected by antibodies in all of 
the sera but with less intensity.
Four of the ponies did not have antibodies to the polypeptides of isolate D, which was 
barely phagocytosed at all; pony 3 had barely detectable antibodies to polypeptides of 84, 
78.5, 52 and 41KDa, which did not seem to confer opsonic ability. All sera contained 
antibodies to the polypeptides of isolate E of 33 to 21 KDa and blood from these ponies 
generally phagocytosed this isolate. In contrast, the rabbit antisera were not opsonic and 
did not react with the 33 KDa polypeptide. It is more difficult to determine whether the 21 
and 22 KDa polypeptides detected by the different species of antisera were distinct or not.
Ribotvping of isolates with primers for the 16S-23S RNA intergenic spacer 
Isolates A, C and D were type A I, which had regions Ia,5a,6a and 7a. Isolate E was type 
0 2 , which had regions lb,3,5b,6b and 7c. Isolate B was type B I, which had region la  
(like type A l)  and regions 5b,6b and 7c (like type D2). To assess if there was any 
association between ribotype and the possession of other properties, all analyses of S. 
zooepidemicus variation were examined for factors which might distinguish isolates E and 
B, but unite the others. In immunoblots of hot acid extracts with rabbit antisera (25KDa 
polypeptides and above), it was found that there was antibody detectable to a broader 
polypeptide size range for isolate B than isolates A,C and D, and antibody to a narrower 
range in isolate E, although there was no correlation between ribotype and antibody raised 
to specific polypeptides.
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Attempts to develop a murine intranasal challenge model of S. zooepidemicus infection 
Selection of a susceptible inbred strain  of mouse, (Experim ent 1). Four of the 
CBA/CA mice challenged with 5 x lO ^cfuof isolate C had significant histological lesions, 
whereas only one of the C57/BL6 mice and none of the BalbC or C3H mice were affected. 
CBA/CA mice were selected for further development of the challenge model. Of the four 
CBA/CA affected mice, two had spleen, heart and lung lesions, one had meningitis and 
early splenitis, and one had pharyngeal abscessation and cellulitis.
Effect of increasing the in tranasal challenge dose, (Experim ent 2). To increase the 
proportion of affected mice the challenge dose was increased to 5.6 x 10^ cfu of isolate C. 
However, three days after challenge, there were no gross lesions visible on dissection or 
inflammation present, but although surface colonization of lingual and oropharyngeal 
mucosa by small to moderate numbers of streptococcus-like bacteria were seen in all mice. 
One of the mice developed abscessation of the sub-mandibular lymph nodes.
In tranasal challenge and histopathology in mice a t post m ortem  examination a t daily 
intervals, (Experim ent 3). All of the test mice on day three had lesions; These were in 
the spleen and mandibular lymph nodes, but lesions from mice exam ined post mortem on 
other days were sporadic. The relative lack of lesions in mice examined more than three 
days after challenge was regarded as an indication of the inconsistency of the model. 
There should have been lesions present in mice examined four days after challenge if at 
three days they had lesions of the severity seen in the group that was examined three days 
after challenge.
Attem pts to enhance the virulence of the S. zooepidemicus challenge, (Experiment 4).
Experience with S.equi has shown from young cultures that serum may enhance the 
virulence of the inoculum. This approach was taken with S. zooepidemicus. Only one 
mouse of the six, challenged with 4.6 x 10^ cfu grown with serum, had lesions, which were 
in the mandibular lymph nodes. The intranasal route of challenge was too inconsistent on 
which to base a model to demonstrate the effects of vaccination on.
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Development of a murine intraperitoneal challenge model of S. zooepidemicus infection 
LDioo 0 Ï  Streptococcus zooepidemicus isolates C and D, (Experim ent 5). The LDioo 
for isolate C was 9.6 x 10^ cfu/ml and for isolate D was 9.6 x 10^ cfu/ml (Figure 14). S. 
zooepidemicus was isolated from the spleen, liver and lung of all mice after euthanasia, 
but none were isolated from the nares.
Vaccination and homologous intraperitoneal challenge, (Experim ent 6).
S. zooepidemicus was isolated from samples of spleen, liver and lung from all mice after 
euthanasia as soon as clinical signs suggested a terminal septicaemia. Vaccination did not 
prevent septicaemia, but did delay the onset of symptoms. Vaccinates homologously 
challenged with isolate C survived for 24 hours or more and one recovered completely, 
whilst control mice challenged with isolate C survived for less than 24 hours. Similarly, 
vaccinates homologously challenged with isolate D survived for 18 hours or more, whilst 
control mice challenged with isolate D survived for less than 18 hours.
Only one mouse survived the experiment, in the group vaccinated and challenged with 
isolate C. Murine plasma collected immediately prior to challenge had poor reactivity to 
the hot acid extract of isolate C, but the surviving mouse had a strong reaction to a range of 
polypeptides from approximately 25 to 52 KDa and also to several low molecular mass 
polypeptides.
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Table 6. Polypeptides (approximate molecular mass in KDa) in hot acid extracts of S. 
zooepidemicus isolates A,B,C,D and E, which react with homologous and heterologous 
anti sera.
Antiserum
Extract A B C D E
A 9a 9b 9 9a 9b 9 9a 9a2 9b 9 9a 9b 9c 9a 9b 9
11 12 17 18 17 11 14 18 17 17
20 23 25 25 22 23 25 25 20
40 41 41 41 41 41
B 9 (trace) 9 9 (trace) 9
11 14 15 11 14 15 17 
25 29 
32 34
14 11 15
52 60 52 60 52 52
C 9a 9b 9 9a 9b 9 9a 9a2 9b 9 9a 9b 9c 9a 9b 9
11 17 18 18 11 18 17
22 23 23
35 35 35 35 35
46 46 46 46 46
D 9b 9c 9 9b 9c 9 9a 9a2 9b 9c 9 
11
9b 9c 9 9a 9b 9
25 25 25 25 25
41 41 41 41 41
E 9a 9b 9 
23
9a 9b 9
22 23 
35 
25
9a 9a2 9b 9
22 23 
35 
25
9a 9b 9c 9 
17
9a 9b 9 
25
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Table 7. Percentage reduction of colony forming units of each S. zooepidemicus isolate in 
rabbit blood containing homologous and heterologous rabbit antisera after 2 hours 
incubation.
Isolate
Rabbit
antiserum
A B C D E
A 26.5 10 -30.6 -18.2 19.1
51.8 60.2 59.8 63.4 71.4
40.5 59.9 48.3 74.6 61
Mean 39.6 43.4 25.8 39.8 50.5
B -96.4 -96.3 -90.9 -96.3 -92.1
-83.6 -87.4 -85.7 -93.2 -83.1
-96.1 -74.7 -95.7 -96.5 -95.8
Mean -92 -86.1 -90.8 -95.3 -90.3
C -96.4 -97 -97 -94.4 -95.2
-87.2 -85.8 -86.5 -51.1 -92.3
-85.4 -73 -91 -91.7 -91.4
Mean -89.7 -85.3 -91.5 -79.1 -93
D -1.7 -68.1 -56.9 -52.6 -62.9
58.4 >71.2 >71.2 41.6 22.1
-70.6 -40.4 -64.2 -60.6 -62.1
Mean -4.6 -12.4 -16.6 -23.9 -34.3
E 82.3 92.4 90.4 81.7 83.3
85.4 87.1 >88.5 >88.5 >88.5
>30 >30 >30 >30 >30
Mean 65.9 69.8 69.6 66.7 67.3
Positive values indicate growth.
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Table 8. Percentage reduction of colony forming units in two hours, of each S. 
zo oep idem icus  isolate in the blood of five young ponies after 2 hours incubation; 
experiment repeated on five separate occasions.
Isolate Pony num ber 
1 2 3 4 5
A 53.6 28.8 0 45.2 63.2
84.6 71.6 87.9 91.6 97.8
-20.8 -65.3 66.4 71.6 35.7
0 -70.6 -13.8 -55.9 -80.3
-60.6 -40.1 -8.2 6.3 -30.5
Mean 11.4 -15.2 26.5 31.8 17.2
B -56.1 -74.7 -77.3 -46.4 -75
-24.7 -69.5 67.7 60.9 -50.5
-83.7 -63.7 -21.6 -56.9 -100
-6.7 -8 -61.7 -36.7 -77.5
-89.5 -45.8 -36.9 -87.8 -80.6
Mean -52.1 -52.3 -26 33.4 -76.7
C -48 -80.3 -84.4 -2 -19.8
59.1 -18.1 65.2 54.2 -44.5
-70.4 -89.4 -17.3 -19.9 -87.5
-36.4 17.4 -47.6 -61.8 -71.9
Mean -23.9 -42.6 -21 -7.4 -55.9
D 42.3 -61.4 28.5 81.2 82.1
78.6 -10.4 80.2 66.6 63.5
23.2 -23.3 34.9 46.7 -80.5
28.1 24.6 39.5 18.6 8.5
24.4 56.3 25.2 29.7 -44.9
Mean 39.3 -2.8 41.7 48.6 -20.7
E -87.5 -89.6 -23.8 21.2
63.7 -62.6 >72.2 >72.2 68.8
-87.3 -84.8 “8.1 -28.1 -85.1
-14.7 -32.2 10 -2.1 -64.7
-7.4 -27.5 -8.8 -12 -43.5
Mean -26.2 -51.8 -4.9 1.2 -20.6
Positive values indicate growth.
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Table 9. Polypeptides (approximate molecular mass in KDa) in hot acid extracts of S. 
zo oep idem icus  isolates A,B,C,D and E, which reacted with antibody in the sera of the 
ponies in group A used in phagocytosis assays (sera collected at the time of the fifth
experiment).
Pony sera
1 2 3 4 5Isolate
A 82 72 63 82 82 82 82
48 46 41 48 46 41 48 46 48 46 41 48 46 41
38 34 33 30 38 34 33 30 33 30 33 30 33 30
27
52 52 52 52 52
48 46 41 48 46 41 48 46 41 48 46 44 41
32 34 32 34 32 34 32 39 37 36 34 32
29 26 29 26 29 26
C 72 63 59 54 59 54 72 63 59 54 72 63 59 54 72 63 59
*
33 32 33 32 33 32 33 32 33 32
29
D 84 52
41
E 32 33 32 33 32 33 33
21 21 29 21 22 21 29 22 21
* = a series of fine bands on immunoblots ranging from 44 to 36 KDa.
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F ig u re  8. Silver stained SDS-PAGE o f  S. zooepidemicus polypeptides (approximate 
M olecular Mass in KDa) in hot acid extracts from isolates A, B, C, D and E. Lanes 1-5 
show extracts o f  isolates A-E respectively.
66
I
45
36
24
215
fl42
107
W ard,C . 1997
Figure 9. Immunoblot showing the reaction o f rabbit antisera to hot acid extracts o f 
S. zooepidemicus isolates A, B, C, D and E with isolate A polypeptides (approxim ate 
M olecular M ass in KDa). Lanes 1-5 show  antisera  to extracts o f  iso lates A-E 
respectively.
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Figure 10. Immunoblot showing the reaction o f rabbit antisera to hot acid extracts o f S. 
zooepidemicus isolates A, B, C, D and E with isolate B polypeptides (approxim ate 
M olecular Mass in KDa). Lane 1 shows antisera to extract o f  isolate E, lane 2 to D, lane 3 
to B, lane 4 to C and lane 5 to A.
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Figure 11. Immunoblot showing the reaction o f rabbit antisera to hot acid extracts o f 
S. zooepidemicus isolates A, B, C, D and E with isolate C polypeptides (approxim ate 
M olecular M ass in K D a). Lanes 1-5 show  antisera to ex tracts o f  iso lates A -E 
respectively.
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Figure 12. Immunoblot showing the reaction o f rabbit antisera to hot acid extracts o f 
S. zooepidemicus isolates A, B, C, D and E with isolate D polypeptides (approxim ate 
M olecular M ass in K D a). Lanes 1-5 show antisera to ex tracts o f  iso lates A-E
respectively.
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Figure 13. Immunoblot showing the reaction o f rabbit antisera to hot acid extracts o f 
S. zooepidemicus isolates A, B, C, D and E with isolate E polypeptides (approxim ate 
M olecular M ass in KDa). Lanes 1-5 show  antisera  to extracts o f  isolates A-E 
respectively.
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5.0 CHAPTER FIVE
CHA RACTERISATION AND CLONIN G OF A STREPTOCOCCAL 
HYALURONATE ASSOCIATED PROTEIN AND ITS ASSESSM ENT AS 
A PROTECTIVE IM M UNOGEN IN A M U RINE STREPTOCOCCUS 
ZOOEPIDEMICUS CHA LLENGE MODEL.
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Objectives
The aims of this work were: i) to attempt to purify the equivalent of the S. equisimilis 
HAP from a highly encapsulated strain of S. equi, from culture supernatant, using a 
modified cholate-solubilization method (Prehm and Mausolf, 1986); ii) to test for the 
presence of HAP by PCR using primers based on the DNA sequence previously published 
for S. equisimilis (Lansing et al. 1993); iii) to clone and express the S. equi HAP, if 
present; iv) to produce antibodies to HAP and recombinant to assess their effects on 
capsulation in vitro", and v) to assess the possibility of protecting against S. zooepidemicus 
in a mouse model of infection.
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Sum m ary
The capsule of S. equi, the cause of strangles, and S. zooepidemicus, associated with equine 
lower airway disease, plays an important role in evading phagocytosis by 
polymorphonuclear leucocytes. It is composed of hyaluronate, making it non- 
immunogenic. A protein, previously described as being strongly bound to cell associated 
and dissolved hyaluronate (hyaluronate associated protein or HAP) from S. equisimilis, 
was investigated (a) for its presence in S. equi and S. zooepidemicus and (b) as a surrogate 
immunogen for the capsule structure with the potential to protect against experimental 
challenge of mice. The purified capsule of S. equi contained a protein of similar 
molecular mass to the S. equisimilis protein (approximately 53 KDa). Primers derived 
from the published sequence of the S. equisimilis protein in a polymerase chain reaction 
(PCR) yielded a product from S. equi and S. zooepidemicus of the expected size and 
endonuclease restriction fragment pattern. The PCR product from S. equi was blunt end 
cloned in frame into the expression vector pPt-Lambda. However, when expression was 
induced in E. coli N4830-1 the recombinant plasmid was stable only if cloned in the 
orientation opposite to that required for expression. Subcloning of two large in frame Ssp I 
fragments of the HAP gene, approximately equivalent to the two halves of the molecule, 
into the expression vector pGEX-3X yielded only the back half in the correct orientation 
(Fragment 4). Two overlapping fragments of the front half would not express in pGEX-3X 
(Fragments a and b), so the front half was expressed as three non-overlapping fragments 
(Fragments 1,2 and 3). Rabbit anti serum to the native protein in purified hyaluronate 
reacted strongly in immunoblots with the glutathione S transferase (GST) fusion product. 
This antiserum and antiserum to the recombinant fusion protein, when soaked into filter 
paper strips, caused a diminution of capsule production by S. equi cultured on blood agar. 
Neither anti serum supplemented into fresh rabbit blood was opsonic for S. equi. 
Immunization with recombinant HAP significantly increased survival time and clearance 
of bacteria in mice challenged intraperitoneally with S. zooepidemicus.
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M aterials and methods
Bacteria and culture media
An isolate of S. equi from the sub-mandibular abscess of a New Forest pony with 
Strangles, in 1990, and S. zooepidemicus isolate C (see Chapter 4), were used throughout; 
both were stored at -50C on cryobeads (Microbank). Stored cultures were revived and 
maintained by culture on horse blood agar (Wilkins-Chalgren anaerobe agar (Unipath Ltd), 
supplemented with 5% (v/v) citrated horse blood) at 37C for 18 hours; where appropriate 
sub-cultures were made in Todd-Hewitt broth at 37C for 18 hours (THE; Unipath). 
Challenges for mice were made by using a 5% (v/v) inoculum of an overnight THE culture 
into THE and incubation at 37C with shaking at 200 rpm for 4 hours.
The transformation competent E. coli strains N4830, N99, JM109, TG I and DHIOE used 
for recombinant HAP production were stored at -70C in 20% (v/v) glycerol in Luria 
Eertani broth (LE); these were propagated in LE broth, or LE agar, with added 80pg/ml 
5-bromo-4-chloro-3-indolyl-6-galactopyranoside (X-gal), lOOpM isopropyl- 
thiogalactoside (IPTG) and lOOpg/ml ampicillin (Sigma) when appropriate. All 
incubations of THE and LE cultures were at 37C unless stated otherwise and blood agar 
plates were incubated at 37C in the presence of 5% (v/v) carbon dioxide in air.
SDS- polvacrvlamide gel electrophoresis
For purified HAP and recombinant HAP expression studies, lOpl volumes of each clone, 
or column fraction and molecular mass markers (Sigma), boiled for 5 minutes in Laemmli 
sample buffer containing marker dye, were separated by sodium dodecyl sulphate - 
polyacrylamide gel electrophoresis (SDS-PAGE), as previously described in Chapter 3, 
with a 12% (w/v) polyacrylamide separating gel and a 4% (w/v) stacking gel in a Mini 
Protean H apparatus (EioRad) and a constant voltage of 200V at room temperature for 
approximately 45 minutes. Proteins in the gels were detected by silver staining, as 
described in Chapter 3.
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Isolation of native HAP using cholate solubilization methods
Isolation and purification methods described previously (Prehm and Mausolf, 1986), with 
modifications, were applied to the culture supernatant of a highly encapsulated S. equi 
culture, pre-diluted to 20% (w/v) culture in 150mM phosphate buffered saline, pH 7.2 
(PBS). Chemicals were supplied by Sigma.
Briefly, 1500 ml of diluted culture prepared as above, was centrifuged for 40 minutes at 
9000g and 4 C. The supernatant and an aqueous solution of 10% (w/v) cetylpyridinium 
chloride was prewarmed to 37C; the two were mixed to a final concentration of 1% (w/v) 
cetylpyridinium chloride and stirred at 37C for 30 minutes, then centrifuged at 10 OOOg at 
4-C for 5 minutes. The pellet was suspended in 40 ml of 10% (w/v) sodium acetate in 
methanol, then centrifuged at lOOOOg for 3 minutes. This pellet was resuspended in 1 ml 
of 40mM  aqueous sodium phosphate buffer, pH 6.8, containing 1% (w/v) sodium cholate. 
The solution was prepared for application to a 1 ml Hydrophobic Interaction 
Chromatography column (HIC, Pharmacia), by diluting 1:4 in 40mM  sodium phosphate 
buffer containing 1% (w/v) sodium cholate and solid ammonium sulphate was dissolved in 
it to a final concentration of IM. The column was equilibrated at room temperature with 
5ml of 40mM  sodium phosphate buffer (pH6.8) containing 1% (w/v) sodium cholate, 
followed by 5ml of 40mM  sodium phosphate buffer (pH6.8), with IM  ammonium sulphate 
containing 1% (w/v) sodium cholate. A 2ml volume of prepared sample was applied and 
the flow through was collected as two 1ml fractions. The column was washed with 5ml of 
40mM sodium phosphate buffer (pH6.8), with IM  ammonium sulphate containing 1% 
(w/v) sodium cholate and 1ml fractions were collected. Aliquots of 2ml 40mM sodium 
phosphate buffer (pH6.8), with 0.8, 0.6, 0.4, 0.2M, or no ammonium sulphate containing 
1% (w/v) sodium cholate, were applied to the column sequentially. Fractions (1ml) were 
collected, then the column was washed with 5ml water and further fractions collected. All 
fractions collected were examined by silver stained SDS-PAGE gels (see above). The 
protein concentrations of fractions identified as likely to contain HAP were measured 
using a bicinchoninic acid assay (Pierce).
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Amplification, cloning and expression of recom binant HAP
Preparation of template DNA for PCR
Streptococcal genomic DNA was extracted using an alkaline lysis method similar to the 
one used by R. Treisman and as described by Sambrook et al. (1989). A washed 
bacterial pellet from a 500ml culture (obtained as above) was resuspended in 18ml of 
solution I, comprising 50mM glucose, 25mM Tris HCl (pH 8.0) and lOmM EDTA (pH
8.0). A freshly prepared solution of lysozyme (2ml of lOmg/ml in lOmM Tris HCl, pH
8.0) was added, followed by 40ml of solution U, comprising 0.2N NaOH and 1% (w/v) 
SDS; the tube was mixed by several inversions, then incubated at room temperature for 10 
minutes. Ice cold solution m  (20ml), comprising 60ml of 5M potassium acetate, 11.5ml of 
glacial acetic acid and 28.5ml of water, was mixed in and the tube incubated on ice for 10 
minutes. The tube was then centrifuged at 10000 g and 4C for 15 minutes and the 
supernatant fraction re-centrifuged as before. The supernatant fraction was transferred to a 
fresh tube and 0.6 volumes of isopropanol added. After thorough mixing, the tube was 
centrifuged at 16C and 12000 g for 5 minutes, and the supernatant fraction carefully 
decanted off, leaving a pellet that was rinsed with 70% (v/v) ethanol. The pellet was dried 
at 37C for 30 minutes, then dissolved in 3ml of TE buffer (pH 8.0).
PCR and cloning of HAP in the expression vector pPL-Lambda 
PCR of HAP DNA:
A forward primer: 5’AAGGCCTATGACAGTACTAGGAACAAA-3 (base position 1-20 
on the published sequence) and reverse primer:
5 ’- A AGGCCT ACGG AAGGT A A AGGGG AT-3 ' (base position 3 ’ (base position 1550- 
1569 on the published sequence), to amplify the whole HAP open reading frame, was 
designed from the published S. equisimilis sequence (Lansing et al. 1993). Primers were 
used at 3.5pl of 50pg/ml reaction, to amplify the HAP sequence with flanking Stul 
restriction enzyme sites, by polymerase chain reaction (PCR) (Mullis et al. 1986). S. equi 
genomic DNA was used as a template for PCR; 0.5pl (lOng) of DNA was added to a 
50pl PCR reaction volume. PCR buffer (5pl; lOOmM Tris HCl, pH 8.3, 15mM MgCL,
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500mM KCl, 1 mg/ml gelatin; Boehringer), dNTPs (8|il of a 1.5mM equal mixture; 
Perkin Elmer) and 29 |il of water were added before overlaying the reaction with mineral 
oil (Sigma). Cycling conditions were 95C for 5 minutes during which 0.5pl of Amplitaq 
DNA polymerase (Perkin Elmer) was added, followed by 30 cycles of 94C for 1 minute, 
55C for 1 minute and 72C for 3 minutes. A negative control PGR reaction was set up in 
the same way, replacing the template DNA with water to monitor contamination.
Analysis of HAP PGR products: The quality, size and quantity of the PGR product was 
checked by first mixing 2pl of product with an equal volume of EOT A sample buffer 
containing bromothymol blue dye, then loading it onto a 1% (w/v) agarose gel set in gel 
apparatus (Pharmacia), along with 2pl each of 1Kb and Lambda DNA molecular weight 
marker (Sigma) loaded into an adjacent lane. The gel was run at 60 Volts for 60 minutes, 
then stained for 30 minutes with 0.05% (w/v) ethidium bromide in tris-acetate EDTA 
buffer containing 0.04M  tris-acetate and O.OOIM EDTA. The gel was viewed on an UV 
transilluminator and photographed using a thermal image camera (Sony).
The quality of the PGR product was assessed visually; acceptable quality was deemed as 
the presence of only one clean band of the correct size in the test and positive control 
lanes, and nothing in the negative control lane. The size of the PGR product was estimated 
from the photograph by firstly plotting the log of the marker molecular weights in Kb, 
against the distance migrated from the wells in milimetres, then measuring the distance 
migrated for the PGR product. A log value for the PGR product was read from the graph 
and the inverse taken to obtain the molecular weight. An estimate of the concentration of 
PGR product or plasmid was estimated by comparing the intensity and width of a band 
with Lambda DNA molecular weight marker bands, which were of known DNA 
concentration.
To check for the presence of the gene in S. zooepidemicus, PGR was also conducted using 
the above primers and conditions, except that similarly extracted S. zooepidernicus
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genomic DNA was used as a template. The PCR product (concentration estimated to be 
Ipg) was cleaned and digested with 2units of Pst I (Pharmacia). One unit of restriction 
enzyme was defined by the manufacturer as the amount needed to completely digest Ipg  of 
lambda DNA to completion in 60 minutes (usually 37C), in a total assay mixture of 50pl. 
All restriction enzymes used were supplied by Pharmacia. lOx One-Phor-All Plus (OPA+) 
buffer (Pharmacia), comprising lOOmM Tris-acetate, pH7.5, lOOmM magnesium acetate 
and 500mM potassium acetate, was added to a final concentration of IX  as recommended 
by the manufacturer for this enzyme, and the volume was made up to 50pl with water. A 
concentration of IX  OPA-h was used throughout unless specified otherwise. The PCR 
product was digested for 18 hours at 37C, then the restriction enzyme was inactivated by 
incubating the mixture at 85C for 15 minutes. The resulting fragment sizes, determined by 
agarose gel electrophoresis in the same way as described below, were compared with the 
predicted sizes calculated by counting the base pairs in the predicted sequence.
Restriction enzyme digestion of HAP PCR products: The PCR product generated as 
above, was cleaned using a W izard DNA clean up kit (Promega), a size exclusion mini­
column based kit designed to remove Taq Polymerase enzyme and buffer ions which might 
inhibit digestion with restriction enzymes. The kit was used according to manufacturer’s 
instructions, except that the DNA was eluted in 30pl of water at 85C, rather than 50pl at 
65C. The entire cleaned PCR product was digested with 2 units of Stu I. lOx OPA-h 
buffer was added to a final concentration of 2X (lOpl) as recommended by the 
manufacturer for this enzyme, and the volume was made up to 50pl with water. The PCR 
product was digested for 18 hours at 37C, then the restriction enzyme was inactivated by 
incubating the mixture at 85C for 15 minutes.
Digestion and dephosphorylation of and pPL-Lam bda cloning vector: The expression 
vector pP^-Lambda was developed for cloning products toxic for E. coli by employing tight 
temperature sensitive repression of the Pl promoter (Pharmacia). The vector was initially 
digested with 5 units of Hpa 1 as described above, and then dephosphorylated to prevent
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the vector ligating to itself. This was done by mixing 0.2 units (0.2pl) of calf alkaline 
phosphatase (Pharmacia) with lOpl of the digested vector. (OPA+ was already present in 
the recommended concentration because it was added for the restriction enzyme digestion 
step). The mixture was incubated at 37C for 30 minutes and the alkaline phosphatase 
enzyme was inactivated by incubating at 85C for 15 minutes. The concentration of 
digested, dephosphorylated vector was determined as described for PCR products, above.
Ligation of HAP PCR product and pPL-Lam bda vector: The amount of PCR product 
(insert) required to mix with 20-50ng of pPL-Lambda vector was calculated by dividing 
the size of the vector in Kb, by the size of the insert in Kb, then multiplying by the amount 
of vector DNA and the molar ratio of insert: vector recommended by the manufacturer 
(Pharmacia). T4 DNA ligase (Pharmcia) was added in excess such that 2 units were added 
to a lOpl reaction volume. One unit of ligase enzyme was defined by the manufacturer as 
the amount needed to catalyze the formation of Inm ol of phosphatase-resistant [^^P]Pi 
from lOpM 5’-[^^P]-oligo (rA)n in 30 minutes at 37C. A final concentration of IX  OPA-f- 
and Im M  ATP were added and the volume was made up to lOpl with water. A negative 
control ligation was set up in the same way, replacing the insert with water, to check both 
for contaminating DNA and to ensure that the vector is not re-ligating back to itself. A 
positive control ligation was also set up using the positive control insert DNA supplied 
with the vector, to test that the reagents were not defective. The mixtures were incubated 
for 18 hours at room temperature, then the T4 DNA ligase was inactivated by incubation at 
65C for 15 minutes.
Transform ation of competent cells with HAP ligated into pPL-Lam bda: The N4830 
and N99 cells were not supplied as competent for transformation, so both required 
preparation as follows. One colony picked from an LB agar plate was used to seed a 4ml 
LB broth grown statically for 18 hours at 4C. This culture was then used to seed a 100ml 
LB broth incubated at 37C with 225rpm shaking, for 2 hours. The resulting culture was 
centrifuged at 10000 g and 4C for 5 minutes. The pellet was resuspended in O.IM calcium 
chloride, incubated on ice for 15 minutes and then centrifuged as before. The pellet was
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resuspended in 4ml of O.IM calcium chloride and incubated on ice for 4 hours. The 
competent cells were aliquoted into pre-chilled microfuge tubes in 50pl amounts and Ipl of 
each ligation mixture was added to a separate aliquot of cells. The tubes were incubated 
on ice for 30 minutes, heat shocked at 42C for 45 seconds, then incubated on ice for a 
further 2 minutes. SOC medium was made up according to Sambrook et a l  (1989). 
Briefly, 20g bactotryptone, 5g yeast extract and 0.5g NaCl were dissolved in 950ml water, 
10ml of 250mM KCl was added and the pH adjusted to 7.0 with 5N NaOH. A 5ml 
volume of 2M MgCl^ was then added and the resulting medium was sterilized by 
autoclaving. The medium was cooled to 60C, then 20ml of filter sterilized IM  glucose 
solution was added. SOC medium kept at room temperature (0.45ml) was added to each 
tube and these were shaken at 225rpm and 37C for 1 hour. These were spread plated onto 
LB ampicillin agar and incubated for 18 hours, then examined for colony growth. The test 
and positive control plates had many colonies and the negative control had none when the 
ligation was deemed successful.
Screening of transform ed cells for expression of recom binant HAP: Bacterial colonies 
from the transformation step were picked using one fresh toothpick per colony, and each 
used to seed a separate 4ml LB ampicillin broth. The cultures were each given numbers 
and incubated statically for 3 hours at 30C, then each was split into two cultures of 2ml 
each; one set was kept at 30C and the other set was immediately incubated at 42C for a 
further 2 hours. One millilitre volumes of each culture were microcentrifuged at 10000 g 
for 5 minutes and the pellets suspended in 50pl of SDS-PAGE gel loading buffer. These 
were boiled and analyzed by SDS-PAGE as described above. For speed, the SDS-PAGE 
gels were stained with rocking for 30 minutes in an aqueous solution of 40% (v/v) 
methanol, 10% (v/v) ethanol and 0.1% (w/v) coomassie blue. Gels were then destained in 
several changes of an aqueous solution of 40% (v/v) methanol and 10% (v/v) ethanol until 
protein bands could easily be distinguished (about 30 minutes). The expected approximate 
size of the recombinant protein was previously calculated from the sequence data, and the 
stained gel was examined for a polypeptide of this size present in the cultures grown at 
42C, but absent in cultures kept at 30C. Plasmid DNA was isolated from the 1ml volumes
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of each culture remaining using a Recovery plasmid mini prep kit (Hybaid), which was 
based upon microfuge spin columns. A restriction digest was set up and incubated as 
above for each plasmid, using 3pl of plasmid DNA, Ipl of OPA+ and lunit each of first 
Pstl and then H pal. The digested plasmids were analyzed by agarose gel electrophoresis 
as described above and the actual size of plasmids were compared with the predicted size.
PCR and cloning of HAP in the PCR cloning vector pGEM -T and expression vector 
pGEX-3X
PCR of HAP DNA: Amplification of the whole HAP open reading frame by PCR was 
repeated, then the product was cleaned and digested with 1 unit of Ssp I using the methods 
described above, which generated two pieces of HAP DNA: a front half, and a back half 
(named Fragment 4). Primers were used to amplify this 5’ piece of the digested HAP open 
reading frame (front half) as two overlapping fragments: Fragment “a” (forward: 5’- as 
forward primer described above [base positions 1-20 on the published sequence], and 
reverse: 5’- AAGGCCTTTACCCCTAGAGAG-3’, [base positions 483-497 on the 
published sequence]), and Fragment “b” (forward: 5’-
AAGGCCTGGCTTGACCTATACAGCA-3’, [base positions 288-306 on the published 
sequence] and reverse:
5’- AAGGCCTAATAGCTGAGGTACCAGAA-3’, [base positions 808-825 on the 
published sequence]). The front half was also amplified as three non-overlapping 
fragments: front (Fragment 1:- forward: as forward primer described above [base
positions 1-20 on the published sequence] and reverse: 5’-
A  AGGCCTATCCTCTGAC AC ATC A ACC-3 ’, [base positions 270-288 on the published 
sequence]), middle (Fragment 2:-
forward: 5 ’ - G T G G  ATCC ATGGCTTG ACCT AT AC AGC A A-3 ’ [base positions 287-307 
on the published sequence] and reverse: 5 ’ -G AGGCCTCTTT ACCCCT AG AG AGTCT-3 , 
[base positions 480-498 on the published sequence]) and back (Fragment 3:- forward:
5 ’ -G G G  ATCC AGGCTG ATGGG A AT A AGGT-3 ’, [base positions 496-514 on the 
published sequence] and reverse:
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5 ’-CAGGCCTATTTGCAAAGTCTAGCTTAC-3’, [base positions 806-825 on the 
published sequence]). These primer sets were used to amplify the HAP sequence with 
flanking Bam H l and S tul restriction enzyme sites so that these inserts would only be able 
to clone into pGEX-3X in the correct orientation. The constituents and volumes used were 
the same as described above. Cycling conditions were as described above, except for the 
annealing temperatures, which were 51, 60, 63, 64 and 64C for Fragments a, b, 1, 2 and 3 
respectively. PCR products were analyzed as described above.
Ligation of HAP PCR products with pGEM -T and transform ation of JM109 
com petent cells: The vector for cloning PCR products, pGEM-T, was supplied by 
Promega. The fragments of HAP DNA amplified above, including the smaller back half 
fragment (Fragment 4) was ligated into pGEM-T, followed by transformation into E. coli 
strain JM109, using methods described above; the pGEM -T vector required no 
preparation however, and the JM109 cells used were supplied as competent. Colonies 
were picked as described above and used to seed separate 4ml LB ampicillin broths, which 
were shaken at 250 rpm and 37C for 6 hours. One mililitre was removed from each 
culture, plasmid extracted and purified using a Recovery plasmid mini prep kit (Hybaid); 
the remaining culture was used to make 20% (v/v) glycerol stocks for long term storage. 
PCR reactions for HAP gene fragments appropriate to each recombinant clone were used 
to confirm that the correct inserts were present. Those confirmed to have the correct insert 
by PCR were sequenced, using the plasmid preparation as template DNA.
Sequencing of pGEM -T clones: Clones were sequenced to check that they were HAP 
fragments and whether there were any differences in the S. equi sequence when compared 
with the published HAP sequence, which is for S, equisimilis. A pre-prepared master mix 
known as A B I - P r is m ^ ^  dye terminator cycle sequencing kit, containing Amplitaq DNA 
polymerase FS was used. Primers SP6 and T7 (Promega), which were complementary to 
sequences flanking the pGEM-T cloning site were used in two separate sequencing 
reactions for each clone to obtain sequence from both directions. Four microlitres of 
master mix was mixed with Ip l of primer at 1.6 pmol/pl, 2pl of water and 3pl of prepared
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template DNA. The standard cycle sequencing program was performed on thermal cycler 
(Hybaid). A 3 minute 95C hot start was followed by 25 cycles of 96C for 30 seconds, 50C 
for 15 seconds and 60C for 4 minutes, finishing on hold at ambient temperature. Each 
extension product was added to a separate 1.5ml microcentrifuge tube containing Ip l of 
3M sodium acetate, pH4.6 and 25pl of 95% (v/v) ethanol. The tubes were vortexed and 
incubated at -80C for 10 minutes, then were microfuged at 10000 g for 30 minutes. The 
ethanol was aspirated from each tube and the pellets rinsed by adding 250pl of 70% 
ethanol and carefully aspirating. The pellets were dried by incubation at 37C for 30 
minutes, then dissolved in 5pl of EDTA formamide buffer, made by dissolving blue 
dextran in 25mM EDTA, pH8.0 to a final concentration of 50mg/ml, then adding four 
volumes of formamide. The samples were heated to 90C for 2 minutes to denature the 
DNA, then 4pl was loaded onto an 4.5% polyacrylamide sequencing gel. The gel was run 
on an ABI-Prism™  377 automated sequencing machine according to the manufacturer’s 
instructions (Perkin Elmer). The automated sequencing machine generated an 
electrophoretogram with each sequence, and this was checked manually to ensure that the 
computer program did not miss any bases and to choose a base manually, where possible, 
when the computer algorithm could not select a base. A sequence data analysis package 
(DNASIS) was used to compare sequence data with the published sequence for HAP 
(Lansing et a l  1993).
Preparation  of HAP fragm ents from  pGEM -T for ligation into pGEX: Four mililitre 
LB ampicillin cultures of each clone (one clone per fragment) shaken at 250 rpm for 6 
hours at 37C, were used to seed separate 100ml LB ampicillin broths. These were then 
shaken at 250 rpm and 37C for 18 hours. Plasmid was extracted and purified from these 
cultures using a Midi plasmid purification kit (Qiagen), which is based upon the alkaline 
lysis method described above and is useful for larger plasmid preparations. The plasmids 
were digested (20pl of each clone) in a 40pl total volume (made up with water), with 2 
units of Stu I in the presence of 4pl of lOX OPA+ to a final concentration of IX, at 37C 
for 6 hours. Then the Stu I was heat inactivated at 37C for 15 minutes and the sizes of 
digested plasmids were checked with those predicted by analysis of lOul of each plasmid
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on an agarose gel as described above for PCR products. The digestion of remaining 
plasmid was completed by adding 2 units of B am H l and 1.2pl of lOX OPA+, since 
BamHI requires a final concentration of 2X OPA+ for optimal activity. The mixture was 
incubated for 18 hours, then the enzyme inactivated as above. The plasmids were digested 
with these enzymes to generate a blunt and a sticky end, such that inserts could not be 
cloned in the wrong orientation.
The HAP fragments were recovered from the digest mixture by electrophoresis in low 
melting point agar. One 1.5% (w/v) low melting point agarose gel for each insert was 
loaded in all wells except the outer two wells, with digested DNA mixed with an equal 
volume of gel loading buffer. The outer two wells contained 2pl of 1Kb molecular weight 
standard and a 2pl amount of the relevant digested DNA. The gel was run at 65Volts for 
75 minutes, then after electrophoresis, the standard and 2pl amounts of clones were cut 
away and stained in ethidium bromide. The stained part of the gel was reassembled with 
the unstained part on a UV transilluminator. The region of unstained gel corresponding to 
the stained HAP fragment was then cut out and purified from the agarose using a Qiaex H 
DNA extraction kit for agarose gels (Qiagen). The concentration of the purified fragments 
were determined using methods described above.
Digestion of pGEX-3X expression vector; Expression vector pGEX-3X, supplied by 
Pharmacia, enables affinity purification of fusion products by a glutathione S transferase 
(GST) tag. The vector (2pl) was digested in a 20pl total volume (made up with water), 
with 2 units of Sma I in the presence of 4pl of lOX OPA+ to a final concentration of 2X, 
at 37C for 6 hours. Then the Sma I was heat inactivated at 37C for 15 minutes and the 
mixture allowed to cool before adding 2 units of B am H l. The mixture was incubated for 
18 hours, then the enzyme inactivated as above.
129
Ward, U. 199/
Ligation of HAP with pGEX-3X and transform ation of DHIOB competent cells:
Purified insert from pGEM -T was ligated into restriction digested pGEX vector, followed 
by transformation into E. coli strain DHIOB, using methods described above for pGEM-T, 
except that IPTG and XGAL were present in the LB ampicillin plates at concentrations 
described above, for selection of colonies containing inserts by blue / white screening. The 
pGEX-3X vector possesses a beta galactosidase gene, which expresses beta galactosidase 
in the presence of an inducer such as IPTG. If a galactose analogue such as X-GAL is also 
present, beta galactosidase converts it into a blue product, resulting in blue bacterial 
colonies. The pGEX-3X multiple cloning site is within the beta galactosidase gene, so if 
an insert is present, on induction with IPTG, the expression of beta galactosidase is 
disrupted and the bacterial colony will remain white. W hite colonies are selected for 
screening.
Screening of transform ed ceils for expression of recom binant HAP or HAP 
fragm ents:
Screening for expression of the correct fusion protein was carried out using similar 
methods to those described for pPL-Lambda, except that expression was induced by the 
addition of lOOmM IPTG to the growth medium, rather than a shift in temperature. 
Briefly, 2ml of LB ampicillin broth was inoculated with one colony, and shaken at 250 
rpm and 37C for 4 hours. Stock IPTG (lOOmM) was added to a final concentration of 
lOOpM, and grown as before for another 90 minutes. The cultures were placed onto ice for 
5 minutes then a 20pl aliquot of each clone centrifuged for 5 minutes at 10000 g. The 
pellet was resuspended in lOpl of sample buffer and analyzed by SDS-PAGE, as described 
previously. The presence of an expressed GST recombinant polypeptide of the predicted 
molecular mass was also confirmed by immunoblotting, using a goat anti GST antibody 
(Pharmacia) diluted 1:2000 and a horseradish peroxidase labeled anti goat antibody 
(Sigma) diluted 1:2000. Those fitting these criteria were sequenced as described above, 
using primers supplied for sequencing from pGEX vectors (Pharmacia).
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Purification of HAP fragm ents expressed as a GST fusion protein of pGEX-3X: One
colony was used to seed a 10ml culture, which was grown statically for 18 hours at 37C. 
This was used to seed 100ml of medium, which was shaken at 200 rpm and 37C for 4 
hours, after which lOOmM IPTG was added and the incubation continued for a further 90 
minutes. The bacteria were pelleted by centrifugation at 8000g and 4C for 10 minutes, 
then resuspended in 50ml of ice cold PBS. The cells were kept on ice and sonicated in 
short bursts of 30 seconds using a micro tip until the cell suspension had cleared. An 
aqueous stock solution of 20% (v/v) triton-XlOO was added to the sonicate at a final 
concentration of 1% (v/v) and the mixture incubated at room temperature with gentle 
mixing for 30 minutes. This was centrifuged at lOOOOg and 4C for 10 minutes, then the 
supernatant kept on ice until it could be loaded onto a 200pl glutathione sepharose 4B 
column. The column was prepared by washing ten times with 200pl volumes of PBS. The 
supernatant fraction was applied to the column, then the column was washed with two 2ml 
volumes of PBS. The GST fusion protein was eluted by applying 200pl of 5mM 
glutathione in 50mM Tris-HCl, (pH8.0). Aliquots of the column fractions were analyzed 
by SDS-PAGE as described above.
S. i.ooepidemicus intraperitoneal challenge of mice immunized with recombinant HAP 
Recombinant HAP was tested for the ability to reduce mortality and morbidity in a murine 
intraperitoneal challenge model for zooepidemicus. Twenty mice were bled as below 
and distributed randomly amongst the groups. Each recombinant HAP GST fusion protein 
(Figure 14) was mixed with an equal volume of Freund’s Incomplete adjuvant (FLA), to 
make 5pg per dose, and 0.1 ml amounts were administered intraperitoneally to groups of 
20 female CBA/CA mice. These were: i) Fragment 1; ii) Fragment 2; iii) Fragment 3; 
iv) Fragment 4; v) Fragments 1, 2 and 3 and vi) Fragments 1,2,3 and 4. Twenty mice were 
not vaccinated with anything, 10 mice were given GST in FIA and 10 mice were given FIA 
only; these mice were combined as a control group in the analysis of results. Mice were 
boosted 28 days later, and bled at 39 days, then at 40 days, the mice were each challenged 
intraperitoneally with 5 x 10^ cfu of S. zooepidemicus. Mice were examined every 4 hours 
for signs of malaise, slow movement and staring coat, to gauge when euthanasia should be
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employed to provide a humane endpoint; the time elapsed between challenge and death 
was noted. The surviving mice at 50 hours post challenge (controls and the groups with a 
significantly different survival curve) were examined post mortem and the livers were 
aseptically removed, ground in a pestle and mortar with PBS and sterile sand, and serial 
dilutions of these were spread onto blood agar plates which were incubated for 18 hours. 
The number of colonies were counted and viable counts were calculated. Mice used in the 
S. zooepidemicus challenge were bled before both immunization and challenge, as 
described in Chapter 4.
Rabbit antisera
Six month old, specific pathogen free, female. New Zealand W hite rabbits (Charles River), 
were used to raise antisera to HAP in purified and recom binant forms (see below). 
Purified HAP vaccine was prepared by boiling 0.5 ml of the pooled HIC column fractions 
2 and 3 in 0.5 ml of sample buffer containing marker dye for 5 minutes. This was 
followed by SDS-PAGE separation, with a 7.5% (v/v) polyacrylamide separating gel and a 
4% (v/v) stacking gel set without a comb, in a Protean II apparatus (BioRad) and a 
constant current of 25mA at room temperature until the dye front reached the bottom of the 
separating gel. The gel was silver stained as above, then 53 and 55KDa bands were cut out 
individually, broken up in 2 ml of sterile distilled water and blended with an equal volume 
of FIA. 20pg of recombinant HAP was blended with an equal volume of FLA. Five 0.2ml 
volumes of each preparation were given sub-cutaneously to separate rabbits and after 4 
weeks, without adjuvant. An additional booster inoculation of 1ml total in FLA 
administered as above was given at 77 days for the purified preparations. Pre­
immunization and 2 weeks post immunization sera were separated from blood taken from 
the peripheral ear vein.
Opsonisation and capsule formation inhibition testing
The S. equi strain was streaked in a straight line across the centre of a blood agar plate. 
Sterile blotting paper cut into 0.5cm x 2cm strips were soaked with either 250pl of PBS as 
a negative control, hyaluronidase (Sigma) dissolved in PBS to 3mg/ml (w/v) as a positive
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control, pre-immune, or immune rabbit serum described above (heated to 56C for 30 
minutes). The strips were then placed at right angles across the bacterial inoculum and the 
plate was incubated for 18 hours, at 37C. The resulting mucoid streak of growth was 
examined for any changes in encapsulation around the blotting paper strips. The antisera 
were also tested for ability to opsonise S. equi, using methods described by Chanter et al. 
(1994).
Characterization of purified and recombinant HAP and antibodv responses by
immunoblotting and dot blotting
Gels for immunoblotting were prepared by boiling 25pg of recombinant HAP, or pooled 
HIC column fractions 2 and 3 (purified HAP), in an equal volume of sample buffer 
containing marker dye and SDS, followed by SDS-PAGE, with a 7.5% (w/v) 
polyacrylamide separating gel and a 4% (w/v) stacking gel in a Protean II apparatus 
(BioRad) and a constant current of 25mA at room temperature until the dye front reached 
the bottom of the separating gel. Polypeptides separated by SDS-PAGE were 
electrophoretically transferred to nitrocellulose and processed as described previously, in 
Chapter 3.
The reactivity of rabbit antisera and murine challenge plasma with native and recombinant 
HAP was analyzed by dot blotting. Native HAP applied as lOpl of pooled HIC column 
fractions 2 and 3 per dot and lOpl of lOpg/ml recombinant HAP applied to a final 
concentration of lOOng per dot were transferred onto nitrocellulose (Schleicher and 
Schuell) using a BioDot apparatus (BioRad) according to the manufacturer’s instructions. 
Blots were detected as described above, with pre-immune and immune rabbit, or mouse 
sera, followed by their corresponding HRP-conjugated immunoglobulin (Sigma). Each 
antiserum/ plasma was diluted in PBS-T alone, plus an aliquot was absorbed with 5pg/ml 
GST, and another with lOpg/ml native or recombinant HAP fragments, at 37C for 1 hour, 
with mixing.
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Statistics
Differences in proportions of immunized and control mice affected by challenge were 
tested by Fischer’s Exact test, survival curves were compared by Logrank test and numbers 
of bacteria in the livers of surviving mice were com pared by the Mann-W hitney test (to 
account for a non-Guassian distribution created by zero values) using the programs of 
Graphpad Prism 2.0 (Cherwell Scientific).
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Results and discussion
Detection of the hvaluronate associated protein (HAP) and gene in S. equi and 
S. zooepidemicus
Hyaluronate and associated proteins, precipitated from S. equi culture supernatant by 
cetylpyridinium chloride and fractionated as the unbound material from hydrophobic 
interaction chromatography (hydrophilic fraction), contained polypeptides of 53 and 
55KDa detected by silver staining of an SDS-PAGE gel (Figure 15).
Polymerase chain reaction using primers derived from the published sequence for the HAP 
from S. equisimilis (Lansing et al. 1993), with 5 ’ Stu I digestion sites for cloning in frame 
into the Hpa I site of the expression vector ppL- Lambda, yielded a product of 
approximately 1.7 Kb from S. equi and S. zooepidemicus DNA. Digestion of the fragment 
with Pst I yielded two fragments of the sizes predicted for the amplified HAP gene. Too 
little protein was present to measure the concentration by available methods but rabbits 
immunized with the purified material produced antibodies reactive with recombinant HAP 
detected by dot blotting (Figure 16).
Cloning and expression of the HAP gene from S. equi
The PCR product from S. equi ligated into pP^-Lambda and transformed into E. coli 
N4830-1, was stable when cloned in both orientations, as revealed by product sizes 
produced by double digestion with Pst I and Hpa I, so long as the incubation temperature 
for the culture was below 31C. Subcultures of recombinants with the insert in the correct 
orientation at 42C, a temperature which inactivates the cI857 repressor of the Pl promoter, 
either did not grow or grew but did not produce any additional protein of the size expected 
of a HAP/N- protein fusion and contained a plasmid of reduced size. There was no effect 
at 42C on the growth or plasmid size of recombinants with the insert in the wrong 
orientation. These results suggested that HAP was so toxic in E. coli that transcription and 
translation failed before the culture died, or deleted the plasmid, although this is a tightly 
controlled expression system. Failure to clone the HAP gene in pPu- Lambda stimulated
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the cloning of sub-domains into the expression plasmid pGEX-3X in an attempt to produce 
immunogenic fusion proteins lacking toxicity for E. coli. The amplified HAP gene was 
digested with Ssp 1 and Stu 1 (site upstream of the gene generated by the forward primer 
used above) yielding two major fragments (“a” and “b”) corresponding with residues 1 to 
275 and 276 to 480 which were cloned into the Sma 1 site of pGEX 3X to give in frame 
fusions. Both of the large fragments were cloned but digestion of the plasmids from 
several induced recombinants revealed that the full inserts were not present, suggesting 
that there was still retention of biological activity and hence toxicity for E. coli. The front 
half was cloned in three separate pieces, the expression of the front polypeptide (Fragment 
1) and back polypeptide (Fragment 3) was achieved and the sequences were similar to S. 
equisimilis, but the middle polypeptide (Fragment 2) produced only one clone containing 
insert, for which there was a frame shift approximately halfway through the coding region. 
There were a few base substitutions at the third position in the codon for S. equi HAP, as 
compared with that of S. equisimilis, which did not alter the amino acid sequence, and 
some single base differences base. See Figures 21-23 for the sequence of S. equi HAP 
deduced from sequencing HAP fragment pGEX clones.
Several recombinants with the latter half of the HAP gene had inducible expression of a 
GST fusion protein of the size expected (approximately 50 KDa) for the cloned fragment 
as a fusion product. One of the recombinants was selected for production of Fragment 4 
protein and the purified protein was used to produce rabbit antibodies that reacted in dot 
blots of the recombinant and purified HAP (Figure 17).
In vitro activitv of antibodv to recombinant HAP
Antiserum to recombinant HAP (Fragment 4) did not possess any detectable opsonic 
activity for S. equi. However, when the anti serum was soaked into filter paper strips 
placed across a streak of S. equi inoculum on a blood agar plate and incubated for 18 
hours, where growth approached the strip, there was a distinct loss of glossy colonial 
appearance, which was consistent with the diminution of capsulation. A similar effect was
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noted when hyaluronidase, but not when pre-immune serum, was used to substitute the 
antiserum.
Protection of mice against S. z.ooepidemicus challenge by immunization with recombinant 
HAP
Up until 27 hours after intraperitoneal challenge with S. zooepidemicus, CBA/CA mice 
immunized with the back half of recombinant HAP had a significantly greater survival rate 
than control mice (p = 0.012, Logrank test) and the proportion of survivors was 
significantly larger (p = 0.02, Fischer’s exact test), whilst mice immunized with the other 
fragments did not (Figure 18). However, survival for the HAP Fragment 4 group was only 
significant up to 27 hours and after that, significance was lost. The survival rates for all 
groups were not significantly different from the control group at 50 hours after challenge 
by Fisher’s Exact Test; it was 35% for control groups and between 35 and 55% for all test 
groups. For survival data, see Figures 24 and 25.
Although the back half of HAP was not toxic to E. coli, which could indicate a lack of 
biological activity, it is possible that antibody bound to the capsule of S. zooepidemicus, 
opsonising and hence encouraging clearance by host phagocytic cells. It is interesting that 
fragments 1, 2 and 3 were not protective in the mouse given that they probably contained 
the biological activity, if this is indicated by toxicity for E. coli. It is possible that they 
could be protective for a different animal model, or that the toxicity resided in the part of 
Fragment 2 which could only be cloned with a frame shift in the base sequence.
Fifty hours after challenge, 7 of 20 controls and 11 of 20 immunized mice survived, but the 
coats of the controls appeared a little more ruffled and they were slower moving than the 
immunized mice. The number of bacteria in the livers of the survivors, identified as S. 
zooepidemicus, was determined at post mortem examination (Figure 19). In the Fragment 
4 immunized mice there was a mean of 1.51x10^ cfu S. zooepidemicus /g of liver whereas 
the controls had a mean of 6.3x10"* cfu /g (p = 0.0003, M ann-W hitney test). The numbers 
of streptococci in the livers of mice immunized with Fragment 4 were concentrated on to
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the exclusion of other groups because there was a lack of significant difference in the 
survival curves of the other groups. The noticeably different clinical appearance between 
the Fragment 4 immunized and control groups prompted the investigation of number of 
streptococci in the livers of survivors, but upon reflection, it would be advisable to repeat 
the experiment and look at the livers of the mice from the other groups too.
Pre-immunization mouse sera did not react with any of the recombinant HAP protein 
fragments, but pre-challenge sera (i.e. post immunization) from mice given fragment 4, or 
GST showed a reaction which could be removed by absorption with fragment 4 (Figure 
20). Most of the other immunized mouse sera had some antibody to the immunizing 
fragment, although the absorptions were less convincing, suggesting the presence of non­
specific antibody. These blots indicated that the antibody response to fragments 1 ,2  and 3 
was weaker than the response to the back half, although a combination of all four 
fragments did not protect perhaps because of antigenic competition. This idea could be 
tested using an ELISA developed for these fragments.
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F ig u re  16. S ilver stained SD S-PA G E o f  HAP precipitated  from S. equi culture 
supernatant by cetylpyridinium  chloride and fractionated as the unbound m aterial from 
hydrophobic interaction chromatography.
HAP
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F igu re  17. Reactivity o f rabbit antisera to HAP precipitated from S. equi culture 
supernatant by cetylpyridinium chloride and fractionated as the unbound material from 
hydrophobic interaction chromatography, with dot blots of recombinant HAP.
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#
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Figure 18. Reactivity o f rabbit antisera to recombinant HAP with dot blots o f HAP 
precipitated from S. equi culture supernatant by cetylpyridinium chloride and fractionated 
as the unbound material from hydrophobic interaction chromatography.
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Figure 21. Reactivity of mouse sera with dot blots o f recombinant HAP.
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Figure 22. Alignment of S. equi HAP Fragment 1 sequenced from pGEX-3X,
with the S. equisimilis sequence (Lansing et al. 1993).
PGEX-3X primer ATC CAA CGT CCT GGG
S. equisimilis ATG AGA GTA CTA
5. equi ATC CAA CGT CCT GGG ATC ATG ACA GTA CTA
Primer ATG ACA GTA CTA GGA A
Thr
GGA ACA AAA GCA TGT AAG CGT CTG GGC TTA GCG GCA GTT ACG 
GGA ACA AAA GCA TGT AAG CGT CTG GGC TTA GCG ACA GTT ACG
Ala
Leu Pro
CTA GCC TCT GTT GCT GCC TTG ATG GCT TGT CCA AAT AAG CAA 
TTA GCC TCT GTT GCT GCC TTG ATG GCT TGT CGA AAT AAG CAA 
Leu Arg
TCA GCG TCA ACA GAC AAA AAG AGT CAG ATT AAT TGG TAT ACG 
TCA GCG TCA ACA GAC AAA AAG AGT CAG ATT AAT TGG TAT ACG
lie Lys
CCA ACT GAG ATC ATC ACA CTT GAT ATT TCA AAA AAT ACA GAT 
CCA ACT GAG ATC ATC ACA CTT GAT ATC TCA GAA AAT ACA GAT
lie Glu
Thr Ser
ACC TAT TCT CGT GCT GCT TTG GCT ATT GGT AAT TCT GGC AGT 
ACG TAT TCT CGT GCTGCT TTG GCT ATT GGT AAT TXT GGC AGT 
Thr Phe
AAC CTT TTG GAT GCT AAA GGG AAA TTA CAG CCT GAT TTA 
AAC CTT TTG GAT GCT AAA GGG AAA TTA CAG CAT GAT TTA
GCT GAA AAG GTT GAT GTG TCA GAG GAT 
GCT GAA AAG GTA GAT GTG TCA GAG GAT 
TTC CAA CTA CAC AGT CTC CTA
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Figure 23. Alignment of S. equi HAP Fragment 2 sequenced from pGEX-3X,
with the S. equisimilis sequence (Lansing et al. 1993).
PGEX ATC CAA CGT CGT GGG
S. equisimilis AT GGG TTG ACC TAT AC A GCA
S. equi ATC CAA CGT CGT GGG ATC CAT GGC TTG ACC TAT ACA GCA 
Primer AT GGC TTG ACC TAT ACA GCA
ACC CTG CGA CAT GGC TTG AAA TGG TCT GAT GGT AGT GAT CTA 
ACC CTG CGA CAT GGC TTG AAA TGG TCT GAT GGT AGT GAT CTA 
A
Glu
ACA GCA GAG GAG TTT GAG TAG AGT TGG GAG CGA ATG GTC GAT 
ACA GCA GAG GAG TTT GTG TAG AGT TGG GAG CGA ATG GTC GAT
Val
*
- CT AAG ACA GCC TCA GAG TAG GCT TAG TTG GCA ACT GAG TCA 
CCT AAG ACA GCC TCA GAG TAG GCT TAG TTG GCA ACT GAG TCA
Val
CAT GTG AAA AAC GCA GAG GAG ATT AAT AGC GGG AAA AAT CCT 
CAT CTG AAA AAC GCA GAG GAG ATT AAT AGC GGG AAA AAT CCT 
Leu
GAT CTA GAG TCT CTA GGG GTA AAG 
GAT CTA GAG TCT CTA GGG GTA AAG 
A GAT CTG AGA GAT CGC CAT TTC
Frame shift
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Figure 24. Alignment of 5. equi HAP Fragment 3 sequenced from pGEX-3X,
with the S. equisimilis sequence (Lansing et al. 1993).
PGEX ATC CAA CGT CGT GGG
S. equisimilis AAG GCT GAT GGG AAT AAG
S. equi ATC CAA CGT CGT GGG AAT AAG
Primer AG GCT GAT GGG AAT AAG
Val
GTT ATT TTT ACC TTA ACG GTG CCG GCA CCA CAA TTT AAG AGC 
GTT ATT TTT ACC TTA ACG GAG CCG GCA CCA CAA TTT AAG AGC 
GT Glu
Leu Ser Val
TTG CTA TCC TTC TCT AAC TTT GTC CCT CAA AAA GAA TCC TTT 
TTG CTG TCC TTC TCA AAC TTT GTT CCT CAA AAA GAA TCC TTT 
Leu Ser Val
GTC AAG GAG GCT GGC AAG GAG TAT GGG ACA ACA TCA GAA AAA 
GTC AAG GAG GCT GGC AAG GAG TAT GGG ACA ACA TCA GAA AAA
CAA ATT TAT TCT GGT CCT TAT ATT GTC AAG GAG TGG AAT GGC 
GTC AAG GAG GCT GGC AAG GAG TAT GGG ACA ACA TCA GAA AAA
ACT AGC GGA ACC TTT AAG CTA GTA AAG AAT AAA AAC TAT TGG 
ACT AGC GGA ACC TTT AAG CTA GTA AAG AAT AAA AAC TAT TGG
GAG GCC AAA AAC GTC AAA ACT GAG ACA GTT AAT GTT CAA ACG 
GAG GCC AAA AAC GTC AAA ACT GAG ACA GTT AAT GTT CAA ACG
GTT AAA AAG CCA GAT ACA GCT GTT CAA ATG TAG AAG CAA GGT 
GTT AAA AAG CCA GAT ACA GCT GTT CAA ATG TAG AAG CAA GGT
AAG CTA GAC TTT GCA AAT 
AAG CTA GAC TTT GCA AAT
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F igure  25. The proportion of mice immunised with HAP Fragments 1,2,  or 3, compared 
with control mice, surviving challenge with S. equi over time.
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Figure  26. The proportion of mice im munised with combinations of HAP Fragments, 
compared with control mice, surviving challenge with S. equi over time.
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DEVELOPMENT OF EQUINE RESPIRATORY CHAT J  J.NGF. MODRT.S 
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Objectives
The main objectives of this study were to develop respiratory challenge models in the 
equine for S. zooepidemicus and A. equuli, which would fulfil Koch’s postulates for these 
bacteria as pathogens in the equine respiratory tract, using the lowest dose of bacterial 
culture, and provide models in which to test potential protective immunogens.
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Summary.
The development of reproducible equine respiratory challenge models for S. 
zooepidemicus and A. equuli in the equine, using non-SPF animals was investigated. 
Ponies judged to be naive to challenge isolates by immunoblotting at 13 days prior to 
challenge were split into two groups; one group was challenged with S. zooepidemicus 
and the other group with A. equuli. There was a gross pathological and histopathological 
dose response detected for challenge with both A. equuli and S. zooepidemicus. Although 
no live bacteria could be cultured from the lung lesions, immunostaining for bacterial 
antigen using rabbit antisera revealed its presence. Tracheal washes taken on the day of 
challenge revealed that the ponies had evidence of bacterial lower airway disease and 
immunoblotting of bacterial extracts with sera taken on the day of challenge suggested 
recently acquired immunity, which may have affected their susceptibility to the challenge 
organisms. If Koch’s postulates are to be satisfactarily fulfilled with these bacteria in the 
lower airway of the equine, specific pathogen free (SPF) animals housed in containment 
facilities should ideally be used for a reproducible challenge model.
One; of the major difficulties presented by a challenge model for these bacteria is that they 
are frequently encountered by the young animal in sequential episodes of disease. We 
have hypothesised that the ongoing susceptibility is related to antigenic variation in the 
surface of M-like proteins of S. zooepidemicus and the iron limited proteins of A. equuli 
which arc potentially protective determinants. Consequently, the selection of non-immune 
animals was an essential part of developing a challenge model. In Chapters 3 and 4, tests 
were developed to assess immune status and these were used in the selection of animals for 
this study. A terminal study was necessary because bacterial pneumonia in foals is 
difficult to recognise and assess the severity of clinically, and often does not correlate well 
with the presence of pulmonary consolidation (Mair, 1989; Koterba, 1984). Another 
potential difficulty with the equine is that examination of the antibody response to 
vaccination with S. pneumoniae type 3 capsule followed by challenge with a large dose of 
an 18 hour culture, revealed worse lesions in vaccinated animals than controls and acute 
respiratory distress indicative of adverse immune reactions. This is contrary to experiences
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with mice and man, which show tracheal signs and limited consolidated pneumonia 
following administration of a large dose of culture. Attempts were therefore made to find 
the lowest dose of culture which would reproduce disease, giving a low antigenic challenge 
and therefore the least chance of complicating the model by adverse immune reactions in 
challenge.
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Materials and methods
Animals
Twenty-one ponies from group A, as detailed in chapter 3, were used. Thirteen days prior 
to challenge with S. zooepidemicus., the nasopharynx of each pony was swabbed and tested 
for the presence of Streptococci and Actinobacillus/Pasteurella species, and influenza. 
Sera were also taken at the same time and tested for reactivity to extracts of S. 
zooepidemicus and A. equuli (see below).
Sera
Ponies were bled 13 days prior to challenge, on the day of challenge and immediately prior 
to eùthanasia. Blood was allowed to clot and sera were collected for immunoblotting, as 
described in chapter 3.
Western immunoblotting
Immunoblots were made from SDS-PAGE of lOOpg of each hot acid extract of S. 
zooepidemicus A-E, or each sodium salicylate extract of A. equuli R, S, X and Y, grown 
with or without 2,2-dipyridyl, as described in chapter 4 and chapter 3, respectively. Pony 
serum was tested at the pre-challenge, challenge day and post-mortem stages of the 
experiment. Antibody reactions were recorded and used to decide whether ponies were 
suitably naive to the chosen isolates prior to challenge, to select a suitable isolate of S. 
zooepidemicus and A. equuli for each challenge and to see the effects of challenge on 
circulating antibody.
Housing and management
Ponies were selected for challenge at the place of supply, an isolated hill farm, where they 
were kept together in a bam. They were then transported together in a three hour journey 
one week later and housed three to a stable with straw bedding. They were provided with 
hay twice per day and water ad libitum. Rates of food and water consumption were noted 
in the settling in period, of one week before the challenge. Any changes in the daily food 
and water consumption as compared with the settling in period were recorded.
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Preparation of inoculum for challenge
Of the extracts of isolates tested by immunoblotting, the pony sera were judged to contain 
least antibody to S. zooepidemicus isolate C and A. equuli isolate R, so these were used 
for the pony challenge. The inoculum was made by growing ten separate 10 ml cultures 
without 2,2-dipyridyl but with shaking at 37 C. After 4 hours, the cultures were pooled 
and tenfold serial dilutions to 10'^ were made in PBS pre-warmed to 37 C. These were 
transported to the challenge site in a polystyrene container to maintain them at 
approximately 37-C and 10ml of each was instilled into the trachea of individual ponies 
using an endoscope. Viable counts were made on an aliquot of the remaining culture after 
it had been administered to the ponies.
Parameters measured
At the same time each morning, rectal temperatures and number of breaths per minute 
were taken and the quality of breathing, presence of purulent or clear ocular or nasal 
discharges, whether ponies were feeding, drinking, or depressed, whether standing or 
recumbent, were noted. These were monitored at more frequent time intervals dependent 
on the severity of symptoms. On the day of challenge, tracheal washes were taken: these 
were fixed with formalin for pathology, mixed with EDTA for cytology, and left plain for 
bacteriology and virus detection. An aliquot of each tracheal wash was sent to David and 
Helena Windsor of Mycoplasma Experience, Reigate, Surrey, for the isolation of 
Mycoplasma spp. For the S. zooepidemicus challenge, two ponies from each challenge 
group were slaughtered three days after challenge and the remaining test ponies 
s lau^ tered  along with two unchallenged control ponies four days after challenge. One of 
the control ponies was kept for use as a confiai in the A. equuli challenge. Similarly for 
the A. equuli challenge, two ponies from each challenge group were slaughtered three days 
after challenge and the remaining test ponies slaughtered along with two unchallenged 
control ponies four days after challenge.
After euthanasia by an overdose of anaesthetic (10ml Somulose) the carcase was weighed, 
the pluck was removed, heart removed and swabbed for bacteriology, the pluck was
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weighed, then to provide lung density measurements, the lung volume measured by 
displacement of water. Tissue pool was taken for virus and mycoplasma isolation. 
Bronchoalveolar lavage (BAL) and tracheal wash (TW) samples were taken for 
histopathology, bacteriology, and virology, then the trachea was weighed to subtract from 
the pluck weight, to give the lung weight. The lung surface was examined for evidence of 
pneumonic lesions and representative regions of affected lung dissected out for histology 
and bacteriology. Tissue pools from each pony, comprising lung, liver, spleen and sub­
mandibular lymph nodes were examined for the presence of Mycoplasma spp., as above.
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Results
Antibodies in the sera of twentv-one ponies 13 days before challenge, to proteins in hot 
acid extracts of five S. zooepidemicus isolates and sodium salicylate extracts of four 
A. eauuli isolates grown in iron limited m edia.
Pony sera taken prior to purchase, were tested for antibody to polypeptides in extracts of 
each S. zooepidemicus isolate, and to IRPs and non-IRPs in extracts of each A. equuli 
isolate separated by SDS-PAGE and transferred to nitrocellulose. There was less antibody 
to extracts in the sera of these ponies than seen in the serum of an old pony, or with rabbit 
antisera raised to extracts of isolates for a previous experiment.
For S. zooepidemicus, all ponies had antibody to a 52 KDa polypeptide in the extract of 
isolate A, and 38% had antibody to a 46 KDa polypeptide. There were also traces of 
antibody to a series of lower molecular weight polypeptides. 90% of ponies had antibody 
to a 35 KDa polypeptide in the extract of isolate B, and 76% had antibody to a 46KDa 
polypeptide but only 33% had antibody to a 52KDa polypeptide. Ninety percent of ponies 
had antibody to a 35 KDa polypeptide in the extract of isolate C, but only 62% had 
antibody to the 46KDa polypeptide. The same 62% also had antibody to a number of 
lower molecular weight polypeptides. All ponies had antibody to a 52 KDa polypeptide in 
the extract of isolate D, and 62% also had antibody to 48,46 and 35KDa polypeptides. 
Only one pony had antibody to a 52 KDa polypeptide in the extract of isolate E, although 6 
of the ponies had antibody to a 48 KDa polypeptide.
Pony sera had antibody least reactive with the extracts of isolates C and E. Isolate C was 
used in the challenge as all ponies had relatively less antibody to higher molecular weight 
polypeptides than to extracts of the three other isolates. Isolate E was previously isolated 
from the premises on which the challenge was earned out, presenting a possible risk of 
infection prior to challenge, so E was excluded.
All four isolates grown in medium in which iron was limited, then sodium salicylate 
extracted, produced seven proteins in iron limited conditions which were absent or much
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fainter in iron replete conditions (IRPs). The molecular masses of these were as described 
in Chapter 3. Pony sera contained antibodies which reacted with the IRPs the in extracts of 
A. equuli isolates X and Y. Most of the reactivity for isolate Y was for the 73 KDa 
polypeptide whereas for isolate X it was for polypeptides of 60 KDa and below. None of 
the sera had antibodies to the IRPs of extracts of R or S, so isolate R was chosen as the 
challenge isolate.
Bacteriological and viroloeical testing of nasopharyngeal swabs from twentv-one ponies 
prior to .5. zooepidemicus challenge.
No influenza antigen was detected by ELISA from the nasopharangeal swab transport 
fluid. S. zooepidemicus was isolated from nine of the twenty-one ponies but in small 
numbers and there was otherwise no significant growth.
STREPTOCOCCUS ZOOEPIDEMICUS CHALLENGE
Bacteria isolated from nasopharvngeal swabs of ponies taken immediately prior to 
challenge with S. zooepidemicus
Twelve ponies were swabbed immediately prior to challenge with S. zooepidemicus (Table 
10). S. zooepidemicus was isolated from all but one pony. B. bronchiseptica was 
isolated from eight of the twelve ponies and coagulase positive staphylococcus were 
isolated from seven of twelve animals. A Pasteurella species was isolated from one of the 
ponies. Non-haemolytic streptococci, coagulase negative staphylococci, bacillus and 
fungus species were also isolated.
Endoscopv examination and tracheal wash bactenoiogv. cytology and virology from ponies 
immediatelv prior to challenge with S. zooepidemicus
Only four of the nine ponies to be challenged had obvious mucopus on endoscopy and in 
the tracheal washes. There were no visible signs of erythema or oedema of the tracheal 
wall. Most of the ponies sampled had an inflammation score of 1/2, and had evidence of a 
predominance of neutrophils or macrophages, thickened or copious mucus. Gram positive 
cocci associated with squames and /or mucus were seen in four and gram negative cocci in
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two of the tracheal washes. Bacteriology of the tracheal washes (Table 11), revealed S. 
zooepidemicus, B. bronchiseptica and coagulase positive staphylococci, each in six 
ponies. The count was greater than 10^ cfu/ml for all B. bronchiseptica isolated, but 
bacterial counts were lower in some tracheal washes for the other bacteria. A widely 
variable count of non-haemolytic Streptococci were also isolated from seven of the eight 
tracheal washes and a high count of Pasteurella spp. was found in one. All ponies tested 
negative for influenza antigens and no Mycoplasma spp. were cultured. Taken together, 
the evidence suggested a mild to moderate bacterial lower airway infection in the ponies 
immediately prior to challenge.
Clinical signs recorded in ponies challenged with S. zooepidemicus 
Rectal temperatures (Table 12) for two of the control ponies were 36.5*C and above on the 
morning of the challenge, but were otherwise lower than this for all ponies throughout the 
experiment. The mean temperatures of the ponies given a 10'^ dilution of culture increased 
24 hours after challenge, but decreased for ponies in other groups including the control 
ponies. By forty-eight hours, the temperatures the 10'^ group had stabilised, but continued 
to decline for those given neat culture, and control groups. Temperatures had stabihsed in 
all groups by 72 hours.
Mean breathing rates (Table 13), were relatively high on the day of challenge for all 
groups, including controls, but gradually declined as the experiment continued for the 
group given a 10'  ^ dilution of culture. Groups given neat and 10'^ diluted culture had 
increased breathing rates 24 hour's after challenge, but by 48 hours, rrates had decreased to 
lower levels than those measured proir to challenge, All ponies challenged with neat 
culture and one of the ponies given 10  ^ were breathing abdomrnally 24 hourrs after 
challenge. By 72 hours, the pony in the 10'* group breathing abdominally 24 hours after 
challenge, was making a raiUng breathing noise and the other two ponies in the 10 group 
were also breathing abdominally at this time.
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Twenty-four hours after challenge, three of the ponies challenged with neat culture showed 
signs of depression and coughing was heard. This also included the group given the 10'^ 
dilution at 48 hours and to all challenged groups at 72 hours, by which time the group 
given 10^ of culture dilution were not eating normally. Seven of the twelve ponies had 
ocular discharge on the day of challenge, which increased to eleven of the twelve 48 hours 
after challenge and included control ponies. Nasal discharges also peaked at 48 hours but 
of the five involved, two were control ponies.
Bacteriologv and cvtologv of tracheal wash (TW) and bronchoalveolar lavage (BAL) 
samples taken post mortem from ponies challenged with S. zooepidemicus, and controls 
Large numbers of B. bronchiseptica and moderate numbers of S. zooepidemicus and 
staphylococcus spp., were isolated from both TW and BAL samples of ponies (Table 14). 
This indicated a B. bronchiseptica infection. Samples were clear or translucent with 
variable flocculation. Eight of the inflammation scores were 1/3 and three (two from 
separate challenge groups and one of the unchallenged ponies) had scores of 0/3. The 
predominant cell types found were neutrophils and epithelial cells, and mucus was 
generally eosinophilic, none of which appeared to be related to challenge dose. Gram- 
positive and negative bacteria were associated with squames and in some cases mucus in 
uninfected controls as well as challenge ponies.
Pathologv and bacteriology of tissue samples taken post mortem from ponies challenged 
with S. zooepidemicus, and controls
Histblogical signs of multifocal lobular pneumonia were found in all three ponies given 
10‘° cfu of culture (Table 15), two of the three given 10® cfu (Table 16)’ and two of the 
three given 10* cfu of culture (Table 17). This was not found in two of the test ponies or 
the uninfected controls (Figure 18). Lateral cardiac and accessory lobe regions were 
consistently affected. The most extensive lesions were found in ponies labelled 14 and A 
(lO'Q cfu) and 9 (10® cfu).
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The controls and two test ponies 8 and 13 revealed evidence of pre-existent lower airway 
inflammatory changes and minor parenchymal lesions. Parasitism may have contributed to 
an eosinophil response seen in some ponies. No significant changes were seen in the upper 
respiratory tract, except for a tracheaitis in pony 13 (10® cfu) and there was no evidence of 
abcessation of respiratory tract lymph nodes. Bacterial colonies were not commonly 
evident in lung sections but immunostaining detected the presence of lesion-associated 
bacterial antigen.
Ocular discharge from control ponies contained predominantly S. zooepidemicus and 
Staphylococcus spp. However, very few S. zooepidemicus were recovered from the 
tissues of the test ponies. For the ponies given 10® cfu, there were moderate to 
largenumbers of B. bronchiseptica in the lymph nodes and normal lung. One lesion 
contoined large numbers of Nocardia spp. Moderate to large numbers of B. 
bronchiseptica and smaller numbers of Staphylococcus spp were also cultured . Ponies 
given 10‘° cfu had B. bronchiseptica and Staphylococcus spp. present in lesions and one of 
the ponies had small numbers of S. zooepidemicus in the bronchial lymph node. The 
apparent dose response and immunoperoxidase positive staining bacteria present in 
sections of tissue suggests that S. zooepidemicus was associated with the lung lesions. 
Gasterophilus spp. and Parascaris equorum were found in the intestines of all ponies. No 
Mycoplasma spp. were cultured from tissue pools, or influenza antigens detected.
Antibodies of twentv-one ponies immediatelv prior to and three/four davs after challeiige.
to proteins in hot acid extracts of five S. zooepidemicus isolates.
The antibodies in the sera of most of the ponies reacted more s i n g l y  and to a wider range 
of polypeptides in all of the extracts than seen in the sera taken 13 days before challenge. 
Alsô the strengths of the reactions were more consistent between ponies. Antibodies in 
serai taken on the day of euthanasia were not appreciably different to those in sera taken on 
the day of challenge.
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ACTINOBACILLUS EQ UU U  CHALLENGE
Bacteria isolated from nasopharyngeal swabs of ponies taken immediately prior to 
challenge with A. eauuli
Nine ponies wei% swabbed immediately prior to A. equuli challenge (Table 19). S. 
zooepidemicus was isolated from all but one pony, B. bronchiseptica was isolated from 
seven out of nine ponies and coagulase positive Staphylococcus spp. were isolated from 
2/9 animals. Pasteurella species were isolated from 4/9 ponies. Non-haemolytic 
streptococci, coagulase negative staphylococci, bacillus, and fungus species were also 
isolated. S. equisimilis, a beta-haemolytic streptococcus and coliform were each isolated 
frorn one of the ponies.
Endoscopv examination and tracheal wash bacteriologv. cvtologv and virology from ponies 
im m ed ia te lv  prior to challenge with A. eauuli
Only three of the ten ponies had obvious mucopus on endoscopy and the tracheal washes 
were mostly clear or translucent with some flocculation. There were no visible signs of 
erythema or oedema of the tracheal wall. Five of the ponies sampled had an inflammation 
score of 1/3, two had 2/3 and one had a score of 0/3. Six of the washes had a 
predominance of neutrophils or macrophages, and most had eosinophilic mucus, of which 
three wer« thickened or copious. Gram positive cocci associated with squames and /or 
mucus were seen in six and gram negative cocci in five of the tracheal washes. S. 
zooepidemicus and B. bronchiseptica were isolated from seven tracheal washes and 
Coagulase positive staphylococci in smaller amounts and variable counts of non- 
haemolytic streptococci were isolated from five and six ponies respectively (Table 20). 
Pasteurella spp. were isolated from three of the tracheal washes, Counts of greater than 
10"^  cfu/ml were found in only half of the samples, which included four with B. 
bronchiseptica , two with S. zooepidemicus, and one with Pasteurella spp. All ponies 
tested negative for influenza antigens and no Mycoplasma spp. were cultured. It is likely 
that the pre-challenge respiratory bacterial infection seen in ponies challenged with S. 
zooepidemicus seven days previously, was also affecting the ponies about to be used fo r
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the A. equuli challenge. However, the evidence suggested that the infection was less 
severe at the time of tracheal wash sampling than that seen in ponies the previous week.
Clinical signs recorded in ponies challenged with A. equuli
Mean rectal temperatures (Table 22), were relatively stable throughout the experiment. 
One pony in the group given a 10^° of culture had a temperature of 37-C on the morning of 
the challenge, and one pony in the group given 10® had a temperature of 36 C immediately 
proir to challenge, which rose to 37-C 24 hours later, then subsided.
Mean breathing rates (Table 22), had increased 24 hours after challenge for all groups, 
including controls, then declined although there was no clear pattern. Two of the three 
ponies given 10^ ® of culture were breathing abdominally 24 hours after challenge and 
ponies in the other test groups were breathing slightly abdominally. Forty-eight hours after 
challenge, the quality of breathing was restored with the exception of one pony in the 
group given 10^ of culture, which was still breathing abdominally. By 72 hours, the group 
given 10^° of culture were again breathing abdominally, as was the pony in the group 
given 10^, which continued until post mortem 3-4 days after challenge.
Five hours after challenge, the group given 10  ^diluted culture were sweating. Twenty-four 
hours after challenge, all of the test ponies had signs of depression and coughing was heard 
from the group given 10^° culture. All test ponies were eating and drinking much less. 
After 48 hours, all ponies were much brighter and higher levels of eating and drinking 
were resumed, but they were still quieter than the controls.
N as^  discharges were only present in two of the ponies on the day of challenge. This 
increased to six 24 hours after challenge, but the majority resolved by the end of the 
experiment.
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Cytology and bacteriology of tracheal wash (TW) and broncho-alveolar lavage (BAL) 
samples taken post mortem from ponies challenged with S. zooepidemicus, and controls 
Large numbers of B. bronchiseptica were isolated from most of the ponies. Pasteurella 
spp. , S. zooepidemicus and Staphylococcus spp. were isolated from some ponies (Table 
23). Samples were clear with variable amounts of flocculation. Inflammation scores were 
either 1/3 or 0/3 for unchallenged controls and challenged ponies, in no particular pattern. 
The predominant cell type were epithelial, apart from two of the ponies in groups given 
10^° and 10® cultures, where macrophages predominated, which may be indicative of 
resolving infection. Mucus was scant and sometimes eosinophilic.
Pathology of the lungs and bacteriology of tissue samples taken post mortem from ponies 
challenged with A. equuli. and controls
The three ponies given 10‘° cfu of culture demonstrated partial to complete consolidation 
of the left cardiac regions (sometimes extending to involve the cranial part of the left 
diaphragmatic region) and right accessory lobes of the lungs. The consolidated areas of 
lung were characterised histologically by alveolar collapse and interstitial infiltration by a 
mixed population of macrophages, lymphocytes, neutrophils and eosinophils, with 
p lu ^ n g  of interposed terminal bronchioles by inspissated exudate. Small foci of alveolar 
septal necrosis were noted within these pneumonic lesions in pony 16. The lesions in this 
group of ponies given neat culture were defined as foci of lobular bronchiolar-interstitial 
pneumonia.
In the group given 10® cfu of culture ponies 15 and 2 demonstrated minor congestion or 
consolidation of the left cardiac regions and right accessory lobes of the lungs. These 
consolidated areas of lung in pony 15 were characterised histologically by alveolar collapse 
and ; interstitial infiltration by macrophages and lymphocytes accompanied by small 
numbers of neutrophils and eosinophils, and thereby resembled minor lesions of the type 
seen in ponies given neat culture, whereas the lesions in pony 2 were more typically 
eosinophil-dominated, and occasional interposed bronchi and bronchioles in this animal 
were plugged by mucus or eosinophilic exudate. The third pony in this group did not
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demonstrate gross pulmonary consolidation, but histological examination of specimens of 
lung also revealed plugging of bronchioles by eosinophilic exudate and there were tiny foci 
of alveolar collapse and infiltration by eosinophils, macrophages and neutrophils. A mild 
subacute tracheitis was recognised microscopically in ponies 5 and 15. Lesional bacteria 
were not recognised on Gram-staining of lung sections in the groups given 10‘° cfu or 10® 
cfu but immunostaining revealed bacterial antigen.
There were no signs of gross pulmonary consolidation in the ponies given 10* cfii of A. 
equuli. Histological examination of lung specimens revealed occasional microscopic foci 
of alveolar collapse and mild interstitial infiltration by macrophages, lymphocytes, and 
neutrophils in the right cardiac and accessory lobes of pony 21. Both ponies had mild 
subacute tracheitis.
The two control ponies did not demonstrate gross pulmonary consolidation. No foci of 
alveolar collapse and interstitial infiltration directly comparable to the pneumonic lesions 
in the test ponies were recognised on histological examination of lung specimens. Both 
ponies had plugging of the distal trachea by inspissated mucopus, corresponding to a 
subacute exudative tracheitis.
All ponies demonstrated some other histological changes in the lungs of greater 
development and resolution which were considered to be not directly related to challenge 
having occurred earlier. Bronchial and bronchiole-associated lymphoid nodules were 
generally prominent, consistent with the age of the animals and often showed follicular or 
micronodal differentiation. There was variable eosinophilic infiltration of bronchial and 
bronchiolar mucosa, and some airways were plugged by mucus entrapping eosinophils and 
macrophages. The latter change was considered likely to reflect a pre-existing airway 
hypersensitivity or endoparasite reaction. No significant changes were recognised in the 
upper respiratory tract or respiratory tract lymph nodes of the ten ponies.
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No A  equuli were recovered from the tissues of the test ponies. For the ponies given 10‘° 
cfu (Table 24), there were moderate numbers of B. bronchiseptica and non-haemolytic 
streptococci in the lymph nodes and normal lung as well as the dorsal cardiac congestion 
found in pony B. Moderate to large numbers of B. bronchiseptica were cultured from 
normal lung of ponies given 10® cfu of culture (Table 25), along with some Acinetobacter, 
Staphylococcus spp. and non-haemolytic streptococci. Pasteurella spp. was cultured from 
the lesion from pony 2.
Ponies given neat culture had Pasteurella spp, S. zooepidemicus , B. bronchiseptica , 
Acinetobacter spp, Nocardia spp and Staphylococcus spp. present in lesions and nomal 
lung. Overall, there is a possibility that there was some Pasteurella spp. associated with 
the lung lesions, although a Pasteurella spp. was isolated from the bronchial lymph node 
of one control pony. Gasterophilus spp and Parascaris equorum were found in the 
intestines of all ponies. No Mycoplasma spp. were cultured from tissue pools, or 
influenza antigens detected.
Antibodies of twentv-one ponies immediatelv prior to and three/four davs after challenge, 
to sodiiiTTi Rfllir.ylate extracts of four A. eauuli isolates grown in iron limited media 
Isolate R was used for the challenge. Although ponies had little circulating antibody to 
sodium salicylate extract of dipyridyl grown R in the month prior to challenge, seven of the 
ponies had antibody to 73, 65 and 48KDa IRPs on the day of challenge. On the day of 
euthanasia, all ponies had circulating antibody to the73 and 65KDa IRPs.
On the day of challenge, there was a big increase in reactive antibody to the extract of 
isolate S; eight of the ponies had circulating antibody to the 73, 65, 60 and 48 KDa IRPs. 
It is of interest to note that on the day of euthanasia, there was no detectable antibody in 
any of the sera to the 73 and 65 KDa IRPs, although reactivity to other polypeptides was 
still strong.
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The antibody reactivity to the extract of isolate X on the day of challenge was stronger than 
previously, and four of the ponies had antibody to both the 73 and 65KDa IRPs; three other 
ponies had antibody reactive with only the 56KDa IRP. On the day of euthanasia, the 
antibody response was stronger and more uniform for all of the ponies, including controls.
The antibody reactivity for the extract of isolate Y was not appreciably different from the 
previous occasion tested on the day of challenge, with reactivity to some IRPs. The 
response on the day of euthanasia was again similar but stronger. These results suggest 
that antibody reactive with extract of the challenge isolate was already on the increase in 
the days prior to challenge. Immunoperoxidase staining of lung lesions using rabbit 
antisera raised to isolate R suggested that bacteria were present.
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7.2 Aetinobacillus and Pasteurella species isolated from the distal trachea of horses 
with bacterial lower airway disease.
When the species of Actinobacillus/Pasteurella involved in equine lower airway disease 
were investgated, results indicated that much of this group of isolates from the lower 
airway of training Thoroughbred horses is accounted for by A. equuli and A. suis -like 
isolates, with A. equuli predominating. This relative importance is in agreement with 
Kim, Phillips and Atherton (1976), for A. suis -like isolates. A retrospective study 
identifiedA. suis -like organisms in the transtracheal aspirates and pleural fluid of horses 
with acute haemorrhagic pulmonary infarction and necrotizing pneumonia (Carr et al. 
1997). This study also found that A. suis -like isolates, and A. ligniersii were associated 
with inflammation of the lower airway, but this should be interpreted within the limitations 
of the data. Previous analysis of bacteria associated with lower airway inflammation 
(Wood et al. 1993), did not differentiate between the species of Aetinobacillus / 
Pasteurella, which is probably why Aetinobacillus is associated with disease in some 
situations but not others. Vaissaire et al. (1988), identified predominantly A. equuli, but 
also A. suis and A. ligniersii , from a range of conditions in mares and foals, which 
supports their pathogenic role in the horse. Whether the association of these bacteria with 
lower airway disease signifies a primary pathogenic role, or forms part of a complex of 
agents with a secondary role remains to be determined. Given the frequency of isolation of 
A. equulU work on it in the context of equine LAD was continued.
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7.3 U t i l i s a t i o n  a n d  binding of equine transferrin by Acrino^flci//iis equuli and 
characterisation of its iron regulated proteins.
Given the taxonomic relatedness and parallel pathogenic roles of Pasteurella / 
Aetinobacillus species in horses (Wood et al. 1993), A. pleuropneumoniae in pigs 
(Sebunya and Sanders, 1983) and P. haemolytica in sheep (Gilmour, 1980), it seemed 
possible that A. equuli could produce a transferrin binding protein, which might enable 
utilisation of iron bound to transferrin. A. equuli grown in iron limited conditions bound 
equine holotransferrin but iron replete cells did not. Similar studies of the related 
bacterium A. pleuropneumoniae revealed that haemoglobin bound the outer 
lipopolysaccharide, yet this was not utilised as an iron source (Bélanger et al. 1995). To 
ensure that this artifact was not disguising the true host iron carrier protein that A. equuli 
obtains iron from, an assay was used to test whether the isolates were able to utilise iron 
complexed with various mammalian carrier proteins as a sole source for growth. These 
equine isolates utilised iron complexed with equine transferrin but not transferrin from 
other species, which might explain why A. equuli is almost exclusively a pathogen of 
equines.
The binding of holotransferrin by sodium salicylate extracts might suggest that the 
transferrin binding part of the mechanism for obtaining iron from transferrin is an outer 
mernbrane protein, or complex of proteins, which has few or no cysteine residues open to 
disulphide cleavage in areas which would compromise the function of the transferrin 
binding site! Although whole bacterial cells and sodium salicylate extracts bound 
transferrin, the culture supernatants did not, suggesting that these A. equuli isolates utilise 
the 1TÛ11 carried by equine transfemn via a direct binding mechanism. If a siderophore 
type mechanism exists for these isolates, it is unlikely that it would be detected by the 
methods employed in this study. Whole cells of isolate R grown in iron limited culture 
bound transferrin, but sodium salicylate extracts of the SMne culture did not; the growth of 
isolate
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R was also slower than the other isolates in medium for which the available iron was 
equally restricted. Taken together, the evidence suggests that there is something different 
abolit the iron scavenging mechanism of isolate R and that in vitro, its iron scavenging 
mechanism is less efficient compared with that of the other isolates. Attempts to identify a 
transferrin binding protein by native PAGE probably failed because the protein had little 
net charge, or that the binding site was altered by Western transfer conditions, or that the 
transferrin receptor is actually a complex of proteins.
Cultures grown in iron limited conditions contained shorter cells which took up safranin 
counterstain more readily than cultures grown in iron replete conditions, suggesting that 
iron limitation could affect the morphology of the four A. equuli isolates. It was noted that 
iron limitation changed lipopolysaccharide (LPS) structure of B, bronchiseptica (Menozzi, 
Gantiez, and Locht. 1991), so it is a possibility that changes in staining behaviour could be 
due to this. Iron limitation also appeared to increase the viscosity of the culture 
supernatants, suggesting an increase in the production of a soluble capsule or slime layer. 
These observations, taken together, suggest that A. equuli may divert cell resources into 
capsule and / or LPS changes in conditions of iron limitation, perhaps as mechanisms to 
aid growth and survival within the host.
The A. equuli isolates produced iron regulated proteins, which were identified as those 
exclusively present or those with visibly increased expression in extracts of iron limited 
cultures. The other proteins (non-lRPs) produced by bacteria both in iron limited and 
normal medium were very similar in molecular mass between all four isolates.
Imrnunoblotting with rabbit antisera to the four isolates suggested good antigenic cross­
relatedness between the non-lRPs of A  equuli and a spectrum of relatedness between the 
IRPs of different isolates. By spectrum of relatedness is meant the lack of cross-reactivity 
between two representative isolates of greatest dissimilarity which both share antigenic 
relatedness with isolates of intermediate relatedness. In molecular antigenic terms, it could 
be hypothesised that the IRPs of the “intermediate isolates” have different epitopes, some
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shared with one of the most “dissimilar isolates” and some shared with the other. For 
isolates S, X and Y, there was evidence that a transferrin binding mechanism was present 
in the extracts with which the rabbits were immunised, so the similarity of the IRP 
molecular masses for the isolates may be an indication of determinants with a common 
function, such as transferrin binding. This may mean that a vaccine could act by 
preventing A. equuli from thriving in the host by depriving it of iron, through blocking the 
bacterial transferrin binding site with specific antibody, so long as the mechanism 
identified is the only iron scavenging mechanism employed by this bacterium. However, 
the natural antibody in the equine sera tested discriminated more clearly between the IRPs 
of the different isolates than the immune rabbit antisera. There is evidence from the study 
of meningococcal transferrin binding proteins that rabbit antisera are generally more cross- 
reactive than, for example, mouse antisera and also that both antigen preparation and 
administration route may affect the extent of cross-reactivity (Ala’Aldeen et al. 1994).
Nevertheless, the greater dissimilarity between isolates R and X detected using rabbit 
antisera were observed with the horse sera. The two younger groups of ponies (A and B) 
reacted only with IRPs in isolates X and Y which suggested either the greatest antigenic 
similarity between these two or that infections with strains related to both of these isolates 
had occurred. Since rabbit antisera revealed strong cross-reactions between IRPs of 
isolates Y and S and the reactivity of equine sera was to relatively few IRPs of isolate Y, 
the latter case seemed most probable. Consequently, the immunogenic relationship 
between isolates detected with rabbit antisera may hold for the equine immune system. 
Either the equine immune system may have responded to epitopes different from those 
rccugnised by tlie rabbit, or the antibodies to IRPs were produced in response to an 
infection by isolates of A. equuli which shared some, but not all, of the antigenic forms of 
IRP present in isolates X and Y. This might explain why there were equine antibodies to 
IRPs of different molecular mass in extracts of the different isolates. The greater cross­
reactivity of antibody to IRPs from different isolates in the sera of older ponies might be 
explained by the exposure to a wider range of A. equuli types related to age and history of 
mixing with other ponies bearing more diverse isolates. Higher titres of antibody to A.
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equuli were associated with increasing age (Nicoletti, Mahler and Scarratt, 1982), which 
would support this hypothesis.
If immunity can depend on antibodies neutralising the transferrin binding capacity of IRPs, 
then these results suggest the need for more than one strain in a vaccine. There seemed to 
be considerable cross-reactivity between the non-lRPs so that, if they also play some role 
in protective immunity, the number of isolates in a vaccine upon which broad immunity to
A. equuli depends may be reduced. However, the general antigenic similarity of the non- 
IRPs of these isolates and antigenic variation of IRPs is suggestive of immune selective 
presisure on an essential virulence determinant to vary, so as to escape immunity arising 
from infections by earlier strains.
In terms of vaccine design, based upon experience with A. pleuropneumoniae and P. 
haemolytica, protective immunity correlates well with the presence of antibody to toxins. 
There is an urgent need to examine these tracheal isolates for the posession of toxins 
similar to the APX group of toxins and P. haemolytica leucotoxin.
Finally, most of the data involves Thoroughbred horses in training. It would be interesting 
to see whether the were any differences in the species isolated from the Thoroughbred 
horse and other breeds over time, and whether there is any correlation between the 
presence of Pasteurella /Aetinobacillus species and the transferrin type. There are seven 
transferrin alleles in the horse, normally analysed in blood typing, some of which are 
strongly associated with certain breeds and may influence the ability of these species of 
bacteria to obtain iron and hence establish infection. If a link were found, animals could 
be targeted for vaccination which may be particularly susceptible.
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7*4 Antigenic and opsonic relatedness of isolates from
the equine trachea.
S. zooepidemicus M-like proteins were recently found to be structurally different from 
Group A M proteins (Walker and Timoney, 1994) and were found to lack some repeats 
found in group A streptococci; it has been hypothesised that M proteins in group A and M- 
like proteins in group C streptococci have different evolutionary origins. Nevertheless, hot 
acid extracted proteins in this study were called M-like proteins because they are presumed 
to function similarly to Lancefield Group A M proteins. Indeed immunisation with hot 
acid extracts from Lanccficld Group C streptococci stimulated opsonogenio antibody as it 
would for Group A streptococci.
The study revealed complex antigenic relationships between the proteins in hot acid 
extracts of the five S. zooepidemicus isolates, yet few differences in sizes of polypeptides 
in silver stained SDS-PAGE gels, which suggested that the proteins present were 
structurally similar. Rabbit antisera contained antibody to proteins in homologous and 
heterologous extracts. A 41KDa protein was thought to be important for protective 
mucosal immunity to S. equi in the horse (Galan and Timoney, 1985). In this study, rabbit 
antibody was cross-reactive to a 41KDa peptide in two of the extracts of isolates; it has 
been suggested that there was a homologue of the S. zooepidemicus M-like protein in S. 
equi (Timoney, Umbach, et al. 1994).
As with A. equuli, the cross-reactivities of antibodies in rabbit antisera suggested a 
spectrum of antigenic relatedness between the higher molecular mass polypeptides in hot 
acid extracts of the five S. zooepidemicus isolates tested. Generally, there was more cross 
reactive antibody to the lower molecular weight fragments, but it should be kept in mind 
that: since these are polypeptides surviving hot acid, many of them are likely to 
behydrolysis end products. This suggests that the whole molecule or large fi-agments may 
have more strain specific conformational epitopes which are less stable and present in only 
small quantities, whilst smaller fragments are likely to be the more stable linear epitopes. 
Also, it is important to recall that rabbits were immunised with the hot acid extracts and
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the smaller, more predominant hydrolysis products may have stimulated a stronger 
immune response than the larger, less concentrated molecules. Isolate B was the exception 
to this with a number of cross reactive higher molecular weight proteins detected by 
antibody present in four of the antisera, perhaps indicating that the extent of hydrolysis in 
the different extracts were not the same. The smaller, more cross-reactive polypeptides 
may have been fragments of R antigen, which were shown to provoke cross-reactive 
antibody, but protective immune responses were not demonstrated (Timoney, 1986). 
These could have given an impression of closer antigenic relatedness and therefore greater 
expectations of the level of cross-protection between isolates than really existed.
The amount of total protein surviving hydrolysis in extracts of isolates D and E was lower 
than in the extracts of the other isolates despite using similar amounts of bacterial cells. 
This might be due to lower levels of M-like protein expression by isolates D and E, or the 
M-like proteins may be smaller in size than isolates A, B, or C.
Pre-immune rabbits had no antibody to protein epitopes in hot acid extracts of the five 
isolates. Different epitopes may be immunodominant for rabbits and equines, so that a 
false idea of relatedness may be gained by studying the antibodies from only one species. 
Antisera raised in one species have shown a different amount of cross reactivity to another, 
and both the method of antigen preparation and route of administration to the animal was 
reported to affect the resulting antisera (Ala’Aldeen et al. 1994). It is not known whether 
antibody to cross-reactive or uniquely recognised M-like protein fragments (or a mixture of 
the two) can provide protection in the equine.
Rabbit antisera to hot acid extracts were used to supplement naive whole rabbit blood for 
in vitro phagocytosis tests, to discover whether all of the antisera had a similar opsonising 
effect. There was evidence for good opsonisation of isolates B and C by all of the antisera 
and it seems possible that antibody to epitopes contained in the higher molecular weight 
fragments could have opsonised these isolates. Isolates A and E were not opsonised even 
by homologous antisera and D was not consistently, despite having cross reactive antibody
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for the 41KDa fragment and a range of smaller polypeptides. This suggested that antibody 
raised to hot acid extracts in rabbits can be opsonic for some but not all heterologous 
isolates, which may be due to other opsonic factors related or unrelated to M-like proteins, 
failing to survive acid hydrolysis. Strain variation in the amount of hyaluronate capsule 
produced might be a possible target for further investigation.
These experiments were repeated using whole young pony blood mixed with the S. 
zooepidemicus isolates. It was hypothesised that young ponies would have been exposed to 
few different strains so any opsonogenic or antigenic cross-relationships would be easier to 
analyse. None of the five pony bloods opsonised isolate D and few antibodies to hot acid 
extracts were detected by immunoblotting. Isolate B was opsonised by all pony bloods and 
immunoblotting revealed antibody to polypeptides ranging from 52 to 26KDa (including 
the 46 and 41KDa polypeptides). Isolate A was opsonised to the greatest extent by the end 
of the experiment and this is reflected in an immunoblot showing antibody to polypeptides 
ran^ng from 37 to 48KDa (again inclusive of 46 and 41KDa polypeptides). Isolate C was 
not jehably phagocytosed throughout the experiment. This relates to an immunoblot 
where there was reactivity to fragments from 50 to 36KDa. As individual animals will 
have had varying titres of antibody, it was difficult to relate the results of phagocytosis 
assays with antibody reactions seen with immunoblotting.
Young pony sera were surveyed for reactivity to the polypeptides in hot acid extracts by 
immunoblotting of SDS-PAGE gels. There was reactive antibody present mostly to the 
higher molecular weight peptides but the relationships between the five isolates were as 
con^lex in the horse as in the rabbit.
Analysis of the 16S-23S RNA type of the five isolates showed that three were the same 
ribotype (eight types exist; Chanter et al. 1996), despite taking samples from outbreaks as 
spatially and temporally separated as possible. There was no obvious relationship between 
antigenic/opsonogenic behaviour and ribotype, or spatial and temporal distribution of the 
isolates, although a general obsevation was made about the variable numbers of peptides of
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25KDa and above picked up by rabbit antisera on immunoblots. M protein genes in S. 
pyogenes are thought to be recombination hot spots, and the M-like protein genes of S. 
zooepidemicus are similar, so we would not necessarily expect a close relationship to 
exist.
For S. pyogenes, it was discovered that capsule and M protein were variably important in 
resistance to phagocytosis, meaning that for some isolates, capsule was the most important 
mechanism, whilst for others, M protein has a more significant effect. Given the complex 
results for S. zooepidemicus it is conceivable that this is the case also.
If immunity can depend on antibodies to M-like proteins, then these results together 
suggest the need for a number of isolates (with antigenically different M-like proteins) in a 
vaccine. There seemed to be reasonable cross-reactivity between the proteins in hot acid 
extracts of the five isolates, but the antigenic variation of M-like proteins is suggestive of 
immune selective pressure on an essential virulence determinant(s) to vary, so as to escape 
immunity following infection by other strains. There is now a need to establish if: a) 
vaccination with bacterins is protective against homologous challenge; b) to assess if 
protection is related to responses to M-like proteins and c) to determine the prevalence and 
significance of different M-like protein types.
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7.5 Characterisation and cloning of a Group C Streptococcal hyaluronate associated 
protein tested in a murine Streptococcus zooepidemicus challenge model.
The strategy adopted was to express recombinant HAP for testing sera and for use in 
vaccination challenge studies, because purification of the native enzyme yielded a low 
concentration of product and involved a protocol which would be unsuitable for industrial 
scale-up. The S. equi strain tested had a similar DNA sequence to that described for S. 
equisimilis HAP (Lansing et al. 1993; described as HS). Some of the differences are 
bases at the third position in the codon, which due to the degeneracy of the genetic code, 
mostly encode the same amino acid. The conservation of the amino acid sequence 
suggests that HAP may fulfil similar roles in both species. Whatever its function is, efforts 
to express recombinant HAP suggest that it is toxic to E. colt and it seems possible that 
the major site of the polypeptide conferring toxicity is likely to involve a frame shifted 
region in fragment 1, which would not otherwise clone into pGEX.
Proteins of 53 and 55 KDa, of similar size to that described for S. equisimilis (Prehm and 
Mausolf, 1986), were purified from the S. equi culture supernatant, which is consistent 
with work which shows that HAP (described as “HS”), is shed into the culture medium of 
growing S. equisimilis (Mausolf et al. 1990). A similar protein could not be found using 
a clmlate solubilization method of isolating HAP from the protoplast membrane (Prehm 
and Mausolf, 1986), although a 42 KDa hydrophobic protein, which could have been HS, 
was identified. As the 53 and 55 KDa proteins co-puiified with HA and were still present 
in purified HA treated to remove non-covalently bound proteins, it is likely that they are 
covalently bound to HA, as some human hyaluronate associated proteins are (Prehm, 
1995); disruption of the bonding by conditions knoum to dissooiate moot covalent bonds 
(Hough-Monroe and Milstone, 1991), was not achieved however. HPLC analysis of 
hyaluronidase treated Streptococcal HA, described by Prehm (1995) might confirm the 
nature of the bonding.
No evidence was found that the 55 KDa protein isolated from the culture supernatant of S. 
equi was immunogenic in the rabbit. The rabbit antisera raised to the 53 KDa protein and
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recombinant protein (fragment 4), detected by immunoblotting and dot blots, showed that 
both were immunogenic in the rabbit and cross-reactive, which was reduced by absorption, 
confirming that the recombinant was a fragment of the 53 KDa protein, as hoped.
Part of the recombinant HAP (fragment 4) significantly delayed the time to death and 
number of viable bacteria in the lungs in mice challenged intraperitoneally with S. 
zooepidemicus. A similar result was obtained for challenge with S. equi (Chanter, 
personal communication). None of the other fragments had a similar effect, even though 
in most cases, mice had some antibody to the fragment they were immunised with. The 
mechanism of protection was not fully investigated, but the in vitro data suggested that it 
could involve interference of capsule production by antibody, as hypothesised. The 
capsule inhibition data was quaUtative, but could be quantified using buoyant density 
centrifugation, as described by DeAngehs and Weigel, (1994), for detection of HA capsule 
from group A Streptococci.
HA is already on the market as an surgical ophthalmological support and other uses are 
being considered, so extensive safety studies have already been completed. However, 
antibodies were found to be covalently bound to hyaluronate in the synovial fluid of 
patients with rheumatoid arthritis, and it is thought likely that antibodies themselves 
become antigenic, leading to acute inflammation (Prehm, 1995). Similarly, antibody to the 
S. pyogenes 56 KDa HAP was found in patients with rheumatic fever, suggesting that it 
might cross-react with heart cells and lead to lysis Prehm, Herrington, et al. 1995). There 
was no evidence of any problems in the rabbits, or mice immunised with HAP. However, 
these studies only concern short term effects, so further work must assess the risk of long 
term autoimmune problems. The next logical step is an equine acceptability trial, then to 
test the potential of recombinant HAP (fragment 4) to protect equines against experimental 
S. zooepidemicus lower airway challenge and/ or natural challenge in the field.
201
Ward, C. 1997
7.6 Ecpi^eStreptococcus zooepidemicus and Actinobacülus cquuü challenge model 
development
There was a histological and gross pathological dose response to challenge with S. 
zooepidemicus, but few challenge organisms were recovered from lung lesions. 
Immunostaining with homologous S. zooepidemicus rabbit anti serum however, revealed 
the presence of S. zooepidemicus antigen. PCR in situ hybridization could be employed in 
the future to confirm that the S. zooepidemicus identified in the lesions was the challenge 
strain.
The results were complicated by the presence of Bordetella bronchiseptica infection, 
which peaked in numbers of organisms and ponies infected at the commencement of the S. 
zooepidemicus challenge. B. bronchiseptica associated with an inflammation score of 1 or 
greater was likely to have affected the results of both challenges, as inflammation was 
already present. The many S. zooepidemicus present in tracheal washes and 
nasopharangeal swabs immediately prior to S. zooepidemicus challenge, and 
immunoblotting evidence indicated that the ponies may have produced additional antibody 
to polypeptides in hot acid extracts of the challenge isolate by the time they arrived. It is 
likely that the ponies became susceptible to disease because of the journey to the Animal 
Health Trust which they made in the week prior to challenge. S. zooepidemicus 
pneumonia was previously associated with transport of horses (Oikawa et al, 1994). 
Posture often adopted whilst travelling has been demonstrated to slow mucocilliary 
transport (Raidal, Love and Bailey, 1996), and in calves, stress has been shown to diminish 
infiltration and production of superoxide by polymorphonuclear leucocytes (Henricks, 
Binkhorst and Nijkamp, 1987).
S. zooepidemicus, Actinobacillus/Pasteurella sp. and B. bronchiseptica are frequently 
isolated alone or in mixtures from the lower respiratory tracts of foals (Mair, 1989; Knight 
& Hirsh, 1982; Darien et a l  1990; Hirsh & Jang, 1987), and polymicrobic infections are 
thought to be common (Martens et al. 1989; Wilson, 1992; Mansmann, T982; Knight &
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Hietala, 1978); these previous observations are consistent with the findings of this current 
experiment.
Parasites were found, and these are associated with unthriftiness and increased 
susceptibility to infection (Morris, 1978; Mansmann, 1982). Large numbers of S. 
zooepidemicus have been previously reported in association with lesions in the gut mucosa 
caused by Gasterophilus spp. (Welsh, 1984), which were found in the intestines of a 
number of the ponies.
There was a clear gross and histopathological dose response for ponies challenged with A. 
equuli although there is some evidence from immunoblotting that there was an increased 
serum antibody titre to some IRPs on the day of challenge, which were not detectable 
before. No live bacteria were recovered from the lesions, but immunostaining revealed 
the presence of antigen. There is little direct relationship between events in the upper and 
lower respiratory tracts in either challenge and it is difficult to distinguish pathogens from 
normal flora in the upper respiratory tract.
For future challenge work, the use of SPF animals would be ideal, but given the practical 
constraints upon use of these animals, revision of methods used for non- SPF animals 
could be more appropriate. Non-SPF animals could be housed in containment facilities 
until most disease has died down, allowing a longer settling in period, then tested for 
immunity to challenge organisms. The screening process for naive animals could 
potentially fail if animals are in the early stages of infection and the reactive circulating 
antibody titres are low because antigen binding sites are in excess of the antibody available 
(Mimms et al, 1995). For example the antibody response to two IRPs in extract of A. 
equuli isolate S was not detected on the day of euthanasia although it was seen on the day 
of challenge, An improvement may be to test for serum antibody a number of times over a 
defined time period. Another useful addition to the data would be to put ponies through 
the same manipulations as the challenge ponies, but without the challenge organisms, since 
inoculation of fluid into the lungs of neonatal calves resulted in pulmonary dysfunction
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(Killingsworth et al. 1987). Although the pathology was related to the challenge dose, it 
would be interesting to know the background pathology caused by the fluid. Aerosol 
designs would also be worth examining as a means of dispensing challenge organisms.
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7.7 Conclusions and future work.
It seems as though A. equuli and A. suis are the most significant of the 
Actinobacillus/Pasteurella species, but it would be useful to know which pathogenic 
determinant(s) they posess that the other species may not, perhaps toxins. It would be 
useful also to be able to demonstrate inhibition of transferrin binding by antibody to iron 
restricted A. equuli, thereby demonstrating a potential mode of action for a vaccine: 
Attention must also be given to the adjuvant used in a potential equine vaccine, since P. 
haemolytica bacterins in oil adjuvant given to calves challenged with P. haemolytica had 
a protective effect, whereas the same in aluminium hydroxide did not. This may be a 
potential problem since Freund’s adjuvants cannot be used in the horse. The dose given 
also had an effect on the efficacy in calves, so this would need careful optimisation.
It now seems unlikely that M-hke proteins of S. zooepidemicus would be cross-protective 
in the horse, but the HAP approach looks more promising. First a reliable challenge model 
in the equine requires development. Intercurrent infections are common in the ponies used 
and even with efforts to isolate them, these infections developed rapidly. Also, the 
pathology could not be reliably attributed to the challenge organisms. This study and some 
of the literature suggested that the role of B. bronchiseptica in equine airway disease is 
worthy of full epidemiological investigation for potential inclusion in a vaccine. Equine
B. bronchiseptica isolates produce a number of IRPs (Ward, In Press) so this might be a 
way forward.
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